Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,A1BG,Alpha-1B-glycoprotein,24414,31,4.26 [0.58-31.29],0.1542380499651305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AAMDC,Mth938 domain-containing protein,23705,29,1.21 [0.63-2.34],0.5643223501846414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AARSD1,Alanyl-tRNA editing protein Aarsd1,27925,35,1.56 [0.95-2.55],0.0777636114313403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABCA2,ATP-binding cassette sub-family A member 2,23606,31,1.18 [0.46-3.04],0.7281715031386868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABHD14B,Protein ABHD14B,27760,34,1.15 [0.69-1.94],0.589606941279833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABL1,Tyrosine-protein kinase ABL1,27925,35,0.93 [0.60-1.45],0.7521528760068972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABO,Histo-blood group ABO system transferase,24402,31,0.94 [0.75-1.20],0.6322456238585614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABRAXAS2,BRISC complex subunit Abraxas 2,23606,31,1.09 [0.65-1.80],0.7499821729240649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27370,35,1.35 [0.99-1.83],0.0604526831515669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23936,31,1.05 [0.64-1.70],0.8566883072305642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24383,31,1.03 [0.71-1.50],0.8618443974678096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAN,Aggrecan core protein,27799,34,1.14 [0.39-3.31],0.815505446060715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE,Angiotensin-converting enzyme,24402,31,2.46 [0.71-8.54],0.155226151466061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,27549,34,1.64 [1.04-2.59],0.0336807968229286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACHE,Acetylcholinesterase,23831,30,1.49 [0.57-3.90],0.4189017461813185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOT13,Acyl-coenzyme A thioesterase 13,24290,31,1.02 [0.77-1.37],0.8681423963121176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,28053,34,1.45 [0.86-2.44],0.1608534509700753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23683,29,1.22 [0.61-2.44],0.5748914178214852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP5,Tartrate-resistant acid phosphatase type 5,28155,34,1.60 [0.67-3.84],0.2889553022734602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP6,Lysophosphatidic acid phosphatase type 6,28263,35,0.77 [0.53-1.13],0.1873096812599553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRBP,Acrosin-binding protein,24264,30,1.22 [0.54-2.76],0.6369409679062892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRV1,Acrosomal protein SP-10,23683,29,1.08 [0.72-1.61],0.7058369341318751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23606,31,1.73 [0.92-3.26],0.0909300702658859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",27549,34,1.11 [0.57-2.15],0.7618013025242523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN2,Alpha-actinin-2,23606,31,0.86 [0.47-1.57],0.6150733371818043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN4,Alpha-actinin-4,27532,33,0.97 [0.36-2.63],0.9471725735441072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,27810,34,2.53 [0.81-7.91],0.1109737561967591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY1,Aminoacylase-1,28053,34,1.35 [0.88-2.09],0.1723384405737765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23606,31,1.18 [0.67-2.07],0.5657696143440925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACYP1,Acylphosphatase-1,23743,30,1.27 [0.76-2.12],0.3613627307656497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA,Adenosine deaminase,28389,35,1.31 [0.60-2.86],0.5025679829072549
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA2,Adenosine deaminase 2,27872,35,2.28 [1.24-4.20],0.0080138338219035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23683,29,1.87 [1.22-2.88],0.0041723148508694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27549,34,2.06 [0.81-5.26],0.131715350759485
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27859,34,1.29 [0.56-2.96],0.5537313799223842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28389,35,0.84 [0.38-1.89],0.6770084164910825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28276,34,1.74 [0.66-4.61],0.2669998583083244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24290,31,1.31 [0.45-3.81],0.623833287399868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23683,29,1.45 [0.56-3.74],0.4397494942550124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28400,34,0.32 [0.10-1.01],0.0527581839385188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27925,35,1.27 [0.62-2.63],0.5122908802505041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27549,34,1.34 [0.69-2.58],0.38546649024114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23683,29,1.88 [0.92-3.87],0.0850699036632976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,28116,35,0.56 [0.30-1.03],0.0611039161629431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,24372,31,2.25 [0.97-5.18],0.0574073563763935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL4,ADAMTS-like protein 4,23705,29,2.15 [0.60-7.65],0.2385241134833888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL5,ADAMTS-like protein 5,24383,31,1.54 [0.70-3.37],0.2839114274425712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27370,35,0.59 [0.18-1.92],0.3787218704866286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADD1,Alpha-adducin,23831,30,0.95 [0.57-1.58],0.8473723977317584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRB3,Adhesion G protein-coupled receptor B3,27810,34,1.96 [0.81-4.74],0.1352913426470562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRD1,Adhesion G-protein coupled receptor D1,23831,30,1.10 [0.48-2.52],0.8255898612045462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE1,Adhesion G protein-coupled receptor E1,24290,31,1.99 [1.15-3.45],0.0142237410185727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE2,Adhesion G protein-coupled receptor E2,28177,35,0.97 [0.35-2.74],0.9593660656064696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE5,Adhesion G protein-coupled receptor E5,28247,34,0.89 [0.33-2.42],0.8209488950610526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRF5,Adhesion G protein-coupled receptor F5,24383,31,1.68 [0.51-5.59],0.3939412718765158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG1,Adhesion G-protein coupled receptor G1,27925,35,1.35 [0.95-1.90],0.0916942096196255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG2,Adhesion G-protein coupled receptor G2,28053,34,0.74 [0.30-1.78],0.4962396383342287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRV1,Adhesion G-protein coupled receptor V1,23603,29,0.99 [0.60-1.65],0.971902921590156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH1B,All-trans-retinol dehydrogenase,23831,30,1.07 [0.70-1.65],0.7430124577935289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27549,34,1.23 [0.88-1.74],0.230144025705372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,24414,31,1.31 [0.79-2.18],0.2887410678353134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,28300,35,2.02 [0.67-6.13],0.2139107315274418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADRA2A,Alpha-2A adrenergic receptor,23606,31,1.28 [0.89-1.83],0.1861206413885995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFAP1,Actin filament-associated protein 1,23831,30,0.96 [0.63-1.46],0.8361015976240685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFM,Afamin,24414,31,0.81 [0.15-4.43],0.8114528569561714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFP,Alpha-fetoprotein,27771,34,1.31 [0.84-2.04],0.2335751408412757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGBL2,Cytosolic carboxypeptidase 2,23603,29,0.87 [0.61-1.23],0.4197724700721363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGER,Advanced glycosylation end product-specific receptor,27982,35,0.97 [0.47-1.99],0.9380073694480924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR2,Anterior gradient protein 2 homolog,27162,35,0.96 [0.71-1.29],0.7725630385057257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR3,Anterior gradient protein 3,27334,35,1.04 [0.64-1.71],0.8685604502331883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,28177,35,2.08 [1.05-4.15],0.036893919286978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRP,Agouti-related protein,28389,35,1.37 [0.78-2.42],0.2746246010981034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGT,Angiotensinogen,24402,31,0.81 [0.15-4.24],0.8016352305984474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGXT,Serine--pyruvate aminotransferase,28053,34,1.34 [0.94-1.90],0.1039588841101534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHCY,Adenosylhomocysteinase,28053,34,0.87 [0.55-1.37],0.5500868604079377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK,Neuroblast differentiation-associated protein AHNAK,23705,29,1.18 [0.41-3.38],0.7589546913974236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK2,Protein AHNAK2,23705,29,0.83 [0.24-2.85],0.7686399309714492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24264,30,1.07 [0.65-1.75],0.7934488621606786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSG,Alpha-2-HS-glycoprotein,24402,31,1.95 [0.57-6.65],0.2850996027195968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSP,Alpha-hemoglobin-stabilizing protein,28001,35,1.56 [1.12-2.19],0.0093845304789437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIDA,"Axin interactor, dorsalization-associated protein",23704,29,1.06 [0.71-1.59],0.7691122872875966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1,Allograft inflammatory factor 1,27370,35,1.03 [0.59-1.81],0.908731344423329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1L,Allograft inflammatory factor 1-like,23705,29,1.08 [0.61-1.91],0.7845581702535236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",27874,35,1.00 [0.76-1.33],0.9760401143370694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK1,Adenylate kinase isoenzyme 1,28053,34,1.67 [1.10-2.55],0.0163719957518908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK2,"Adenylate kinase 2, mitochondrial",24309,30,0.90 [0.65-1.25],0.5419295341954142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKAP12,A-kinase anchor protein 12,23831,30,0.99 [0.19-5.34],0.995095228046447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B1,Aldo-keto reductase family 1 member B1,27370,35,1.00 [0.68-1.49],0.9816049443907612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B10,Aldo-keto reductase family 1 member B10,23704,29,1.32 [0.83-2.10],0.2448295362229845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1C4,Aldo-keto reductase family 1 member C4,27549,34,1.01 [0.56-1.81],0.9700837097633898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23683,29,1.12 [0.70-1.79],0.6315610639081155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT1S1,Proline-rich AKT1 substrate 1,27384,35,0.93 [0.60-1.46],0.7582540260105172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT2,RAC-beta serine/threonine-protein kinase,24343,30,0.95 [0.73-1.24],0.7107489816737729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT3,RAC-gamma serine/threonine-protein kinase,27229,35,0.65 [0.38-1.11],0.1142971601650332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALCAM,CD166 antigen,28400,34,2.05 [0.49-8.65],0.3281392083386085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH1A1,Retinal dehydrogenase 1,28041,35,1.65 [1.07-2.56],0.024220447922839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24264,30,1.34 [0.82-2.21],0.2452145959843734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27994,35,1.25 [0.87-1.78],0.2269451549222238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24343,30,1.29 [0.66-2.50],0.4588680418129743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALMS1,Alstrom syndrome protein 1,23936,31,1.82 [1.16-2.85],0.0092991948207061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPI,Intestinal-type alkaline phosphatase,23683,29,1.13 [0.85-1.50],0.4045994432923558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPP,"Alkaline phosphatase, placental type",27925,35,1.15 [0.89-1.49],0.2803539820684946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBN,Ameloblastin,27532,33,0.82 [0.24-2.82],0.7529988187335179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,28263,35,2.37 [0.55-10.32],0.2489954065931504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24372,31,1.98 [0.67-5.81],0.2151774869421302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMFR,E3 ubiquitin-protein ligase AMFR,27384,35,0.81 [0.48-1.35],0.4221988181530266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO1,Amphoterin-induced protein 1,23704,29,0.78 [0.34-1.77],0.5519954304795986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO2,Amphoterin-induced protein 2,27925,35,0.63 [0.17-2.29],0.4810495302423151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMN,Protein amnionless,27532,33,1.74 [1.00-3.01],0.0504065831995725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOT,Angiomotin,23831,30,0.82 [0.34-2.00],0.661171433202467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOTL2,Angiomotin-like protein 2,24183,30,0.87 [0.39-1.91],0.7276290926289422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMPD3,AMP deaminase 3,24309,30,1.18 [0.73-1.91],0.4936197358014793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22873,30,1.02 [0.51-2.03],0.9488113666760162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2A,Pancreatic alpha-amylase,26994,33,0.86 [0.45-1.66],0.6636270034857241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2B,Alpha-amylase 2B,26155,33,0.78 [0.41-1.50],0.4582973530530818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANG,Angiogenin,27956,35,1.57 [0.70-3.55],0.2725886990939909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT1,Angiopoietin-1,27968,35,0.89 [0.63-1.25],0.5068587640607339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,28300,35,2.14 [1.03-4.44],0.0402892582986794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,27633,34,1.72 [0.62-4.82],0.2983133535189347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL2,Angiopoietin-related protein 2,28084,35,1.05 [0.50-2.20],0.8933492829645863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL3,Angiopoietin-related protein 3,28055,35,1.48 [0.63-3.47],0.3642083813857182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,28134,35,1.18 [0.63-2.24],0.6046845913797777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL7,Angiopoietin-related protein 7,28300,35,0.62 [0.28-1.35],0.226474989510609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANK2,Ankyrin-2,23606,31,1.25 [0.85-1.83],0.2600780971185414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23683,29,1.02 [0.66-1.58],0.9329929591662368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRA2,Ankyrin repeat family A protein 2,23522,29,0.51 [0.25-1.06],0.069527438720907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRD54,Ankyrin repeat domain-containing protein 54,27370,35,1.64 [1.17-2.29],0.0040033675724275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23705,29,1.48 [0.78-2.80],0.226605421317649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANPEP,Aminopeptidase N,28085,35,2.27 [0.87-5.90],0.0919296552575244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA1,Annexin A1,23696,30,1.09 [0.53-2.23],0.8080292514104086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA10,Annexin A10,27384,35,0.98 [0.68-1.43],0.9237461523700616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA11,Annexin A11,27982,35,0.97 [0.62-1.51],0.8916502838966407
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,23363,29,1.40 [0.93-2.10],0.111545610126805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA3,Annexin A3,28276,34,1.06 [0.69-1.61],0.8015572825437179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA4,Annexin A4,27910,33,0.95 [0.63-1.45],0.8159478915962004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA5,Annexin A5,27288,35,2.04 [0.90-4.59],0.086131973498173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27532,33,0.93 [0.52-1.65],0.7971893726145409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC3,Membrane primary amine oxidase,28135,35,2.12 [0.83-5.38],0.1147037182018126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP1G2,AP-1 complex subunit gamma-like 2,24264,30,1.02 [0.67-1.56],0.9160902993827028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP2B1,AP-2 complex subunit beta,23704,29,1.02 [0.50-2.08],0.9579959026219794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3B1,AP-3 complex subunit beta-1,24290,31,1.04 [0.68-1.61],0.848241289643928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3S2,AP-3 complex subunit sigma-2,24309,30,0.94 [0.46-1.94],0.8669315356371714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,27925,35,1.37 [0.80-2.35],0.2560255697362193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APCS,Serum amyloid P-component,24211,30,0.82 [0.30-2.25],0.6928785441372687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28223,35,1.57 [1.01-2.43],0.0433553236683417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APLP1,Amyloid-like protein 1,28053,34,0.88 [0.49-1.58],0.676201262392997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA1,Apolipoprotein A-I,24414,31,1.95 [0.83-4.63],0.1274399658118279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA2,Apolipoprotein A-II,24402,31,1.17 [0.59-2.32],0.6543086106465792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA4,Apolipoprotein A-IV,24414,31,1.29 [0.55-3.03],0.5568489052816593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOB,Apolipoprotein B-100,24402,31,3.15 [0.71-14.01],0.1308780625674976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOBR,Apolipoprotein B receptor,23705,29,0.56 [0.26-1.21],0.1425816824918833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOC1,Apolipoprotein C-I,24363,31,1.68 [0.81-3.49],0.1625206602909599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOD,Apolipoprotein D,23280,29,0.99 [0.43-2.26],0.9817890417325182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOE,Apolipoprotein E,24414,31,1.22 [0.87-1.70],0.2536831052049679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOF,Apolipoprotein F,24402,31,1.16 [0.42-3.18],0.7784712748826633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOH,Beta-2-glycoprotein 1,28041,35,0.77 [0.33-1.80],0.5494028799902783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOL1,Apolipoprotein L1,24402,31,0.71 [0.38-1.32],0.2763507197131153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOM,Apolipoprotein M,28101,35,0.83 [0.28-2.40],0.726745362007629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APP,Amyloid-beta precursor protein,27991,35,1.00 [0.64-1.56],0.9895417059992824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APPL2,DCC-interacting protein 13-beta,23831,30,0.86 [0.64-1.17],0.3364473759839117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APRT,Adenine phosphoribosyltransferase,27827,33,1.75 [0.90-3.40],0.1007186480493124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARAF,Serine/threonine-protein kinase A-Raf,23936,31,0.74 [0.42-1.32],0.3076366991348443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,27925,35,1.92 [1.12-3.30],0.0183616438941566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARF6,ADP-ribosylation factor 6,24290,31,1.09 [0.79-1.49],0.6011411698483833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARFIP1,Arfaptin-1,24343,30,1.04 [0.64-1.70],0.8712565248228115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG1,Arginase-1,27907,34,1.45 [0.83-2.54],0.1909907731279747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG2,"Arginase-2, mitochondrial",24264,30,1.08 [0.48-2.42],0.8595458750169601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP1,Rho GTPase-activating protein 1,27370,35,0.89 [0.47-1.67],0.7113114834701382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP25,Rho GTPase-activating protein 25,27370,35,1.17 [0.74-1.86],0.5097770539191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP30,Rho GTPase-activating protein 30,23936,31,0.79 [0.28-2.24],0.6545180594366053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP45,Rho GTPase-activating protein 45,23831,30,0.86 [0.56-1.32],0.487328105016176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP5,Rho GTPase-activating protein 5,23522,29,1.11 [0.70-1.75],0.6694576074334688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF1,Rho guanine nucleotide exchange factor 1,24309,30,1.00 [0.68-1.47],0.9845042848075928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF10,Rho guanine nucleotide exchange factor 10,24343,30,0.96 [0.66-1.39],0.8255793488971472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF12,Rho guanine nucleotide exchange factor 12,28032,35,0.80 [0.60-1.06],0.1159247637632943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF5,Rho guanine nucleotide exchange factor 5,23603,29,0.87 [0.51-1.46],0.5855127179989131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID3A,AT-rich interactive domain-containing protein 3A,23603,29,0.39 [0.14-1.10],0.0743990441479002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID4B,AT-rich interactive domain-containing protein 4B,27384,35,1.01 [0.49-2.07],0.9758151267295736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL13B,ADP-ribosylation factor-like protein 13B,23606,31,0.96 [0.58-1.58],0.8702441875990992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23606,31,0.96 [0.41-2.24],0.9243379602753432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARMCX2,Armadillo repeat-containing X-linked protein 2,23603,29,1.47 [1.05-2.05],0.0259876780419659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNT,Aryl hydrocarbon receptor nuclear translocator,27532,33,1.06 [0.48-2.37],0.8808890985036245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23606,31,1.47 [0.93-2.33],0.0982188469557522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSA,Arylsulfatase A,28041,35,0.72 [0.38-1.39],0.3334196850913649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSB,Arylsulfatase B,27925,35,0.80 [0.46-1.37],0.4098259765078789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART3,Ecto-ADP-ribosyltransferase 3,28135,35,0.67 [0.28-1.59],0.360730759836419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART5,Ecto-ADP-ribosyltransferase 5,23603,29,1.49 [1.06-2.09],0.0203306537121872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARTN,Artemin,27532,33,1.37 [0.89-2.09],0.1487759838258932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH1,Acid ceramidase,24171,31,0.79 [0.37-1.69],0.5377957280900264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH2,Neutral ceramidase,27859,34,0.78 [0.48-1.28],0.3308656223401967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR1,Asialoglycoprotein receptor 1,27859,34,2.41 [1.03-5.66],0.0430435335374135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR2,Asialoglycoprotein receptor 2,24402,31,2.64 [0.79-8.82],0.1147533266306877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPN,Asporin,24383,31,0.63 [0.17-2.36],0.4905613864927054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPSCR1,Tether containing UBX domain for GLUT4,24343,30,0.89 [0.53-1.48],0.6472779594919444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23705,29,0.91 [0.64-1.30],0.6102416476578615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASS1,Argininosuccinate synthase,23606,31,1.08 [0.71-1.65],0.7140212486414086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27384,35,0.85 [0.49-1.46],0.551063191798389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF4,Cyclic AMP-dependent transcription factor ATF-4,23522,29,1.59 [0.70-3.63],0.2661519643115074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG16L1,Autophagy-related protein 16-1,24290,31,0.96 [0.65-1.41],0.8378233416989259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG4A,Cysteine protease ATG4A,27370,35,1.46 [0.95-2.26],0.0852495778505817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATOX1,Copper transport protein ATOX1,28116,35,0.96 [0.64-1.45],0.8571234108289815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23606,31,0.72 [0.29-1.77],0.4744023476521202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23606,31,0.39 [0.11-1.35],0.1377504176361161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23606,31,0.80 [0.30-2.13],0.6570789274243427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B4,Protein ATP1B4,23522,29,1.13 [0.50-2.55],0.7664731051551837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23606,31,1.04 [0.61-1.78],0.8819165316485886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23606,31,1.20 [0.69-2.10],0.510537162773639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5IF1,"ATPase inhibitor, mitochondrial",28177,35,0.84 [0.64-1.09],0.1859140760753818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5PO,"ATP synthase subunit O, mitochondrial",27384,35,0.52 [0.24-1.12],0.0961185122988307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6AP2,Renin receptor,27370,35,1.09 [0.54-2.18],0.8131208345267907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1D,V-type proton ATPase subunit D,27925,35,1.56 [0.63-3.87],0.336627308868308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1F,V-type proton ATPase subunit F,27334,35,0.94 [0.60-1.47],0.7806823739374622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G1,V-type proton ATPase subunit G 1,23705,29,1.21 [0.76-1.93],0.433169218326113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G2,V-type proton ATPase subunit G 2,23606,31,1.28 [0.99-1.66],0.0580143858361823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRAID,All-trans retinoic acid-induced differentiation factor,24290,31,1.30 [0.60-2.83],0.5107041037579183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRN,"Attractin, Isoform 2",24414,31,0.56 [0.07-4.30],0.5765006412258997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN10,Ataxin-10,27384,35,0.79 [0.53-1.17],0.2304961012402621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2,Ataxin-2,23603,29,1.23 [0.95-1.59],0.1172107087972441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2L,Ataxin-2-like protein,24343,30,0.90 [0.42-1.92],0.7913199606416327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN3,Ataxin-3,24309,30,1.31 [0.76-2.24],0.3320096846629026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXIN1,Axin-1,28032,35,0.85 [0.63-1.16],0.3099575568474371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXL,Tyrosine-protein kinase receptor UFO,28135,35,1.78 [0.63-5.07],0.2782571267551366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZI2,5-azacytidine-induced protein 2,24343,30,0.91 [0.48-1.71],0.7602202660579337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZU1,Azurocidin,27206,33,1.30 [0.95-1.79],0.1049112954933714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,24414,31,1.50 [0.99-2.26],0.0548374060703639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23606,31,0.36 [0.06-2.17],0.2625600747848742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23705,29,2.08 [0.79-5.48],0.1373966456505279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",28177,35,2.12 [0.80-5.61],0.1305144660169304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GAT1,"Beta-1,4-glucuronyltransferase 1",28041,35,1.18 [0.35-4.00],0.7859758347902844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BABAM1,BRISC and BRCA1-A complex member 1,23683,29,1.06 [0.35-3.17],0.92240364079389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BACH1,Transcription regulator protein BACH1,28032,35,0.97 [0.64-1.45],0.8658309618507449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG3,BAG family molecular chaperone regulator 3,27810,34,0.84 [0.40-1.74],0.6370103475625444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG4,BAG family molecular chaperone regulator 4,23683,29,1.14 [0.58-2.24],0.6958004901710442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG6,Large proline-rich protein BAG6,27549,34,0.81 [0.35-1.88],0.6316607767094959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27370,35,1.42 [0.95-2.12],0.0904100477542467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAMBI,BMP and activin membrane-bound inhibitor homolog,27370,35,1.52 [0.63-3.71],0.35174255299586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BANK1,B-cell scaffold protein with ankyrin repeats,28032,35,0.80 [0.61-1.05],0.1038862616774572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAP18,Chromatin complexes subunit BAP18,24309,30,1.12 [0.71-1.77],0.6129185009701767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BATF,Basic leucine zipper transcriptional factor ATF-like,23704,29,1.14 [0.80-1.63],0.4719425661700623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAX,Apoptosis regulator BAX,27333,35,1.03 [0.75-1.43],0.8387729688709336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAM,Basal cell adhesion molecule,28041,35,1.56 [0.48-5.10],0.4640492680293937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,27859,34,0.47 [0.20-1.12],0.088225066222917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24383,31,1.31 [0.48-3.59],0.6014726385753543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23603,29,0.96 [0.48-1.92],0.9005249917483469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,23945,29,0.83 [0.24-2.86],0.7657257429828426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2,Apoptosis regulator Bcl-2,24290,31,0.97 [0.49-1.90],0.9288704681951708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L1,Bcl-2-like protein 1,24309,30,0.98 [0.70-1.39],0.9208512179393716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",28032,35,0.67 [0.36-1.25],0.2088065449182211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L15,Bcl-2-like protein 15,23683,29,1.36 [0.85-2.17],0.1937582622447598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7A,B-cell CLL/lymphoma 7 protein family member A,23522,29,0.80 [0.42-1.52],0.4951516393266191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24264,30,1.43 [0.78-2.62],0.2418343060721796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCR,Breakpoint cluster region protein,28032,35,0.79 [0.57-1.09],0.1523522485459228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BDNF,Brain-derived neurotrophic factor,24372,31,1.02 [0.68-1.54],0.9133424002695724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BECN1,Beclin-1,23705,29,1.11 [0.62-1.97],0.7260676284647716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BEX3,Protein BEX3,23522,29,1.00 [0.46-2.17],0.9937294039447104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGLAP,Osteocalcin,24372,31,1.47 [1.01-2.14],0.0460296551259862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGN,Biglycan,27331,35,0.94 [0.73-1.21],0.6413619458670787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHLHE40,Class E basic helix-loop-helix protein 40,23603,29,1.14 [0.72-1.79],0.5837368497147627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23606,31,1.38 [0.35-5.45],0.6443715711099083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BID,BH3-interacting domain death agonist,28032,35,1.15 [0.75-1.74],0.523081051432547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIN2,Bridging integrator 2,28041,35,0.77 [0.55-1.08],0.1250158654681062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIRC2,Baculoviral IAP repeat-containing protein 2,27370,35,0.92 [0.57-1.48],0.7209081958219438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLMH,Bleomycin hydrolase,28400,34,0.71 [0.28-1.76],0.455350307715874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLNK,B-cell linker protein,23683,29,1.04 [0.44-2.46],0.925145391566073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23603,29,0.91 [0.54-1.55],0.7303161416452855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24309,30,0.84 [0.35-2.00],0.697014840396109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLVRB,Flavin reductase,28041,35,1.51 [1.02-2.23],0.0400190119684408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP10,Bone morphogenetic protein 10,23831,30,2.31 [0.65-8.20],0.1963046739729894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP4,Bone morphogenetic protein 4,27810,34,0.68 [0.34-1.37],0.2813387081507013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP6,Bone morphogenetic protein 6,27499,34,0.89 [0.43-1.86],0.7566615559451592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMPER,BMP-binding endothelial regulator protein,23831,30,2.80 [1.10-7.15],0.0308529166633893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24383,31,1.45 [0.61-3.45],0.4008168406604881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23683,29,1.33 [0.65-2.71],0.4332594946178429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOC,Brother of CDO,27549,34,0.88 [0.24-3.24],0.8520246614087176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA1,BolA-like protein 1,23603,29,1.17 [0.64-2.13],0.6036259415495476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA2_BOLA2B,BolA-like protein 2,23705,29,1.89 [0.99-3.62],0.055028289273585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFA2,BPI fold-containing family A member 2,22854,28,0.83 [0.59-1.16],0.2667385578805816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB1,BPI fold-containing family B member 1,28003,34,1.06 [0.67-1.69],0.8052559057780249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB2,BPI fold-containing family B member 2,24343,31,1.01 [0.59-1.72],0.9766404383897036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRAP,BRCA1-associated protein,24061,31,0.96 [0.71-1.29],0.7711185426532561
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD1,Bromodomain-containing protein 1,23936,31,1.02 [0.33-3.13],0.9674843959500902
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD2,Bromodomain-containing protein 2,23603,29,0.67 [0.20-2.23],0.5106313428041875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD3,Bromodomain-containing protein 3,23606,31,0.95 [0.45-1.98],0.8901346169175187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRDT,Bromodomain testis-specific protein,23606,31,0.78 [0.30-2.01],0.6045473809243416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRK1,Protein BRICK1,27384,35,0.92 [0.48-1.78],0.8104528107604274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRME1,Break repair meiotic recombinase recruitment factor 1,23603,29,0.67 [0.24-1.91],0.4558356913222769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRSK2,Serine/threonine-protein kinase BRSK2,24343,30,1.28 [0.55-2.98],0.5627350438328647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSG,Basigin,28339,35,0.67 [0.18-2.49],0.5484449663875133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSND,Barttin,23522,29,1.84 [1.12-3.01],0.0162245963230893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28318,34,1.22 [0.57-2.62],0.6033626667592422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST2,Bone marrow stromal antigen 2,28318,34,1.68 [1.17-2.41],0.0049695344395271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTC,Probetacellulin,27370,35,1.16 [0.79-1.70],0.4370640830328814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTD,Biotinidase,24414,31,0.88 [0.17-4.49],0.8774483612127223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTLA,B- and T-lymphocyte attenuator,23522,29,0.86 [0.52-1.43],0.5645200966168759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN1A1,Butyrophilin subfamily 1 member A1,24220,30,1.16 [0.54-2.52],0.7009374060422346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN2A1,Butyrophilin subfamily 2 member A1,28177,35,1.67 [0.57-4.90],0.3542117244161563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN3A2,Butyrophilin subfamily 3 member A2,28032,35,1.26 [0.57-2.77],0.5702744782352951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTNL10,Butyrophilin-like protein 10,23522,29,2.10 [1.34-3.27],0.0010792268988741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C19orf12,Protein C19orf12,27384,35,1.23 [0.85-1.78],0.2612159161388747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1GALT1C1,C1GALT1-specific chaperone 1,23606,31,1.13 [0.39-3.29],0.8157057603094401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,28243,35,2.99 [0.92-9.77],0.0696369699902767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24343,30,1.08 [0.67-1.75],0.7498365357923148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QL2,Complement C1q-like protein 2,23683,29,0.84 [0.36-1.96],0.6930081510987267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28135,35,1.43 [0.75-2.73],0.2738485343032101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23831,30,1.31 [0.50-3.44],0.5779540280063333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24343,30,1.26 [0.45-3.48],0.660338116733473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23788,30,0.57 [0.32-1.03],0.0638289775114399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1R,Complement C1r subcomponent,24414,31,2.59 [1.24-5.44],0.0117834488666038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1RL,Complement C1r subcomponent-like protein,24376,31,2.01 [0.35-11.51],0.4313638760018368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1S,Complement C1s subcomponent,24414,31,6.39 [2.38-17.16],0.0002333052796849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2,Complement C2,28101,35,3.16 [0.72-13.82],0.1270925802801637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2CD2L,Phospholipid transfer protein C2CD2L,27334,35,1.36 [0.77-2.43],0.2897420174539448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2orf69,UPF0565 protein C2orf69,23704,29,0.78 [0.38-1.64],0.5174693419584299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C3,Complement C3,23181,27,0.98 [0.42-2.32],0.9655225186653548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C4BPB,C4b-binding protein beta chain,28116,35,0.82 [0.39-1.71],0.5924883456728403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C5,Complement C5,24414,31,1.28 [0.16-10.56],0.8173620256901113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,23843,30,3.32 [1.30-8.47],0.0122709145190334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7orf50,Uncharacterized protein C7orf50,24309,30,1.39 [0.45-4.29],0.5703023212423206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C8B,Complement component C8 beta chain,24414,31,1.62 [0.54-4.89],0.3882491079483098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9,Complement component C9,24402,31,0.94 [0.52-1.70],0.8340078016508606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9orf40,Uncharacterized protein C9orf40,24290,31,1.47 [0.99-2.19],0.0564307926191594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA1,Carbonic anhydrase 1,27409,35,1.49 [0.92-2.43],0.1085838760441552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA11,Carbonic anhydrase-related protein 11,27370,35,1.31 [0.61-2.79],0.4894366869920084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,27925,35,0.98 [0.39-2.43],0.9579701893727168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA13,Carbonic anhydrase 13,27723,34,0.87 [0.66-1.14],0.303467711346466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA14,Carbonic anhydrase 14,28300,35,0.40 [0.18-0.91],0.0288625634748394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA2,Carbonic anhydrase 2,27964,35,1.62 [1.09-2.39],0.016342771480859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA3,Carbonic anhydrase 3,28353,34,1.14 [0.71-1.82],0.5893875026584959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA4,Carbonic anhydrase 4,28400,34,0.98 [0.28-3.43],0.9788186066410912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA5A,"Carbonic anhydrase 5A, mitochondrial",27549,34,1.39 [1.06-1.84],0.0183075976823306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA6,Carbonic anhydrase 6,27949,35,0.71 [0.45-1.11],0.1363429355655447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA7,Carbonic anhydrase 7,23936,31,1.11 [0.44-2.84],0.8218414460019716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA8,Carbonic anhydrase-related protein,23683,29,1.25 [0.39-4.00],0.7096780652302485
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA9,Carbonic anhydrase 9,28300,35,1.06 [0.57-1.99],0.8515612194833411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CABP2,Calcium-binding protein 2,23704,29,0.82 [0.45-1.51],0.5244804657988845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23603,29,0.71 [0.21-2.44],0.5857843157444196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23606,31,0.70 [0.31-1.60],0.3996892513781528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23603,29,0.89 [0.48-1.68],0.7281936058486748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24343,30,0.95 [0.64-1.43],0.8182266348228511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACYBP,Calcyclin-binding protein,23780,30,0.92 [0.66-1.28],0.6123340403423894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CADPS,Calcium-dependent secretion activator 1,23704,29,0.44 [0.14-1.43],0.1722611088623224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB1,Calbindin,27925,35,0.74 [0.38-1.41],0.3524502212936573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB2,Calretinin,27384,35,1.54 [0.69-3.42],0.2933972409472477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCA,Calcitonin,27809,34,1.05 [0.66-1.67],0.8377171417171829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCB,Calcitonin gene-related peptide 2,24309,30,0.74 [0.27-1.99],0.5468768185577855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28219,35,0.77 [0.58-1.04],0.084083415736796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23705,29,0.93 [0.58-1.49],0.7598557378522067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALY,Neuron-specific vesicular protein calcyon,23606,31,1.07 [0.45-2.56],0.878319204723758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27370,35,1.06 [0.56-2.02],0.8583550084943363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23704,29,0.60 [0.27-1.32],0.2038085721065279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24343,30,0.88 [0.63-1.23],0.4535896050199233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CANT1,Soluble calcium-activated nucleotidase 1,27982,34,0.58 [0.13-2.59],0.4782500322253563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,27873,34,1.69 [1.11-2.58],0.0152250452476397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPN3,Calpain-3,24264,30,1.71 [1.18-2.49],0.0050874436044953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPS,Calcyphosin,24309,30,0.76 [0.41-1.41],0.3839671831510536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CARHSP1,Calcium-regulated heat-stable protein 1,27384,35,1.79 [1.09-2.96],0.0223695293283536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASC3,Protein CASC3,23704,29,0.76 [0.31-1.83],0.5358696621635471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP1,Caspase-1,27384,35,1.09 [0.71-1.65],0.6989335845200477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP10,Caspase-10,27384,35,1.02 [0.67-1.55],0.9293758044917754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP2,Caspase-2,28032,35,0.90 [0.58-1.40],0.6478423476856197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP3,Caspase-3,28400,34,0.83 [0.59-1.15],0.2606131427566755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP4,Caspase-4,23936,31,0.97 [0.78-1.20],0.7908154649966901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP7,Caspase-7,24309,30,1.03 [0.68-1.54],0.9051459229681884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP8,Caspase-8,28226,35,1.18 [0.76-1.85],0.4612688647579125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP9,Caspase-9,23683,29,1.13 [0.66-1.93],0.6595023025870788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASQ2,Calsequestrin-2,23606,31,0.57 [0.21-1.53],0.2617504461215756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAT,Catalase,24032,30,1.49 [0.83-2.68],0.180943045258416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLIF,Cobalamin binding intrinsic factor,28021,34,1.14 [0.74-1.75],0.542426723190045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN1,Cerebellin-1,23603,29,0.92 [0.60-1.41],0.6990195484642108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN4,Cerebellin-4,28300,35,0.93 [0.36-2.37],0.8785647272581044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBS,Cystathionine beta-synthase,23705,29,1.42 [0.80-2.52],0.228513078558267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBX2,Chromobox protein homolog 2,23606,31,0.65 [0.21-2.06],0.4690637746377094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27859,34,1.08 [0.73-1.61],0.6988992210146123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCAR2,Cell cycle and apoptosis regulator protein 2,24309,30,1.13 [0.68-1.89],0.6342685752876998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC134,Coiled-coil domain-containing protein 134,24264,30,0.98 [0.50-1.94],0.958975275535671
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC28A,Coiled-coil domain-containing protein 28A,23704,29,1.32 [0.40-4.42],0.6505178482716882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC50,Coiled-coil domain-containing protein 50,24343,30,1.38 [1.03-1.85],0.0316652114282033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,28053,34,2.51 [1.15-5.50],0.021323754389184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23705,29,1.20 [0.71-2.03],0.5038915465381382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL11,Eotaxin,28389,35,1.83 [0.86-3.89],0.1178724175313493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL13,C-C motif chemokine 13,28340,34,0.77 [0.49-1.19],0.2365136962807132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL14,C-C motif chemokine 14,27956,35,0.69 [0.32-1.49],0.3452420494722454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL15,C-C motif chemokine 15,28400,34,1.36 [0.73-2.54],0.3252214514461907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL16,C-C motif chemokine 16,28400,34,1.08 [0.63-1.86],0.7719368408616748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL17,C-C motif chemokine 17,27984,35,0.94 [0.68-1.30],0.706125197669444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL18,C-C motif chemokine 18,27658,35,1.33 [0.98-1.79],0.0670013733788489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL19,C-C motif chemokine 19,28318,34,1.17 [0.96-1.42],0.1283320797549957
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL2,C-C motif chemokine 2,27810,34,0.71 [0.40-1.28],0.2593676098783848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL20,C-C motif chemokine 20,28389,35,1.13 [0.82-1.55],0.4488523389570156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,28177,35,1.74 [1.11-2.74],0.0167038304535213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL22,C-C motif chemokine 22,27737,35,1.22 [0.70-2.12],0.487857021868478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,28177,35,1.50 [0.78-2.89],0.2288623409443215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL24,C-C motif chemokine 24,28134,35,1.13 [0.79-1.61],0.5083654558414525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,28389,35,2.09 [1.19-3.68],0.0106501902249674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL26,C-C motif chemokine 26,28032,35,0.93 [0.66-1.31],0.6670474153228552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL27,C-C motif chemokine 27,28053,34,0.99 [0.62-1.59],0.9728494229365728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL28,C-C motif chemokine 28,27948,35,1.03 [0.63-1.67],0.919359199181685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL3,C-C motif chemokine 3,28032,35,1.03 [0.73-1.45],0.8732408903265658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL4,C-C motif chemokine 4,28079,35,1.36 [0.98-1.89],0.0622379159410683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL5,C-C motif chemokine 5,28135,35,0.92 [0.69-1.23],0.5857349512212644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL7,C-C motif chemokine 7,28032,35,1.22 [0.78-1.91],0.3724619684346932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL8,C-C motif chemokine 8,28263,35,1.58 [0.98-2.54],0.062546420922865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN1,CCN family member 1,27885,35,1.20 [0.80-1.80],0.3764516295253799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN2,CCN family member 2,28059,35,0.70 [0.42-1.16],0.1643190636313183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,28354,34,1.00 [0.40-2.46],0.9926838810634164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN4,CCN family member 4,28300,35,0.95 [0.46-1.96],0.8862659582224476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,28041,35,1.24 [0.58-2.64],0.5781431055737632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCND2,G1/S-specific cyclin-D2,23936,31,1.22 [0.47-3.12],0.6838239210052139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCNE1,G1/S-specific cyclin-E1,23683,29,1.21 [0.92-1.59],0.1651965552236797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCS,Copper chaperone for superoxide dismutase,27859,34,1.43 [0.78-2.61],0.2452871298037666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCT5,T-complex protein 1 subunit epsilon,27370,35,0.81 [0.39-1.65],0.5571199898953101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD101,Immunoglobulin superfamily member 2,24290,31,0.76 [0.36-1.63],0.4871092712043212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD109,CD109 antigen,28041,35,1.09 [0.46-2.61],0.8400206451063967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD14,Monocyte differentiation antigen CD14,27435,35,2.76 [1.53-4.97],0.0007118245691868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD160,CD160 antigen,28389,35,1.11 [0.59-2.08],0.7518310698614717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD163,Scavenger receptor cysteine-rich type 1 protein M130,28135,35,2.02 [1.10-3.70],0.0229312231545399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164,Sialomucin core protein 24,28041,35,0.75 [0.21-2.62],0.6463650099600258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164L2,CD164 sialomucin-like 2 protein,23704,29,1.03 [0.38-2.75],0.9607295339736234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD177,CD177 antigen,27994,35,1.17 [0.90-1.54],0.2414390898761877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD1C,T-cell surface glycoprotein CD1c,28116,35,1.24 [0.36-4.25],0.7322218522531263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2,T-cell surface antigen CD2,23606,31,0.86 [0.32-2.33],0.76947628851804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200,OX-2 membrane glycoprotein,28032,35,1.69 [0.60-4.74],0.3185391352845087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200R1,Cell surface glycoprotein CD200 receptor 1,27931,34,1.91 [0.86-4.23],0.1117762700858078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD207,C-type lectin domain family 4 member K,27454,33,1.16 [0.52-2.56],0.7174583750598913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD209,CD209 antigen,28111,34,1.26 [0.60-2.64],0.5482659357103026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD22,B-cell receptor CD22,28389,35,1.46 [0.72-2.93],0.2930356069962951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD226,CD226 antigen,23683,29,0.98 [0.43-2.26],0.9683766930822568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD244,Natural killer cell receptor 2B4,28389,35,0.47 [0.16-1.41],0.1794831318993956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD248,Endosialin,24372,31,1.12 [0.49-2.57],0.792881007605069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,28116,35,1.12 [0.54-2.29],0.7651210342975019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,27859,34,1.77 [0.80-3.93],0.1609914489018778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,28032,35,2.57 [1.11-5.94],0.0268436863678036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD28,T-cell-specific surface glycoprotein CD28,27370,35,1.67 [0.79-3.50],0.1765394495661058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2AP,CD2-associated protein,28053,34,1.13 [0.71-1.81],0.5963709369158829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300A,CMRF35-like molecule 8,23831,30,3.31 [1.21-9.00],0.019263331440271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300C,CMRF35-like molecule 6,28318,34,1.95 [0.94-4.05],0.072374565747237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300E,CMRF35-like molecule 2,28210,35,2.17 [1.13-4.15],0.0193783581566309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LF,CMRF35-like molecule 1,28300,35,2.00 [1.21-3.31],0.0071946437606413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LG,CMRF35-like molecule 9,28041,35,0.85 [0.37-1.91],0.6879789011314293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,27925,35,1.11 [0.42-2.94],0.826621272340112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD33,Myeloid cell surface antigen CD33,28116,35,0.86 [0.60-1.25],0.4395034614621546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD34,Hematopoietic progenitor cell antigen CD34,28220,34,0.78 [0.45-1.35],0.375479606284168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD36,Platelet glycoprotein 4,23683,29,0.69 [0.32-1.51],0.3547720530093843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27925,35,0.86 [0.33-2.25],0.753471046084812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3D,T-cell surface glycoprotein CD3 delta chain,23603,29,0.43 [0.11-1.62],0.2119246401738764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23936,31,1.46 [0.85-2.52],0.1715508778662518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3G,T-cell surface glycoprotein CD3 gamma chain,23683,29,0.95 [0.62-1.45],0.8074772131428212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD4,T-cell surface glycoprotein CD4,27986,35,1.94 [1.16-3.27],0.0121144777144043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40,Tumor necrosis factor receptor superfamily member 5,28036,35,0.81 [0.44-1.48],0.4872540700183686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40LG,CD40 ligand,28389,35,0.86 [0.59-1.24],0.419565075261555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD46,Membrane cofactor protein,27862,35,0.88 [0.30-2.54],0.8115176849542145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD48,CD48 antigen,28134,35,2.49 [0.98-6.34],0.0552029228865864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5,T-cell surface glycoprotein CD5,28263,35,0.61 [0.25-1.51],0.2887171709197128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD55,Complement decay-accelerating factor,27048,35,1.44 [0.49-4.24],0.5044216470572083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD58,Lymphocyte function-associated antigen 3,27977,35,0.98 [0.18-5.16],0.9764041833898216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD59,CD59 glycoprotein,27006,31,1.80 [0.49-6.62],0.3772126804224062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5L,CD5 antigen-like,24284,30,3.01 [1.73-5.22],8.80946631162579e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD6,T-cell differentiation antigen CD6,28339,35,0.90 [0.52-1.57],0.7038979117469218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD63,CD63 antigen,27810,34,0.75 [0.42-1.36],0.3469476456004834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD69,Early activation antigen CD69,27899,34,0.80 [0.57-1.11],0.1845094012819352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,23647,29,2.75 [1.67-4.53],7.279821822221538e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD70,CD70 antigen,28032,35,1.26 [0.64-2.52],0.5036953432452497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD72,B-cell differentiation antigen CD72,23831,30,1.90 [0.90-4.00],0.0906632849344062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,28318,34,1.94 [0.87-4.31],0.1033654332369711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,28389,35,1.75 [0.96-3.19],0.0664676197541383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD80,T-lymphocyte activation antigen CD80,24383,31,2.75 [1.30-5.79],0.0078107929111808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD82,CD82 antigen,23936,31,0.98 [0.43-2.23],0.9529583734058128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD83,CD83 antigen,28032,35,2.29 [1.07-4.86],0.0317387286775555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD84,SLAM family member 5,28032,35,0.84 [0.33-2.10],0.7053947931665601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD86,T-lymphocyte activation antigen CD86,24290,31,2.40 [0.84-6.91],0.1035030768280453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD8A,T-cell surface glycoprotein CD8 alpha chain,28318,34,0.57 [0.30-1.05],0.0718784649802214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD93,Complement component C1q receptor,26959,35,1.04 [0.39-2.77],0.9343834241608686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99,CD99 antigen,28041,35,1.44 [0.31-6.63],0.6428869049346184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99L2,CD99 antigen-like protein 2,28041,35,2.01 [0.61-6.66],0.2518544165995411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDA,Cytidine deaminase,24345,31,0.63 [0.30-1.36],0.2402578952692872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDAN1,Codanin-1,24309,30,0.34 [0.06-1.85],0.2119239227278996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC123,Cell division cycle protein 123 homolog,23522,29,0.62 [0.30-1.28],0.1934140771946293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC25A,M-phase inducer phosphatase 1,23522,29,1.18 [0.54-2.61],0.6770119533628408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC26,Anaphase-promoting complex subunit CDC26,24250,31,1.03 [0.64-1.66],0.910885632564854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC27,Cell division cycle protein 27 homolog,27370,35,1.03 [0.63-1.69],0.8997850241134552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC37,Hsp90 co-chaperone Cdc37,28116,35,0.89 [0.62-1.26],0.5054111530312422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24290,31,0.90 [0.65-1.26],0.5560591407110973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDCP1,CUB domain-containing protein 1,27859,34,1.44 [0.87-2.38],0.1513586831419693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH1,Cadherin-1,27093,35,1.37 [0.75-2.48],0.3041285178316368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH15,Cadherin-15,28268,34,0.59 [0.32-1.07],0.0815775071081706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH17,Cadherin-17,28053,34,1.21 [0.80-1.83],0.3706755014882572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH2,Cadherin-2,28053,34,1.73 [0.77-3.88],0.1859080211562779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH22,Cadherin-22,23936,31,0.91 [0.26-3.21],0.8879967223162524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH23,Cadherin-23,24309,30,0.64 [0.16-2.58],0.5270878566505336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH3,Cadherin-3,28318,34,0.59 [0.24-1.42],0.2380825525575504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH4,Cadherin-4,23603,29,0.66 [0.27-1.62],0.3672599416198548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH5,Cadherin-5,28400,34,0.51 [0.18-1.43],0.1992204346261931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH6,Cadherin-6,28053,34,1.13 [0.53-2.45],0.7472573024309459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR1,Cadherin-related family member 1,27384,35,0.81 [0.38-1.72],0.5839275117824807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR2,Cadherin-related family member 2,27925,35,1.44 [0.95-2.18],0.0842323848534376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR5,Cadherin-related family member 5,28053,34,1.04 [0.48-2.25],0.9136498091254208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK1,Cyclin-dependent kinase 1,23522,29,1.08 [0.40-2.92],0.8718571322156636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24343,30,1.11 [0.65-1.87],0.7090763938122171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKL5,Cyclin-dependent kinase-like 5,23603,29,1.14 [0.60-2.16],0.6862371122799149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN1A,Cyclin-dependent kinase inhibitor 1,27925,35,0.90 [0.68-1.18],0.451682327032383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,27925,35,0.90 [0.66-1.21],0.4839889518182013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDNF,Cerebral dopamine neurotrophic factor,27925,35,0.36 [0.14-0.94],0.0371679251625893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,28082,35,0.98 [0.33-2.96],0.9733919281936676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDSN,Corneodesmosin,28298,35,0.97 [0.49-1.92],0.9222071805706789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,28075,35,4.50 [1.39-14.59],0.0121850315476434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24290,31,0.61 [0.42-0.90],0.0120429957008537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23936,31,0.70 [0.35-1.38],0.3020830935263472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24290,31,0.49 [0.25-0.96],0.0387939590989069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23936,31,1.06 [0.49-2.28],0.8867204260298948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,28032,35,1.48 [1.07-2.04],0.0172611707458889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27370,35,0.82 [0.42-1.60],0.5548744890375361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26995,35,1.46 [0.94-2.28],0.0942178612342737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24372,31,1.89 [1.25-2.84],0.0023370246969873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27549,34,2.11 [1.33-3.33],0.0013890532071635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPA,CCAAT/enhancer-binding protein alpha,23683,29,1.70 [1.06-2.73],0.0281171746530995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPB,CCAAT/enhancer-binding protein beta,27549,34,1.74 [0.95-3.20],0.074042641731857
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA2A,Chymotrypsin-like elastase family member 2A,24372,31,0.61 [0.37-1.01],0.0533889609569106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA3A,Chymotrypsin-like elastase family member 3A,28350,33,1.10 [0.66-1.84],0.7039488089776842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23831,30,0.67 [0.19-2.33],0.5241118450242843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEMIP2,Cell surface hyaluronidase,23683,29,1.65 [0.81-3.39],0.1686294472382281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEND1,Cell cycle exit and neuronal differentiation protein 1,23603,29,0.68 [0.30-1.52],0.3465449345967748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPF,Centromere protein F,23936,31,1.34 [0.77-2.34],0.300569159208806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPJ,Centromere protein J,23936,31,1.04 [0.65-1.67],0.8601891303291822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP112,Centrosomal protein of 112 kDa,23606,31,1.00 [0.46-2.17],0.9971221195547982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP152,Centrosomal protein of 152 kDa,23522,29,1.20 [0.58-2.50],0.6263442678576981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP164,Centrosomal protein of 164 kDa,27532,33,1.12 [0.74-1.71],0.5901534836085018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP170,Centrosomal protein of 170 kDa,23705,29,0.76 [0.46-1.26],0.2793635338700986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP20,Centrosomal protein 20,27370,35,0.83 [0.55-1.25],0.3704014495281028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP290,Centrosomal protein of 290 kDa,23936,31,1.11 [0.61-2.02],0.7255938114758151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP350,Centrosome-associated protein 350,23522,29,1.54 [0.65-3.63],0.323758278589602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP43,Centrosomal protein 43,27329,33,1.19 [0.77-1.82],0.4300956690337617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP85,Centrosomal protein of 85 kDa,27370,35,1.03 [0.65-1.64],0.8973144105194422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CERT,Ceramide transfer protein,27384,35,1.04 [0.64-1.68],0.8844754296361077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES1,Liver carboxylesterase 1,28100,33,1.03 [0.73-1.46],0.848098884436354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES2,Cocaine esterase,27925,35,1.13 [0.67-1.90],0.638094536988083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES3,Carboxylesterase 3,27925,35,1.05 [0.69-1.59],0.8367098277362934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN2,Centrin-2,27384,35,0.82 [0.51-1.30],0.3927230081460489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN3,Centrin-3,24290,31,0.99 [0.65-1.51],0.9706124239172216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFB,Complement factor B,23964,30,1.90 [0.66-5.48],0.2323018996504804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFC1,Cryptic protein,27370,35,1.59 [1.00-2.53],0.049525238629754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFD,Complement factor D,24414,31,2.19 [0.94-5.12],0.0707461189556673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFH,Complement factor H,23002,27,2.78 [0.62-12.43],0.1797969720825792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR2,Complement factor H-related protein 2,24239,30,1.38 [0.70-2.73],0.3526941496006517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR4,Complement factor H-related protein 4,24366,31,1.00 [0.62-1.61],0.993011445468225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR5,Complement factor H-related protein 5,24091,30,1.36 [0.58-3.16],0.4809648783445327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFI,Complement factor I,24414,31,1.59 [0.30-8.48],0.5857111503484886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFP,Properdin,24414,31,0.62 [0.12-3.06],0.555069052755694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGA,Glycoprotein hormones alpha chain,28041,35,1.16 [0.78-1.75],0.461210143801986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24402,31,0.87 [0.36-2.10],0.7581228567898318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGN,Cingulin,23704,29,1.20 [0.54-2.67],0.6569165017467777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGREF1,Cell growth regulator with EF hand domain protein 1,28053,34,1.31 [0.66-2.61],0.4417138060303975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27370,35,1.38 [0.89-2.13],0.15194236143872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAD,Chondroadherin,23831,30,1.37 [0.67-2.77],0.3877855348648379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24309,30,1.72 [0.89-3.34],0.1055635669637584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD6,MICOS complex subunit MIC25,24264,30,2.61 [1.43-4.78],0.0018309159052584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHEK2,Serine/threonine-protein kinase Chk2,27549,34,0.47 [0.18-1.20],0.1129220774148799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGA,Chromogranin-A,24372,31,1.05 [0.70-1.58],0.8255687115792596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGB,Secretogranin-1,28220,34,1.01 [0.48-2.15],0.9752134303096076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,27388,35,1.45 [1.07-1.97],0.0169230956833254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHIT1,Chitotriosidase-1,28164,34,1.07 [0.86-1.34],0.523422191997005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHL1,Neural cell adhesion molecule L1-like protein,28090,35,1.88 [0.79-4.48],0.1514149315616832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHM,Rab proteins geranylgeranyltransferase component A 1,23704,29,0.92 [0.51-1.65],0.7679559538687195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP1A,Charged multivesicular body protein 1a,27859,34,0.92 [0.63-1.34],0.6540360472177691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP6,Charged multivesicular body protein 6,24383,31,1.03 [0.58-1.85],0.9145522771303174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHP1,Calcineurin B homologous protein 1,23603,29,0.87 [0.52-1.47],0.6109914242878416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,28134,35,1.36 [0.54-3.44],0.5159762503685791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL2,Chordin-like protein 2,28053,34,0.76 [0.42-1.36],0.3533237404766883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRM1,Muscarinic acetylcholine receptor M1,23704,29,0.74 [0.25-2.24],0.599315556339828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIAPIN1,Anamorsin,28116,35,0.96 [0.60-1.53],0.8562147554428031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CILP,Cartilage intermediate layer protein 1,24372,31,1.37 [0.73-2.57],0.3305650641850395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CINP,Cyclin-dependent kinase 2-interacting protein,23936,31,0.96 [0.43-2.15],0.9264787931571312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIRBP,Cold-inducible RNA-binding protein,24290,31,0.89 [0.63-1.26],0.5105681648956072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIT,Citron Rho-interacting kinase,23704,29,1.47 [0.79-2.76],0.225029007406264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,28241,35,1.92 [0.77-4.83],0.1634386405660053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,24372,31,1.90 [1.11-3.27],0.0197321921515099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27931,35,0.75 [0.52-1.06],0.106550092543512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLASP1,CLIP-associating protein 1,23522,29,0.92 [0.55-1.55],0.7527288615941349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLC,Galectin-10,28015,34,1.22 [0.81-1.83],0.3367174943829628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC10A,C-type lectin domain family 10 member A,27859,34,1.05 [0.47-2.35],0.9126596052357198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC11A,C-type lectin domain family 11 member A,27991,35,1.60 [0.87-2.95],0.1298938183337111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC12A,C-type lectin domain family 12 member A,23683,29,3.01 [1.07-8.48],0.0373843682498046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC14A,C-type lectin domain family 14 member A,28041,35,1.46 [0.57-3.74],0.4258179365817471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1A,C-type lectin domain family 1 member A,27549,34,1.09 [0.43-2.77],0.852262240510329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1B,C-type lectin domain family 1 member B,28318,34,0.71 [0.52-0.98],0.0379961252998249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC2L,C-type lectin domain family 2 member L,23704,29,1.06 [0.55-2.06],0.861948167400497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC3B,Tetranectin,23853,30,0.65 [0.12-3.50],0.6154632337234094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4A,C-type lectin domain family 4 member A,28032,35,0.71 [0.32-1.54],0.3808120727282699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4C,C-type lectin domain family 4 member C,28032,35,1.32 [0.70-2.46],0.3890143110215769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,28032,35,1.94 [1.27-2.96],0.0022184996277214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4G,C-type lectin domain family 4 member G,28032,35,1.24 [0.51-3.00],0.6303445888025532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4M,C-type lectin domain family 4 member M,24331,31,0.88 [0.44-1.75],0.7157630878100942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,27953,34,2.28 [0.94-5.54],0.0692887087807655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC6A,C-type lectin domain family 6 member A,27370,35,2.44 [1.49-3.98],0.0003722361269118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC7A,C-type lectin domain family 7 member A,28389,35,1.65 [0.88-3.09],0.1222070374493757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLGN,Calmegin,23704,29,1.86 [0.99-3.53],0.0553010176569596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIC5,Chloride intracellular channel protein 5,23704,29,0.43 [0.11-1.67],0.222944432932624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLINT1,Clathrin interactor 1,23522,29,1.16 [0.62-2.17],0.6384098595637766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIP2,CAP-Gly domain-containing linker protein 2,28032,35,0.90 [0.70-1.17],0.4381061938683086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,28300,35,2.88 [0.82-10.13],0.0988206096090987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLNS1A,Methylosome subunit pICln,23704,29,0.76 [0.25-2.34],0.6362806064906654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27809,34,0.99 [0.72-1.34],0.9243678404441644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPS,Colipase,28001,35,0.94 [0.62-1.42],0.7613876403449051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSPN,Claspin,27334,35,0.93 [0.37-2.33],0.8806239790914037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN1,Calsyntenin-1,27384,35,1.33 [0.83-2.13],0.231840005903321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,28389,35,0.95 [0.44-2.06],0.905823307187837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN3,Calsyntenin-3,24309,30,1.87 [0.80-4.40],0.1508880825777057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLTA,Clathrin light chain A,27549,34,1.17 [0.64-2.15],0.6138606047896655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLU,Clusterin,24414,31,1.47 [0.76-2.84],0.2516460780530309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLUL1,Clusterin-like protein 1,28006,34,1.19 [0.63-2.22],0.5945277271083622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMC1,COX assembly mitochondrial protein homolog,24383,31,1.03 [0.71-1.48],0.881695801597686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMIP,C-Maf-inducing protein,24264,30,0.86 [0.57-1.30],0.4869145851817938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNDP1,Beta-Ala-His dipeptidase,28135,35,0.75 [0.41-1.37],0.346401870196993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23603,29,0.92 [0.44-1.93],0.8253809495183009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23661,29,1.10 [0.71-1.71],0.6749332782732007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY2,Protein canopy homolog 2,27549,34,0.66 [0.33-1.30],0.2271585939179026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY4,Protein canopy homolog 4,27925,35,0.83 [0.56-1.22],0.3450894083534475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNST,Consortin,28053,34,0.82 [0.62-1.08],0.1577705922390317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTF,Ciliary neurotrophic factor,23603,29,0.92 [0.32-2.62],0.8754507023261955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN1,Contactin-1,28400,34,0.55 [0.18-1.68],0.2914672259342238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN2,Contactin-2,28300,35,1.36 [0.71-2.62],0.3528039018970913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN3,Contactin-3,28041,35,0.78 [0.33-1.86],0.573425382730771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN4,Contactin-4,28041,35,1.30 [0.37-4.62],0.681497984845137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN5,Contactin-5,28135,34,0.52 [0.22-1.22],0.1341094024979849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP2,Contactin-associated protein-like 2,28032,35,1.30 [0.66-2.57],0.4465079409186335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP4,Contactin-associated protein-like 4,23704,29,0.88 [0.58-1.33],0.5358946806358865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COCH,Cochlin,24383,31,1.47 [0.75-2.88],0.263527178012566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL15A1,Collagen alpha-1(XV) chain,24372,31,1.22 [0.35-4.32],0.7551371998827375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,28149,34,2.99 [0.86-10.40],0.0844689354615543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL1A1,Collagen alpha-1(I) chain,28400,34,1.93 [0.59-6.30],0.2754805668762369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL24A1,Collagen alpha-1(XXIV) chain,24290,31,0.90 [0.52-1.55],0.7059871388893098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL28A1,Collagen alpha-1(XXVIII) chain,23704,29,1.17 [0.77-1.76],0.4619125085044191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL2A1,Collagen alpha-1(II) chain,23705,29,0.85 [0.54-1.34],0.4762586640799867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL3A1,Collagen alpha-1(III) chain,24372,31,4.20 [1.53-11.51],0.0053049409319909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,28053,34,1.85 [0.91-3.76],0.0881714997712562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A4,Collagen alpha-4(IV) chain,23895,31,0.92 [0.48-1.74],0.7894849522088965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL5A1,Collagen alpha-1(V) chain,23831,30,2.04 [1.15-3.61],0.0144663932300706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,28400,34,2.37 [1.12-5.03],0.0237869113756887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A1,Collagen alpha-1(IX) chain,28032,35,1.23 [0.64-2.33],0.5360405254998493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A2,Collagen alpha-2(IX) chain,23936,31,0.85 [0.36-2.00],0.7155298760542975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,28032,35,1.59 [0.52-4.87],0.4182409783337736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD1,COMM domain-containing protein 1,23705,29,1.09 [0.62-1.92],0.7693643673652373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD9,COMM domain-containing protein 9,24264,30,1.19 [0.54-2.66],0.6631581959533563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMP,Cartilage oligomeric matrix protein,27742,35,0.84 [0.34-2.04],0.6974210642151504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMT,Catechol O-methyltransferase,27240,34,0.93 [0.64-1.33],0.6779664292117034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPB2,Coatomer subunit beta',23606,31,0.72 [0.31-1.67],0.4448461206043469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPE,Coatomer subunit epsilon,27384,35,0.80 [0.38-1.69],0.5602084315727321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23705,29,1.13 [0.54-2.38],0.7407561144534245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO1A,Coronin-1A,27497,34,0.94 [0.66-1.34],0.7398940417030566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,23603,29,1.03 [0.42-2.50],0.9531471745638292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",27925,35,0.79 [0.50-1.23],0.2899424074813921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX6B1,Cytochrome c oxidase subunit 6B1,24383,31,0.98 [0.35-2.74],0.9652361231976938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA1,Carboxypeptidase A1,28400,34,0.99 [0.62-1.59],0.9787953012424496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA2,Carboxypeptidase A2,28216,34,0.91 [0.57-1.44],0.6840082179643505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA4,Carboxypeptidase A4,23356,29,0.58 [0.28-1.22],0.1530016302764418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB1,Carboxypeptidase B,28400,34,1.04 [0.65-1.69],0.857621347500532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB2,Carboxypeptidase B2,24363,31,0.77 [0.17-3.36],0.7240328593677242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPE,Carboxypeptidase E,28101,35,0.85 [0.41-1.75],0.6611364146719658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPLX2,Complexin-2,23522,29,1.88 [1.00-3.52],0.0487416957760205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPM,Carboxypeptidase M,28194,34,2.97 [1.39-6.35],0.0047961855366994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23683,29,2.46 [0.95-6.35],0.0626538014916979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPPED1,Serine/threonine-protein phosphatase CPPED1,28318,34,1.42 [0.92-2.18],0.1146646449809886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPQ,Carboxypeptidase Q,24332,31,1.26 [0.52-3.03],0.6131044631921692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPTP,Ceramide-1-phosphate transfer protein,23606,31,1.28 [0.61-2.69],0.5191484597677323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPVL,Probable serine carboxypeptidase CPVL,28248,35,1.20 [0.57-2.55],0.6333873111450228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM1,Probable carboxypeptidase X1,28116,35,0.96 [0.63-1.46],0.8443787874197691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,24383,31,1.95 [0.58-6.53],0.2791642719160618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR1,Complement receptor type 1,24311,31,1.72 [0.82-3.64],0.1535431992753227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR2,Complement receptor type 2,28135,35,0.91 [0.47-1.74],0.7673587102749244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27370,35,0.72 [0.48-1.07],0.101041613932845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRADD,Death domain-containing protein CRADD,27809,34,1.02 [0.69-1.52],0.9210780380463068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREB3,Cyclic AMP-responsive element-binding protein 3,23522,29,0.97 [0.49-1.91],0.921443127228886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREBZF,CREB/ATF bZIP transcription factor,23522,29,1.16 [0.32-4.29],0.8186034815595892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREG1,Protein CREG1,27661,35,1.58 [0.79-3.15],0.1955006995162068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD1,Protein disulfide isomerase CRELD1,23831,30,1.07 [0.42-2.68],0.8911950344052124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD2,Protein disulfide isomerase CRELD2,28134,35,0.82 [0.46-1.45],0.4922710393095978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRH,Corticoliberin,27325,35,1.09 [0.78-1.53],0.6239717612438433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHBP,Corticotropin-releasing factor-binding protein,28032,35,1.02 [0.36-2.83],0.976752053426802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHR1,Corticotropin-releasing factor receptor 1,27549,34,1.20 [0.78-1.86],0.4109210764853764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,28177,35,1.02 [0.23-4.54],0.9789060309393308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,27859,34,1.63 [0.79-3.38],0.1888665534925289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP2,Cysteine-rich secretory protein 2,28300,35,0.72 [0.44-1.17],0.1801082826703315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP3,Cysteine-rich secretory protein 3,24162,31,2.02 [0.58-7.01],0.2668117832728779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRKL,Crk-like protein,28079,35,0.89 [0.68-1.17],0.3977862566965651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRLF1,Cytokine receptor-like factor 1,28177,35,1.45 [0.46-4.61],0.5270394360857534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRNN,Cornulin,27220,34,0.78 [0.50-1.22],0.2698399309672483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAC1,Cartilage acidic protein 1,28400,34,0.92 [0.34-2.44],0.859933806071221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAM,Cytotoxic and regulatory T-cell molecule,27859,34,1.09 [0.60-1.99],0.780803283612241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAP,Cartilage-associated protein,23704,29,1.03 [0.50-2.11],0.9347102695977012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRX,Cone-rod homeobox protein,27549,34,1.09 [0.84-1.40],0.5207110517922141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB1,Beta-crystallin B1,24383,31,1.04 [0.63-1.71],0.8719085600093487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB2,Beta-crystallin B2,24309,30,1.25 [0.85-1.83],0.2494239292034299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYGD,Gamma-crystallin D,24309,30,1.21 [0.85-1.72],0.2880489031233382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYM,Ketimine reductase mu-crystallin,23603,29,0.93 [0.56-1.52],0.7624915543699035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYZL1,Quinone oxidoreductase-like protein 1,23705,29,1.12 [0.76-1.65],0.5725607460581934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSDE1,Cold shock domain-containing protein E1,23606,31,0.87 [0.63-1.22],0.4205370262553413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,28177,35,4.36 [1.71-11.12],0.0020249792378423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1R,Macrophage colony-stimulating factor 1 receptor,24402,31,2.10 [1.14-3.85],0.0168848550605025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2,Granulocyte-macrophage colony-stimulating factor,23606,31,0.67 [0.23-1.91],0.4521611885684454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27859,34,1.27 [0.80-2.02],0.303842639267173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RB,Cytokine receptor common subunit beta,23683,29,1.54 [0.68-3.53],0.3038014971101305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3,Granulocyte colony-stimulating factor,27532,33,0.66 [0.34-1.27],0.2152077476886473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3R,Granulocyte colony-stimulating factor receptor,23683,29,2.07 [1.05-4.11],0.0367109767119882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSH1,Chorionic somatomammotropin hormone 1,24402,31,0.57 [0.18-1.86],0.3540911831316714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK1D,Casein kinase I isoform delta,23683,29,1.52 [0.99-2.34],0.0581793081721091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK2A1,Casein kinase II subunit alpha,24343,30,1.22 [0.57-2.58],0.6104580904443605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG4,Chondroitin sulfate proteoglycan 4,24372,31,1.35 [0.49-3.76],0.5617433448710644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG5,Chondroitin sulfate proteoglycan 5,23603,29,1.27 [0.67-2.40],0.4698193216619849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,23606,31,1.12 [0.81-1.55],0.4911813432999478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST1,Cystatin-SN,21119,29,0.76 [0.52-1.10],0.1441792091198664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,28088,35,3.04 [1.28-7.23],0.0119334829082989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST5,Cystatin-D,27533,34,1.09 [0.63-1.89],0.747492498481032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST6,Cystatin-M,27330,33,1.02 [0.53-1.96],0.9466503677654317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,28079,35,1.04 [0.77-1.40],0.8021647920147267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,27665,34,1.50 [0.77-2.91],0.228598611124379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTAG1A_CTAG1B,Cancer/testis antigen 1,23886,31,0.50 [0.30-0.84],0.0084983290043861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTBS,Di-N-acetylchitobiase,24071,31,2.88 [0.97-8.59],0.0575644165496494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTF1,Cardiotrophin-1,27549,34,0.96 [0.67-1.37],0.8085779152670832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTHRC1,Collagen triple helix repeat-containing protein 1,24372,31,1.74 [0.53-5.78],0.3634005535995062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTLA4,Cytotoxic T-lymphocyte protein 4,24372,31,1.83 [0.98-3.40],0.0570994552226635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTNNA1,Catenin alpha-1,23603,29,0.44 [0.10-1.86],0.2627349207335729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRB1,Chymotrypsinogen B,28041,35,0.92 [0.54-1.58],0.7578741582499564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRC,Chymotrypsin-C,28033,35,0.93 [0.59-1.47],0.765805750068287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRL,Chymotrypsin-like protease CTRL-1,24309,30,1.07 [0.66-1.75],0.7748930086417292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,28057,34,1.29 [0.72-2.31],0.3863876503509758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSC,Dipeptidyl peptidase 1,27990,35,1.49 [0.79-2.81],0.2212082304568092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSD,Cathepsin D,26163,35,1.51 [0.81-2.82],0.1965711105231203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSE,Cathepsin E,23831,30,1.55 [0.84-2.87],0.1634667767661086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSF,Cathepsin F,28116,35,0.89 [0.43-1.84],0.7553879692492322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSH,Pro-cathepsin H,27465,33,0.80 [0.54-1.21],0.2929833886332681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSL,Cathepsin L1,28053,34,2.98 [1.02-8.69],0.0457067464630356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSO,Cathepsin O,28389,35,1.43 [0.57-3.58],0.4465736838490565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,22135,29,2.56 [0.61-10.76],0.198915839279562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSV,Cathepsin L2,28208,35,0.54 [0.26-1.13],0.1010263814525704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSZ,Cathepsin Z,28030,35,1.24 [0.50-3.10],0.6477385198801386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23704,29,1.89 [1.20-2.98],0.006276317761174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CWC15,Spliceosome-associated protein CWC15 homolog,24161,31,1.06 [0.63-1.78],0.8341258938465453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CX3CL1,Fractalkine,27859,34,1.33 [0.55-3.23],0.5287090305947938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,28032,35,1.73 [1.06-2.82],0.0271072918848821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL1,Growth-regulated alpha protein,27993,35,0.79 [0.57-1.11],0.1827686887778287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL10,C-X-C motif chemokine 10,28177,35,1.33 [0.92-1.91],0.1256465379947073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL11,C-X-C motif chemokine 11,28318,34,0.98 [0.67-1.42],0.9014222894493392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL12,Stromal cell-derived factor 1,27532,33,0.76 [0.34-1.67],0.4878559584955323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL13,C-X-C motif chemokine 13,28318,34,1.37 [0.95-1.97],0.0947315233080297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL14,C-X-C motif chemokine 14,27532,33,0.46 [0.22-0.97],0.0413994548059053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,28347,34,5.29 [1.87-14.97],0.0017054025484704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,28389,35,1.89 [1.19-2.99],0.0065658508846922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL3,C-X-C motif chemokine 3,28036,35,0.85 [0.63-1.15],0.2843062968185201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL5,C-X-C motif chemokine 5,27956,34,0.81 [0.63-1.04],0.1053537875612905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL6,C-X-C motif chemokine 6,28389,35,0.78 [0.53-1.15],0.2143363956748152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL8,Interleukin-8,27821,34,0.89 [0.56-1.40],0.6074017534977816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,28177,35,1.50 [1.07-2.12],0.019342032468273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5A,Cytochrome b5,23522,29,0.92 [0.54-1.57],0.7592879561697783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5R2,NADH-cytochrome b5 reductase 2,24003,31,1.18 [0.67-2.08],0.5667120745369664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23606,31,0.83 [0.51-1.36],0.4590460037489718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTH3,Cytohesin-3,23522,29,1.04 [0.64-1.68],0.8705049938929129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTL1,Cytokine-like protein 1,24372,31,2.38 [0.68-8.33],0.1731818090847569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAAM1,Disheveled-associated activator of morphogenesis 1,23831,30,0.82 [0.53-1.26],0.3703767331850967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAB2,Disabled homolog 2,28300,35,0.90 [0.70-1.17],0.4353411463863345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAG1,Dystroglycan,28177,35,0.82 [0.45-1.52],0.5385924175126134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAND5,DAN domain family member 5,23683,29,0.99 [0.53-1.85],0.973868178989314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPK2,Death-associated protein kinase 2,23683,29,1.37 [0.86-2.17],0.1817048314980404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,28032,35,0.92 [0.73-1.16],0.4813287168299288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DARS1,"Aspartate--tRNA ligase, cytoplasmic",27809,34,0.93 [0.62-1.41],0.7469396187403581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBH,Dopamine beta-hydroxylase,24364,31,1.03 [0.75-1.39],0.8748201319880693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBI,Acyl-CoA-binding protein,27900,35,1.00 [0.69-1.46],0.999847515506218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBN1,Drebrin,23683,29,1.39 [0.75-2.56],0.2926639726865466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBNL,Drebrin-like protein,28177,35,0.85 [0.62-1.17],0.3258349840659955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",28116,35,1.86 [0.86-4.02],0.1157778181106228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCC,Netrin receptor DCC,23704,29,1.56 [0.57-4.26],0.3885702930844373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCDC2C,Doublecortin domain-containing protein 2C,23522,29,0.49 [0.24-0.98],0.0443986344057332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCLRE1C,Protein artemis,23522,29,0.72 [0.21-2.46],0.6000263184943261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCN,Decorin,27549,34,0.88 [0.22-3.59],0.8637088217992969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTD,Deoxycytidylate deaminase,23831,30,0.91 [0.63-1.30],0.587923374841951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN1,Dynactin subunit 1,28300,35,0.80 [0.50-1.26],0.3318883441673774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN2,Dynactin subunit 2,27925,35,0.95 [0.69-1.31],0.7560256446496012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN6,Dynactin subunit 6,27384,35,1.01 [0.66-1.54],0.9730842893895932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTPP1,dCTP pyrophosphatase 1,28053,34,1.20 [0.47-3.06],0.7008417970544203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D1,DCN1-like protein 1,23603,29,0.98 [0.59-1.62],0.9367561414123264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D2,DCN1-like protein 2,23522,29,0.89 [0.54-1.45],0.6308034100551622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCXR,L-xylulose reductase,28116,35,1.44 [0.88-2.37],0.1507186799459177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDA1,DET1- and DDB1-associated protein 1,23606,31,0.67 [0.24-1.88],0.4442646005015691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27925,35,1.34 [0.73-2.45],0.3515144107731542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDC,Aromatic-L-amino-acid decarboxylase,28021,34,1.29 [0.72-2.32],0.3888907555321921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDHD2,Phospholipase DDHD2,24343,30,1.03 [0.61-1.73],0.9183791599329292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDI2,Protein DDI1 homolog 2,23831,30,1.35 [0.87-2.08],0.1766820640910897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,28318,34,1.29 [0.37-4.50],0.6855095497800263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDT,D-dopachrome decarboxylase,24372,31,1.64 [0.80-3.37],0.1794678306317232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX1,ATP-dependent RNA helicase DDX1,24290,31,0.82 [0.38-1.78],0.6204343597939714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX25,ATP-dependent RNA helicase DDX25,23704,29,0.64 [0.20-2.07],0.4521310237473256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX39A,ATP-dependent RNA helicase DDX39A,23683,29,0.84 [0.17-4.31],0.8390709719406992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX4,Probable ATP-dependent RNA helicase DDX4,23683,29,1.24 [0.75-2.06],0.4063263692119057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX53,Probable ATP-dependent RNA helicase DDX53,23704,29,0.84 [0.30-2.37],0.7401325815021245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX58,Antiviral innate immune response receptor RIG-I,27370,35,1.24 [0.81-1.88],0.3177773419454495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",28032,35,0.77 [0.57-1.05],0.1029147839393996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFA1_DEFA1B,Neutrophil defensin 1,27464,35,1.72 [1.16-2.56],0.0073683631666044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB103A_DEFB103B,Beta-defensin 103,23521,29,0.96 [0.40-2.32],0.9230641637334012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB104A_DEFB104B,Beta-defensin 104,23603,29,0.92 [0.46-1.81],0.8039513529169575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB116,Beta-defensin 116,23603,29,1.10 [0.72-1.69],0.6540272428164602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,23603,29,1.23 [0.78-1.94],0.3701075013394681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB4A_DEFB4B,Beta-defensin 4A,27631,35,1.06 [0.86-1.29],0.593463457796856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENND2B,DENN domain-containing protein 2B,23606,31,1.69 [1.13-2.52],0.0105495974887516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENR,Density-regulated protein,23683,29,1.16 [0.64-2.11],0.6171670767062947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DFFA,DNA fragmentation factor subunit alpha,28389,35,0.94 [0.60-1.46],0.7737059505316608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGCR6,Protein DGCR6,23603,29,0.93 [0.39-2.21],0.8691841238671801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKA,Diacylglycerol kinase alpha,23683,29,1.14 [0.60-2.14],0.6957078900110547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKZ,Diacylglycerol kinase zeta,27532,33,1.55 [0.73-3.29],0.2577268328906091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHODH,Dihydroorotate dehydrogenase,23606,31,1.03 [0.48-2.23],0.9351884982452636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHPS,Deoxyhypusine synthase,24264,30,1.26 [0.59-2.72],0.5527680438801634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24309,30,1.51 [0.86-2.64],0.1496382068712052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIABLO,"Diablo homolog, mitochondrial",27953,34,0.85 [0.65-1.11],0.2351340292154426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK1C,Divergent protein kinase domain 1C,23704,29,1.36 [0.65-2.84],0.4066255816048257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK2B,Divergent protein kinase domain 2B,23831,30,0.76 [0.23-2.47],0.6507713721746973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK1,Dickkopf-related protein 1,28318,34,0.74 [0.46-1.21],0.230571063041322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK3,Dickkopf-related protein 3,28400,34,0.70 [0.25-1.94],0.4890453627128046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK4,Dickkopf-related protein 4,27808,34,1.83 [1.09-3.06],0.0220907228489404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKKL1,Dickkopf-like protein 1,27925,35,0.68 [0.51-0.92],0.010921295711352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLG4,Disks large homolog 4,24309,30,0.81 [0.49-1.35],0.4274137434413932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLGAP5,Disks large-associated protein 5,24343,30,1.25 [0.75-2.06],0.3904866858730411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLK1,Protein delta homolog 1,28400,34,0.53 [0.32-0.90],0.0173780560544202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,28116,35,1.27 [0.47-3.41],0.6407599335439664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL4,Delta-like protein 4,23705,29,0.83 [0.46-1.51],0.5413098427200702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMD,Dystrophin,23705,29,1.10 [0.56-2.17],0.7725142499258916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMP1,Dentin matrix acidic phosphoprotein 1,23705,29,1.35 [0.71-2.56],0.3575321725319311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA1,DnaJ homolog subfamily A member 1,23522,29,0.80 [0.33-1.94],0.6272955194838438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA2,DnaJ homolog subfamily A member 2,28291,35,0.88 [0.61-1.25],0.4745234779304486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA4,DnaJ homolog subfamily A member 4,24309,30,1.42 [0.90-2.25],0.1290018080190711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB1,DnaJ homolog subfamily B member 1,27925,35,1.01 [0.72-1.43],0.9403077229213608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB14,DnaJ homolog subfamily B member 14,24290,31,0.89 [0.53-1.51],0.6750651932113669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB2,DnaJ homolog subfamily B member 2,23831,30,1.29 [0.70-2.38],0.4183848806877213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB6,DnaJ homolog subfamily B member 6,23613,29,0.87 [0.57-1.32],0.5099091675335474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB8,DnaJ homolog subfamily B member 8,27549,34,0.91 [0.51-1.62],0.7460082050763317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC21,DnaJ homolog subfamily C member 21,24309,30,0.89 [0.36-2.22],0.8094131378442206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23705,29,1.16 [0.78-1.74],0.4644657701980156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC9,DnaJ homolog subfamily C member 9,24290,31,1.51 [0.99-2.31],0.058022313743021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNER,Delta and Notch-like epidermal growth factor-related receptor,27991,35,0.43 [0.14-1.31],0.1359130279411807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNLZ,DNL-type zinc finger protein,23603,29,0.66 [0.36-1.22],0.183659597943641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM1,Dynamin-1,24290,31,1.08 [0.81-1.46],0.5936820414577307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM3,Dynamin-3,24343,30,0.72 [0.36-1.44],0.3586115845990006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNMBP,Dynamin-binding protein,27859,34,0.87 [0.52-1.45],0.5799736987537099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPEP,Aspartyl aminopeptidase,24309,30,1.37 [0.76-2.46],0.291144857688947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,28122,35,1.82 [1.05-3.13],0.0318139847109326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOC2B,Double C2-like domain-containing protein beta,23704,29,0.86 [0.30-2.50],0.7843137775154366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOCK9,Dedicator of cytokinesis protein 9,23603,29,1.05 [0.78-1.40],0.7441437679206577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK1,Docking protein 1,24309,30,0.97 [0.75-1.24],0.7817003075140866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK2,Docking protein 2,28053,34,0.86 [0.68-1.10],0.2418684641728016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP1,Dipeptidase 1,27809,34,1.28 [0.66-2.48],0.462178924766367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP2,Dipeptidase 2,27925,35,1.28 [0.48-3.41],0.6214585759531397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP10,Inactive dipeptidyl peptidase 10,28032,35,1.54 [0.76-3.14],0.2326720173634989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP4,Dipeptidyl peptidase 4,27488,35,1.57 [0.58-4.25],0.3741745047402129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP6,Dipeptidyl aminopeptidase-like protein 6,27925,35,0.73 [0.30-1.74],0.4768971707499704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP7,Dipeptidyl peptidase 2,27812,33,0.91 [0.56-1.48],0.6968239675708285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,28400,34,0.75 [0.25-2.27],0.6145112787425704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPY30,Protein dpy-30 homolog,28223,35,1.32 [0.86-2.03],0.205222487239166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRAXIN,Draxin,27859,34,1.12 [0.55-2.28],0.7635954437868073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRG2,Developmentally-regulated GTP-binding protein 2,27925,35,0.72 [0.42-1.25],0.2478101142241228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,27703,35,2.29 [1.15-4.58],0.0188056742625474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSCAM,Down syndrome cell adhesion molecule,24343,30,2.18 [0.88-5.39],0.0921440063909383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG2,Desmoglein-2,28041,35,1.35 [0.46-3.97],0.5860294308532519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG3,Desmoglein-3,28216,35,0.66 [0.28-1.55],0.3362333701400187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG4,Desmoglein-4,27830,35,0.83 [0.46-1.49],0.5271623514650712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTD1,D-aminoacyl-tRNA deacylase 1,23831,30,1.00 [0.67-1.49],0.9948604543224872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,24224,30,1.04 [0.50-2.18],0.918663027470709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23704,29,1.23 [0.79-1.92],0.3580606442612107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,27925,35,1.07 [0.31-3.71],0.919468362852937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTYMK,Thymidylate kinase,24383,31,1.31 [0.81-2.12],0.2699859882279572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUOX2,Dual oxidase 2,27549,34,0.86 [0.53-1.41],0.5577430983893108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP13,Dual specificity protein phosphatase 13 isoform A,24264,30,0.90 [0.39-2.07],0.8041826019056908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP29,Dual specificity phosphatase 29,23704,29,0.64 [0.31-1.29],0.2125391632673087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP3,Dual specificity protein phosphatase 3,27384,35,0.93 [0.64-1.37],0.7250326654063868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24290,31,1.09 [0.79-1.50],0.5960240785557341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DXO,Decapping and exoribonuclease protein,24309,30,1.22 [0.58-2.55],0.6030215044835193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24264,30,1.05 [0.52-2.13],0.8914295923919203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT1,Dynein light chain Tctex-type 1,23704,29,1.04 [0.68-1.60],0.8462578678583894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT3,Dynein light chain Tctex-type 3,24264,30,0.88 [0.40-1.95],0.7535581065886185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27859,34,0.94 [0.69-1.30],0.7267109863472143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,28263,35,1.19 [0.46-3.11],0.71926957583812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECE1,Endothelin-converting enzyme 1,27384,35,1.25 [0.54-2.93],0.6008471677340617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24383,31,1.19 [0.81-1.76],0.3841462483988621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23705,29,1.05 [0.73-1.50],0.7993332191426168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECI2,Enoyl-CoA delta isomerase 2,23606,31,1.04 [0.60-1.80],0.8826141625763447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECM1,Extracellular matrix protein 1,23728,30,1.10 [0.42-2.90],0.8431965259597286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECSCR,Endothelial cell-specific chemotaxis regulator,23603,29,0.49 [0.16-1.43],0.1898970980562674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,28300,35,2.10 [1.02-4.31],0.0427155717693534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDAR,Tumor necrosis factor receptor superfamily member EDAR,28032,35,0.84 [0.60-1.16],0.2831308064739991
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDDM3B,Epididymal secretory protein E3-beta,24264,30,0.96 [0.51-1.81],0.8954109549267303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23606,31,0.53 [0.16-1.77],0.3004436736732727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDF1,Endothelial differentiation-related factor 1,24343,30,1.12 [0.72-1.76],0.6052384135602613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27549,34,1.40 [0.65-3.01],0.3919070746384949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,23705,29,2.93 [1.06-8.11],0.0381847748958726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDNRB,Endothelin receptor type B,23683,29,1.87 [1.30-2.69],0.0007681484539152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EEF1D,Elongation factor 1-delta,24383,31,0.95 [0.66-1.39],0.8042617432362699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24290,31,1.92 [0.75-4.90],0.1746852557438378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB2,Dynein regulatory complex protein 8,23936,31,0.57 [0.20-1.64],0.2999696373335372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,28083,35,2.08 [0.85-5.09],0.1101747062738036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFHD1,EF-hand domain-containing protein D1,24343,30,0.91 [0.33-2.48],0.8488193686052309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,27991,35,1.97 [0.72-5.34],0.1842500384825192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,27810,34,1.69 [0.64-4.43],0.288131729451564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNB2,Ephrin-B2,23704,29,1.01 [0.57-1.81],0.9647809398191448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGF,Pro-epidermal growth factor,27987,35,0.78 [0.60-1.03],0.081661569692222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFL7,Epidermal growth factor-like protein 7,27370,35,1.52 [0.78-2.99],0.2213625062418927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFLAM,Pikachurin,24290,31,1.43 [0.52-3.93],0.4866752211488512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFR,Epidermal growth factor receptor,28400,34,0.57 [0.25-1.29],0.1769523584832484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGLN1,Egl nine homolog 1,28032,35,1.29 [0.87-1.91],0.2075776532152638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHBP1,EH domain-binding protein 1,24383,31,0.91 [0.57-1.43],0.6746516501726285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHD3,EH domain-containing protein 3,23705,29,1.00 [0.74-1.35],0.992364089656881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24309,30,0.92 [0.48-1.79],0.8132921515709767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24213,31,1.09 [0.81-1.46],0.579799855011822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23606,31,0.50 [0.26-0.96],0.0382386887537778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23705,29,0.82 [0.33-2.03],0.6752210690668751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4B,Eukaryotic translation initiation factor 4B,27859,34,1.29 [0.75-2.21],0.3531539655162091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4E,Eukaryotic translation initiation factor 4E,23683,29,1.20 [0.82-1.76],0.3478682947192808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,28053,34,1.57 [1.05-2.34],0.0278589926773818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28389,35,0.88 [0.65-1.18],0.3786219160489446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24343,30,0.71 [0.40-1.26],0.2429646518782455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5,Eukaryotic translation initiation factor 5,23606,31,0.85 [0.36-2.02],0.719040035764221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5A,Eukaryotic translation initiation factor 5A-1,27532,33,1.53 [0.73-3.20],0.2551992109719413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAC1,Zinc phosphodiesterase ELAC protein 1,24343,30,1.00 [0.67-1.49],0.988676729526968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAVL4,ELAV-like protein 4,23603,29,0.99 [0.64-1.52],0.960959891501615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,24383,31,3.06 [1.27-7.41],0.012912321356526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOA,Elongin-A,27925,35,1.33 [0.90-1.97],0.1572313288706235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOB,Elongin-B,23606,31,0.74 [0.27-1.98],0.5443764554717319
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,27532,33,0.73 [0.37-1.43],0.3573590211523849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENDOU,Poly(U)-specific endoribonuclease,22523,25,0.72 [0.35-1.47],0.3628033304589141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENG,Endoglin,28400,34,1.14 [0.20-6.66],0.8834499099835179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO1,Alpha-enolase,28021,34,1.00 [0.68-1.46],0.9893161047215532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO2,Gamma-enolase,28318,34,0.96 [0.61-1.51],0.8442863797036826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO3,Beta-enolase,23705,29,0.67 [0.36-1.27],0.2203326242952241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOPH1,Enolase-phosphatase E1,24264,30,0.87 [0.42-1.82],0.7088222678054388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23606,31,0.80 [0.21-2.96],0.7342561744284226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPEP,Glutamyl aminopeptidase,23606,31,0.82 [0.31-2.15],0.6887547623247519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28400,34,1.28 [0.42-3.87],0.6615743549826509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28177,35,0.63 [0.41-0.98],0.0401615125468698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23705,29,0.65 [0.25-1.69],0.3736030403014261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27240,35,1.23 [0.87-1.74],0.2332104245266237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENSA,Alpha-endosulfine,24264,30,1.01 [0.53-1.91],0.9808811790069776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27370,35,1.46 [0.80-2.64],0.2164494484662717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27549,34,0.94 [0.23-3.82],0.9365095098819852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27549,34,1.55 [0.45-5.30],0.4828601197249046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTR1,Endosome-associated-trafficking regulator 1,23705,29,0.76 [0.40-1.44],0.4028245242506977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EP300,Histone acetyltransferase p300,23683,29,1.68 [0.75-3.73],0.2048903059811268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPB41L5,Band 4.1-like protein 5,23704,29,1.53 [1.18-1.98],0.0011675557665197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPCAM,Epithelial cell adhesion molecule,28041,34,1.04 [0.75-1.43],0.8216733824997394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPGN,Epigen,24264,30,0.77 [0.29-2.02],0.5891822828824477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA1,Ephrin type-A receptor 1,28122,35,1.51 [0.62-3.70],0.3629692937614738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA10,Ephrin type-A receptor 10,27384,35,1.13 [0.74-1.71],0.5758571229260815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,27039,34,1.89 [0.77-4.63],0.1627605702664496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA4,Ephrin type-A receptor 4,23831,30,0.89 [0.27-2.99],0.8561286751277409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,28400,34,1.70 [0.54-5.40],0.3664657033361084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,27809,34,1.67 [0.65-4.30],0.2858811211891454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHX2,Bifunctional epoxide hydrolase 2,27549,34,1.27 [0.85-1.90],0.2369391292275306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,23936,31,0.75 [0.29-1.98],0.5662502782482002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPO,Erythropoietin,28032,35,0.89 [0.58-1.37],0.6023902598176485
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPPK1,Epiplakin,23705,29,0.97 [0.62-1.53],0.8968923501458723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28260,35,1.60 [0.68-3.76],0.2843695419175959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB2,Receptor tyrosine-protein kinase erbB-2,28116,35,1.24 [0.39-4.00],0.7146658490598814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB3,Receptor tyrosine-protein kinase erbB-3,27929,35,0.60 [0.13-2.81],0.5130634087370911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB4,Receptor tyrosine-protein kinase erbB-4,28116,35,0.45 [0.18-1.13],0.0892317452368015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBIN,Erbin,27925,35,0.84 [0.63-1.11],0.2191125309279066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERC2,ERC protein 2,23704,29,1.03 [0.65-1.62],0.902630196367318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERCC1,DNA excision repair protein ERCC-1,23522,29,1.79 [1.10-2.92],0.0189108369708657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EREG,Proepiregulin,27809,34,0.87 [0.59-1.28],0.477128650635422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERI1,3'-5' exoribonuclease 1,23936,31,0.57 [0.19-1.75],0.3291107300676182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERMAP,Erythroid membrane-associated protein,23683,29,0.59 [0.26-1.33],0.2010523418001026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24264,30,1.93 [0.95-3.93],0.0688445605949383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP29,Endoplasmic reticulum resident protein 29,23831,30,0.93 [0.70-1.25],0.6496043047454543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP44,Endoplasmic reticulum resident protein 44,27885,35,0.35 [0.11-1.12],0.07682467440715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,23606,31,0.88 [0.40-1.95],0.7538617135146052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESAM,Endothelial cell-selective adhesion molecule,28400,34,0.65 [0.25-1.70],0.3810390005026055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESM1,Endothelial cell-specific molecule 1,28032,35,2.08 [0.93-4.66],0.0750707538991065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESPL1,Separin,23522,29,1.26 [0.72-2.19],0.4220603579615167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESR1,Estrogen receptor,23683,29,1.36 [0.88-2.11],0.1663921028929506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESYT2,Extended synaptotagmin-2,24309,30,0.91 [0.59-1.38],0.6500707035181992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI2B,Protein EVI2B,23522,29,1.12 [0.48-2.59],0.7982764948636536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI5,Ecotropic viral integration site 5 protein homolog,23683,29,1.05 [0.71-1.54],0.8125016767034093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVPL,Envoplakin,23936,31,0.60 [0.18-2.00],0.4068838138924607
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXOSC10,Exosome component 10,23606,31,1.20 [0.75-1.93],0.4477120718388213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXTL1,Exostosin-like 1,23606,31,0.94 [0.44-2.00],0.8639821018398461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EZR,Ezrin,28318,34,0.30 [0.08-1.08],0.0645474510206217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F10,Coagulation factor X,24402,31,1.41 [0.47-4.24],0.5430156051730317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11,Coagulation factor XI,24055,30,0.46 [0.13-1.57],0.2154157568564148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11R,Junctional adhesion molecule A,28041,35,0.88 [0.52-1.50],0.6444532731508487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F12,Coagulation factor XII,24414,31,1.63 [0.71-3.77],0.2489563356759563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F13B,Coagulation factor XIII B chain,24284,30,1.53 [0.41-5.68],0.5219652804544932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2,Prothrombin,24414,31,0.99 [0.10-9.79],0.9931488888642476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2R,Proteinase-activated receptor 1,28134,35,0.81 [0.49-1.35],0.419733542878267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F3,Tissue factor,28122,35,0.65 [0.22-1.94],0.4378975154159579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F7,Coagulation factor VII,28088,35,0.90 [0.34-2.43],0.8423981554701127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F9,Coagulation factor IX,28101,35,3.83 [0.78-18.84],0.0989485055895873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP1,"Fatty acid-binding protein, liver",28032,35,1.15 [0.85-1.54],0.3661759023949323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP2,"Fatty acid-binding protein, intestinal",28053,34,0.84 [0.57-1.24],0.3835757457205769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",24383,31,0.82 [0.41-1.63],0.5790902641042094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",28400,34,1.22 [0.68-2.17],0.4993361589033583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP5,Fatty acid-binding protein 5,28237,34,1.11 [0.72-1.71],0.6493872403543496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP6,Gastrotropin,27513,34,0.94 [0.54-1.63],0.8253853522965264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP9,Fatty acid-binding protein 9,28032,35,0.94 [0.55-1.59],0.8130922083125435
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FADD,FAS-associated death domain protein,28053,34,0.92 [0.62-1.36],0.6674054485918919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM13A,Protein FAM13A,24290,31,0.92 [0.56-1.53],0.7561303382893467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171A2,Protein FAM171A2,24343,30,1.17 [0.98-1.41],0.0904121278901496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171B,Protein FAM171B,24264,30,0.68 [0.15-2.97],0.6063662057546708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM172A,Cotranscriptional regulator FAM172A,23705,29,0.92 [0.51-1.64],0.7711179201187722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM20A,Pseudokinase FAM20A,24383,31,2.35 [0.77-7.15],0.131050707246252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3B,Protein FAM3B,27925,35,1.32 [0.61-2.87],0.478708868180459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,28021,34,1.34 [0.49-3.65],0.5704380960464448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3D,Protein FAM3D,24290,31,1.11 [0.74-1.65],0.6254715616843374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAP,Prolyl endopeptidase FAP,28400,34,0.36 [0.13-1.04],0.0581228737088923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FARSA,Phenylalanine--tRNA ligase alpha subunit,23704,29,0.74 [0.41-1.33],0.315114358061296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAS,Tumor necrosis factor receptor superfamily member 6,28300,34,1.10 [0.47-2.53],0.8302260044553814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FASLG,Tumor necrosis factor ligand superfamily member 6,28389,35,0.97 [0.44-2.13],0.9415969921261031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBLN2,Fibulin-2,24372,31,1.88 [0.69-5.10],0.2166356078677151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBN2,Fibrillin-2,23704,29,0.92 [0.50-1.70],0.7927406091988581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBP1,"Fructose-1,6-bisphosphatase 1",28053,34,1.08 [0.72-1.60],0.7181390642901969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24383,31,1.50 [0.96-2.33],0.0738131377105229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAR,Immunoglobulin alpha Fc receptor,28032,35,1.91 [1.05-3.48],0.0345113189859474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24343,30,1.83 [0.54-6.21],0.3354368114149704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER2,Low affinity immunoglobulin epsilon Fc receptor,28041,35,1.24 [0.70-2.20],0.4653801646078637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,27915,35,0.84 [0.54-1.28],0.4100525964230331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27370,35,0.90 [0.54-1.50],0.6878314361873965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,28045,35,1.51 [0.81-2.81],0.1984432166773431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN1,Ficolin-1,24364,31,2.88 [1.44-5.77],0.0028613679565546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN2,Ficolin-2,27914,35,0.92 [0.46-1.83],0.8031744430287905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL1,Fc receptor-like protein 1,28053,34,1.22 [0.62-2.38],0.5692024815749628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL2,Fc receptor-like protein 2,28264,35,1.38 [0.78-2.46],0.2658545801631704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL3,Fc receptor-like protein 3,27532,33,1.22 [0.69-2.15],0.496473258090332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL5,Fc receptor-like protein 5,28041,35,1.34 [0.81-2.20],0.2557640984015282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL6,Fc receptor-like protein 6,28032,35,0.82 [0.53-1.26],0.3681812339766614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,27370,35,1.60 [1.12-2.29],0.0096676671763893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",23606,31,1.19 [0.74-1.89],0.4718566580761946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX2,"Ferredoxin-2, mitochondrial",23606,31,1.31 [0.78-2.20],0.3012011458386342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FEN1,Flap endonuclease 1,27370,35,1.30 [0.96-1.75],0.0917030087851407
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FES,Tyrosine-protein kinase Fes/Fps,27370,35,0.92 [0.48-1.77],0.800436351495049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FETUB,Fetuin-B,28101,35,0.98 [0.40-2.41],0.9626972703717528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGA,Fibrinogen alpha chain,23828,28,1.64 [0.54-4.97],0.3785077711832978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24343,30,0.95 [0.62-1.45],0.811617199372864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF12,Fibroblast growth factor 12,23683,29,1.49 [1.00-2.21],0.0494692689134815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF16,Fibroblast growth factor 16,23683,29,0.92 [0.42-2.05],0.8455815231858027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF19,Fibroblast growth factor 19,28177,35,1.23 [0.84-1.80],0.2774702102903024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF2,Fibroblast growth factor 2,28032,35,0.79 [0.50-1.25],0.3117928772562829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF20,Fibroblast growth factor 20,23683,29,0.94 [0.39-2.29],0.8926947428563694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF21,Fibroblast growth factor 21,28263,35,1.33 [1.08-1.64],0.008277550563862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,28252,35,1.45 [1.01-2.08],0.0443970029087355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF3,Fibroblast growth factor 3,23683,29,0.87 [0.25-3.06],0.8306645990333827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF5,Fibroblast growth factor 5,27532,33,1.64 [0.74-3.61],0.220361929905455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF6,Fibroblast growth factor 6,23683,29,1.54 [0.94-2.53],0.0879787454172848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF7,Fibroblast growth factor 7,23522,29,1.08 [0.72-1.61],0.7217156607853161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF9,Fibroblast growth factor 9,23476,29,0.76 [0.32-1.81],0.5361756914840105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP1,Fibroblast growth factor-binding protein 1,28116,35,0.48 [0.23-1.03],0.0610438781602268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP2,Fibroblast growth factor-binding protein 2,24372,31,0.73 [0.38-1.43],0.3596234832715345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP3,Fibroblast growth factor-binding protein 3,24309,30,0.72 [0.28-1.85],0.4932176913828313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR2,Fibroblast growth factor receptor 2,28116,35,1.98 [0.60-6.54],0.2635657739936378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR4,Fibroblast growth factor receptor 4,23831,30,1.64 [0.88-3.06],0.1159555893789151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,24402,31,1.77 [1.07-2.93],0.026156388709048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGR,Tyrosine-protein kinase Fgr,27384,35,1.44 [1.05-1.97],0.0224516417655094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FH,"Fumarate hydratase, mitochondrial",23603,29,0.96 [0.60-1.53],0.8722510618744346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23606,31,0.45 [0.19-1.05],0.0649543550797372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIT,Bis(5'-adenosyl)-triphosphatase,27384,35,1.17 [0.78-1.76],0.447990862390641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FIS1,Mitochondrial fission 1 protein,28024,35,0.83 [0.56-1.23],0.3608230040978802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24343,30,0.95 [0.67-1.35],0.78365695376642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28164,35,0.89 [0.68-1.16],0.3711234483699005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27859,34,1.44 [0.72-2.86],0.3012770041614663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27859,34,0.98 [0.71-1.34],0.8825289600433537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27334,35,1.26 [0.76-2.09],0.372931486563525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBPL,FK506-binding protein-like,24290,31,1.13 [0.64-1.97],0.6771459869234431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLI1,Friend leukemia integration 1 transcription factor,27370,35,0.95 [0.73-1.25],0.7334716085913423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27859,34,2.06 [0.93-4.56],0.0734773831129288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,27879,35,1.30 [0.36-4.61],0.6893221501738589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3,Receptor-type tyrosine-protein kinase FLT3,27370,35,1.14 [0.46-2.87],0.775914036970107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3LG,Fms-related tyrosine kinase 3 ligand,28389,35,1.04 [0.44-2.48],0.9288476311411772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT4,Vascular endothelial growth factor receptor 3,28116,35,1.07 [0.45-2.57],0.8736960573214301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMNL1,Formin-like protein 1,27384,35,1.23 [0.88-1.73],0.223781237576754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMR1,Synaptic functional regulator FMR1,27370,35,0.79 [0.33-1.86],0.5858407977566974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FN1,Fibronectin,24414,31,0.89 [0.25-3.12],0.8569946789730166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNDC1,Fibronectin type III domain-containing protein 1,24309,30,0.85 [0.41-1.75],0.6598274734345293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24264,30,1.62 [0.80-3.31],0.182657761075112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLH1,Glutamate carboxypeptidase 2,23683,29,1.24 [0.98-1.56],0.0689748939000653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR1,Folate receptor alpha,27980,35,1.05 [0.37-2.97],0.924131809952652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR2,Folate receptor beta,28318,34,2.34 [0.90-6.11],0.0823456484359531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR3,Folate receptor gamma,28025,35,0.89 [0.73-1.08],0.2289350537440073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOS,Proto-oncogene c-Fos,23476,29,1.24 [0.48-3.20],0.6618870280281104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOSB,Protein fosB,27384,35,1.58 [1.02-2.44],0.0403434658098304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXJ3,Forkhead box protein J3,23683,29,0.84 [0.37-1.93],0.6808446898109076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO1,Forkhead box protein O1,28032,35,0.87 [0.61-1.23],0.4251721982909147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO3,Forkhead box protein O3,27370,35,1.18 [0.89-1.57],0.2433061378689204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD4B,FERM domain-containing protein 4B,23606,31,0.66 [0.38-1.15],0.1411481554936001
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD7,FERM domain-containing protein 7,23704,29,1.82 [0.86-3.86],0.117327775132254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRZB,Secreted frizzled-related protein 3,27763,34,1.06 [0.36-3.13],0.9131320854062152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSHB,Follitropin subunit beta,23705,29,1.53 [0.92-2.54],0.101073434991068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FST,Follistatin,28134,35,0.69 [0.37-1.29],0.2437668562161935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL1,Follistatin-related protein 1,23705,29,2.12 [0.52-8.68],0.2963893851048192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,27991,35,1.57 [0.65-3.82],0.3192375961867388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FTCD,Formimidoyltransferase-cyclodeaminase,24269,30,1.29 [0.90-1.85],0.1677567869608261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUCA1,Tissue alpha-L-fucosidase,28203,34,0.74 [0.54-1.03],0.0754014513261725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUOM,Fucose mutarotase,23831,30,1.43 [0.87-2.35],0.1589603916051674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FURIN,Furin,28116,35,0.93 [0.39-2.19],0.8620528069374087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUS,RNA-binding protein FUS,27322,35,1.49 [0.77-2.90],0.2388222447169441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23894,31,0.77 [0.40-1.48],0.4404486322723726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28318,34,1.57 [0.84-2.96],0.1582217490668556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT8,"Alpha-(1,6)-fucosyltransferase",27859,34,0.49 [0.28-0.87],0.0140643369319867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXN,"Frataxin, mitochondrial",28300,35,0.96 [0.64-1.44],0.8497854355072634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXYD5,FXYD domain-containing ion transport regulator 5,27532,33,0.79 [0.48-1.29],0.3471436886139428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FYB1,FYN-binding protein 1,28001,35,0.88 [0.64-1.21],0.429978765496094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD10,Frizzled-10,23704,29,0.71 [0.32-1.56],0.3914661414523693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD8,Frizzled-8,23603,29,0.50 [0.17-1.42],0.1917975058244994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24264,30,0.96 [0.45-2.03],0.9089318688592124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23936,31,1.11 [0.69-1.79],0.6699022340194642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23603,29,0.77 [0.38-1.53],0.4492062422096351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD1,Glutamate decarboxylase 1,23522,29,1.00 [0.25-3.92],0.9984957337520955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD2,Glutamate decarboxylase 2,23683,29,1.51 [0.89-2.55],0.1244941411283814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23936,31,0.98 [0.47-2.05],0.9575307863351584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23705,29,1.19 [0.64-2.24],0.5833541454646813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAGE2A,G antigen 2A,23522,29,0.71 [0.34-1.49],0.3711518528550489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAL,Galanin peptides,28177,35,0.65 [0.41-1.02],0.0625704747260157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,27925,35,2.39 [0.90-6.32],0.0800218247183186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28300,35,0.44 [0.15-1.31],0.1405294887490971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27532,33,1.23 [0.60-2.53],0.5690847018014453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24383,31,1.81 [0.59-5.56],0.2982006633468521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT7,N-acetylgalactosaminyltransferase 7,27925,35,1.22 [0.29-5.26],0.7850691196098024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAMT,Guanidinoacetate N-methyltransferase,23606,31,0.58 [0.17-1.97],0.3790090807605961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23328,29,3.73 [0.97-14.44],0.0563008043312678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GART,Trifunctional purine biosynthetic protein adenosine-3,24343,30,0.83 [0.46-1.49],0.5276302708667978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS2,Growth arrest-specific protein 2,23936,31,0.98 [0.50-1.93],0.9535821318234616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS6,Growth arrest-specific protein 6,28200,34,2.78 [0.90-8.57],0.0755373866021816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GASK1A,Golgi-associated kinase 1A,23606,31,0.95 [0.43-2.10],0.898525594448972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAST,Gastrin,24309,30,0.99 [0.74-1.32],0.9453519346924087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23522,29,1.28 [0.33-5.02],0.7242925419353475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23705,29,0.91 [0.57-1.44],0.6844750056328955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBA,Lysosomal acid glucosylceramidase,23704,29,1.55 [0.98-2.46],0.0631924678539248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP1,Guanylate-binding protein 1,24264,30,1.53 [0.94-2.47],0.0873242545776497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP2,Guanylate-binding protein 2,27532,33,0.81 [0.47-1.38],0.4366204022765434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP4,Guanylate-binding protein 4,27384,35,0.68 [0.35-1.34],0.2665490531745887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP6,Guanylate-binding protein 6,23606,31,0.58 [0.20-1.62],0.2963668267378918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GC,Vitamin D-binding protein,24414,31,1.37 [0.37-5.09],0.6371194803123627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCC1,GRIP and coiled-coil domain-containing protein 1,24309,30,0.96 [0.70-1.32],0.80432593475668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCG,Pro-glucagon,27370,35,1.14 [0.90-1.44],0.2925768786717506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23247,29,1.82 [1.17-2.82],0.0074840920127815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCLM,Glutamate--cysteine ligase regulatory subunit,23606,31,1.37 [0.77-2.44],0.2823505442390147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27925,35,1.14 [0.48-2.69],0.7692329204884962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,28400,34,1.88 [1.25-2.85],0.0026248492249113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF2,Growth/differentiation factor 2,28053,34,0.99 [0.42-2.31],0.981704347189216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDNF,Glial cell line-derived neurotrophic factor,27384,35,0.77 [0.35-1.71],0.5217337411608601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GET3,ATPase GET3,24383,31,1.46 [0.92-2.30],0.104839045738659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,27329,35,1.17 [0.60-2.29],0.6429650288179953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFER,FAD-linked sulfhydryl oxidase ALR,27370,35,1.05 [0.67-1.66],0.8273166334689965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27370,35,0.92 [0.70-1.21],0.5534183798729592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,28263,35,2.14 [0.79-5.81],0.1352546918269912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA2,GDNF family receptor alpha-2,27925,35,1.01 [0.24-4.25],0.984895672092666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA3,GDNF family receptor alpha-3,27768,34,2.07 [0.73-5.89],0.1740394466888726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRAL,GDNF family receptor alpha-like,23597,30,1.13 [0.68-1.88],0.6248913229274501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGA1,ADP-ribosylation factor-binding protein GGA1,27384,35,1.06 [0.71-1.60],0.7636224697504597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGACT,Gamma-glutamylaminecyclotransferase,24383,31,0.98 [0.61-1.58],0.9408480096606842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGCT,Gamma-glutamylcyclotransferase,24342,31,1.08 [0.54-2.16],0.8244914293168863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGH,Gamma-glutamyl hydrolase,27535,35,1.81 [0.85-3.87],0.1230896931835449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT1,Glutathione hydrolase 1 proenzyme,27991,35,1.67 [1.04-2.68],0.0344853987833382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT5,Glutathione hydrolase 5 proenzyme,27859,34,2.78 [1.03-7.46],0.0426011051170779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH1,Somatotropin,28021,34,0.93 [0.78-1.11],0.4360315302651772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH2,Growth hormone variant,27370,35,1.09 [0.92-1.28],0.319461646311442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHR,Growth hormone receptor,23831,30,0.97 [0.29-3.22],0.9563720764468776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRHR,Growth hormone-releasing hormone receptor,27384,35,1.01 [0.57-1.76],0.9839959335502088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRL,Appetite-regulating hormone,28053,34,1.05 [0.72-1.54],0.7935218634346959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GID8,Glucose-induced degradation protein 8 homolog,24343,30,1.36 [0.61-3.03],0.4509332955012147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIGYF2,GRB10-interacting GYF protein 2,24343,30,0.80 [0.50-1.27],0.343996491329765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP7,GTPase IMAP family member 7,23831,30,0.65 [0.20-2.16],0.4843984343476296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP8,GTPase IMAP family member 8,23522,29,1.46 [0.82-2.60],0.1942761266786013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIP,Gastric inhibitory polypeptide,23705,29,1.83 [0.90-3.76],0.0971852004247391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC2,PDZ domain-containing protein GIPC2,24309,30,1.99 [0.74-5.35],0.1725851398774083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC3,PDZ domain-containing protein GIPC3,24290,31,1.01 [0.72-1.42],0.954739796624181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPR,Gastric inhibitory polypeptide receptor,23683,29,0.89 [0.38-2.09],0.7963029287819197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIT1,ARF GTPase-activating protein GIT1,23683,29,1.06 [0.73-1.53],0.765551907604225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GJA8,Gap junction alpha-8 protein,23522,29,1.36 [0.91-2.05],0.1374682896665889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GKN1,Gastrokine-1,26853,35,1.39 [0.47-4.13],0.550977339266941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLA,Alpha-galactosidase A,23780,30,0.59 [0.25-1.40],0.2281136295023057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLB1,Beta-galactosidase,27859,34,0.74 [0.36-1.54],0.4240673045851844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLI2,Zinc finger protein GLI2,23683,29,1.97 [1.08-3.60],0.028198461826509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLO1,Lactoylglutathione lyase,27549,34,1.92 [1.18-3.12],0.0088959727257017
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLOD4,Glyoxalase domain-containing protein 4,27981,35,1.50 [0.65-3.47],0.3391178590943245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLP1R,Glucagon-like peptide 1 receptor,23603,29,1.37 [0.61-3.07],0.4494138836397532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX,Glutaredoxin-1,27881,33,1.67 [1.03-2.70],0.0363908023484419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23831,30,0.98 [0.67-1.45],0.9240665713207707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27384,35,1.01 [0.53-1.94],0.9671510841207926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLYR1,Putative oxidoreductase GLYR1,24264,30,1.30 [0.81-2.09],0.2732250111021217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GM2A,Ganglioside GM2 activator,23802,30,1.54 [0.86-2.76],0.1490074943150265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMFG,Glia maturation factor gamma,24383,31,1.05 [0.66-1.67],0.8423228785311804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR,GMP reductase 1,28389,35,1.21 [0.65-2.24],0.5483347757792141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR2,GMP reductase 2,23831,30,1.00 [0.59-1.68],0.9908515380068168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNAS,Neuroendocrine secretory protein 55,24343,30,1.25 [0.90-1.74],0.1906634241624506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27370,35,1.16 [0.74-1.81],0.5172778119089199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23704,29,0.97 [0.47-2.03],0.9392044881219536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNLY,Granulysin,28041,35,0.72 [0.47-1.12],0.1418805886536866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA1,Glucosamine-6-phosphate isomerase 1,23705,29,1.45 [0.64-3.26],0.3699001395681675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA2,Glucosamine-6-phosphate isomerase 2,23831,30,0.77 [0.30-1.97],0.582125815089843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLGA3,Golgin subfamily A member 3,24343,30,1.20 [0.78-1.83],0.4079389622552584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLM2,Protein GOLM2,28318,34,0.94 [0.24-3.62],0.9292836516827366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,28032,35,0.84 [0.63-1.11],0.2205848054452866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GORASP2,Golgi reassembly-stacking protein 2,24290,31,0.82 [0.40-1.70],0.5979844646053045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOT1,"Aspartate aminotransferase, cytoplasmic",24372,31,1.49 [0.77-2.89],0.2319705652294951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BA,Platelet glycoprotein Ib alpha chain,27919,35,0.76 [0.30-1.88],0.5484436780037281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BB,Platelet glycoprotein Ib beta chain,23606,31,0.92 [0.55-1.52],0.7399430072328896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27187,34,1.12 [0.80-1.56],0.5154074470074926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP5,Platelet glycoprotein V,23831,30,0.68 [0.28-1.66],0.3945278668096066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP6,Platelet glycoprotein VI,28001,35,0.84 [0.61-1.17],0.3030115863559215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPA33,Cell surface A33 antigen,27925,35,1.01 [0.81-1.28],0.9031876887519033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC1,Glypican-1,28300,35,0.36 [0.13-0.98],0.045543454171006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC5,Glypican-5,27859,34,0.99 [0.58-1.70],0.9850584992719508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPD1,Glycerol-3-phosphate dehydrogenase,24264,30,1.72 [1.01-2.93],0.0464434332637232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPHA2,Glycoprotein hormone alpha-2,24290,31,0.81 [0.34-1.93],0.6353118242138169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPI,Glucose-6-phosphate isomerase,24402,31,1.16 [0.59-2.29],0.6619645405416597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24290,31,0.84 [0.55-1.28],0.4100645057025232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPKOW,G-patch domain and KOW motifs-containing protein,27384,35,1.37 [0.60-3.15],0.4546175725614808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPNMB,Transmembrane glycoprotein NMB,27298,32,2.18 [0.74-6.44],0.159745915961582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR101,Probable G-protein coupled receptor 101,23603,29,0.93 [0.49-1.76],0.8171367725803367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR158,Probable G-protein coupled receptor 158,24343,30,0.93 [0.33-2.63],0.8945588978063495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR15L,Protein GPR15L,24290,31,0.80 [0.47-1.35],0.4050210787832072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR37,Prosaposin receptor GPR37,27549,34,2.11 [1.37-3.25],0.0007065588447566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPRC5C,G-protein coupled receptor family C group 5 member C,24264,30,1.60 [1.14-2.25],0.0066198665768157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRAP2,GRB2-related adapter protein 2,28053,34,0.90 [0.71-1.13],0.3641332974141282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24383,31,1.33 [0.79-2.25],0.2769524845228849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIK2,"Glutamate receptor ionotropic, kainate 2",24343,30,1.30 [0.60-2.78],0.503435641352945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23603,29,1.13 [0.65-1.98],0.6571675689997807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRK5,G protein-coupled receptor kinase 5,27549,34,1.05 [0.59-1.85],0.8762558953885622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRN,Progranulin,27900,35,2.10 [0.69-6.43],0.1926785251835124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRP,Gastrin-releasing peptide,23705,29,0.91 [0.47-1.78],0.7873448305757821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRPEL1,"GrpE protein homolog 1, mitochondrial",27925,35,1.34 [0.89-2.02],0.1543392179286113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRSF1,G-rich sequence factor 1,23391,29,1.00 [0.65-1.54],0.991179394276776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSAP,Gamma-secretase-activating protein,27370,35,1.11 [0.82-1.51],0.5083567684544977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSN,Gelsolin,24301,31,0.66 [0.12-3.66],0.6317186772382171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSR,"Glutathione reductase, mitochondrial",24271,31,4.12 [1.35-12.53],0.0126674559269003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA1,Glutathione S-transferase A1,28015,34,1.14 [0.82-1.58],0.4446385717381734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA3,Glutathione S-transferase A3,27370,35,1.17 [0.82-1.66],0.379854473776253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTM4,Glutathione S-transferase Mu 4,23606,31,0.83 [0.47-1.46],0.5182789446263939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTP1,Glutathione S-transferase P,27208,35,0.97 [0.62-1.51],0.8763209084453657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTT2B,Glutathione S-transferase theta-2B,24309,30,0.99 [0.86-1.14],0.8718938242352459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23936,31,1.16 [0.79-1.72],0.4451023967888861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTPBP2,GTP-binding protein 2,23704,29,0.97 [0.63-1.50],0.9053715296345076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCA2A,Guanylin,27907,35,1.34 [0.55-3.28],0.5160049030053047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCY2C,Heat-stable enterotoxin receptor,23936,31,0.89 [0.55-1.42],0.6163388755256398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUK1,Guanylate kinase,23606,31,0.92 [0.37-2.31],0.8610140778426882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUSB,Beta-glucuronidase,28155,34,0.92 [0.56-1.51],0.7439009511333219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GYS1,"Glycogen [starch] synthase, muscle",27549,34,0.97 [0.70-1.35],0.8690396144357648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMA,Granzyme A,28389,35,0.60 [0.25-1.46],0.2590761082544963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMB,Granzyme B,28032,35,0.62 [0.37-1.03],0.0626430290965756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMH,Granzyme H,27549,34,0.71 [0.45-1.12],0.1436324007221208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,H2AP,Huntingtin-interacting protein M,23522,29,1.13 [0.61-2.11],0.6961819833516456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23606,31,0.89 [0.48-1.67],0.7183313645494462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28226,35,1.48 [1.00-2.18],0.0488396100504107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAO1,Hydroxyacid oxidase 1,28300,35,1.05 [0.84-1.31],0.6835752059901745
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HARS1,"Histidine--tRNA ligase, cytoplasmic",28041,35,0.95 [0.65-1.40],0.8135507991775817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,28263,35,1.00 [0.62-1.60],0.9951833728448805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,28041,35,2.53 [1.30-4.91],0.0063385081278018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBEGF,Proheparin-binding EGF-like growth factor,28226,35,0.80 [0.53-1.19],0.263166122886639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBQ1,Hemoglobin subunit theta-1,28300,35,1.42 [0.92-2.18],0.1113726459430211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBZ,Hemoglobin subunit zeta,24383,31,0.86 [0.62-1.20],0.3747955234875582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCG22,Protein PBMUCL2,23606,31,0.63 [0.24-1.63],0.339080571616017
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCLS1,Hematopoietic lineage cell-specific protein,28389,35,1.26 [0.74-2.14],0.403125686492042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC8,Histone deacetylase 8,23683,29,1.32 [0.89-1.95],0.1666723222416938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC9,Histone deacetylase 9,23603,29,0.79 [0.39-1.58],0.5024940549166864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDDC2,5'-deoxynucleotidase HDDC2,24290,31,1.70 [0.87-3.32],0.1179361531749401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGF,Hepatoma-derived growth factor,28269,35,1.34 [0.98-1.84],0.0692030559316531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGFL2,Hepatoma-derived growth factor-related protein 2,24309,30,1.23 [0.74-2.03],0.4275073498320764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEBP1,Heme-binding protein 1,27549,34,1.28 [0.83-1.97],0.2601453426951831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEG1,Protein HEG homolog 1,23831,30,2.23 [0.66-7.56],0.196761323733589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPACAM2,HEPACAM family member 2,24309,30,0.76 [0.34-1.71],0.5090206416561702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPH,Hephaestin,24383,31,4.43 [1.19-16.48],0.0263755366600344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEXIM1,Protein HEXIM1,28032,35,0.76 [0.52-1.10],0.149113949817859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,28389,35,2.70 [1.42-5.14],0.002479429164209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGFAC,Hepatocyte growth factor activator,24172,30,0.75 [0.23-2.49],0.6409676255715975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27370,35,0.96 [0.65-1.42],0.8470543213843531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HHEX,Hematopoietically-expressed homeobox protein HHEX,24309,30,1.03 [0.66-1.60],0.894004957018244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIF1A,Hypoxia-inducible factor 1-alpha,23683,29,1.08 [0.67-1.75],0.7470404058365512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1,Huntingtin-interacting protein 1,23606,31,1.42 [0.64-3.12],0.3863873857325448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1R,Huntingtin-interacting protein 1-related protein,24271,30,0.89 [0.39-2.03],0.777878745152931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HJV,Hemojuvelin,24343,30,1.20 [0.56-2.56],0.6369469689860268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HK2,Hexokinase-2,27549,34,0.91 [0.30-2.78],0.8650920095646711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",24343,30,4.03 [1.31-12.41],0.0152864296689973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27940,35,1.02 [0.45-2.35],0.9570825354299644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",28032,35,2.55 [1.05-6.20],0.038135760847055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMBS,Porphobilinogen deaminase,28300,35,2.10 [1.04-4.24],0.0392841322894174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMCN2,Hemicentin-2,23784,30,0.95 [0.53-1.73],0.8735861811525516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23705,29,1.08 [0.54-2.16],0.8297770451446902
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23606,31,0.57 [0.23-1.44],0.2356859414660029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMMR,Hyaluronan mediated motility receptor,23482,29,0.55 [0.21-1.46],0.2300237408055656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX1,Heme oxygenase 1,27736,32,0.89 [0.47-1.70],0.7274079256491726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX2,Heme oxygenase 2,27384,35,1.42 [0.87-2.32],0.1585938142329398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNF1A,Hepatocyte nuclear factor 1-alpha,23704,29,0.40 [0.16-0.98],0.0446509300684985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNMT,Histamine N-methyltransferase,27723,34,1.52 [0.85-2.71],0.1564684563421906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27449,34,0.94 [0.64-1.40],0.7748914421113375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24343,30,1.32 [0.73-2.38],0.3560685824530488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPCAL1,Hippocalcin-like protein 1,28389,35,0.84 [0.57-1.23],0.3646712207520775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPGDS,Hematopoietic prostaglandin D synthase,27370,35,0.74 [0.33-1.66],0.4673198682332365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPSE,Heparanase,24059,31,0.97 [0.68-1.38],0.8490325504110969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRAS,GTPase Hras,23902,31,1.23 [0.97-1.57],0.0928571956561384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23705,29,1.61 [0.73-3.55],0.2421473573391898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRG,Histidine-rich glycoprotein,24284,30,0.89 [0.30-2.63],0.8389265014280789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS1BP3,HCLS1-binding protein 3,23705,29,1.06 [0.72-1.56],0.7571855756821766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27925,35,0.77 [0.35-1.67],0.5029313074427706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28300,35,1.66 [0.78-3.52],0.1868296044292532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23683,29,0.81 [0.28-2.30],0.6918016095012458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSBP1,Heat shock factor-binding protein 1,23705,29,1.19 [0.83-1.71],0.3420355012640601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,28032,35,1.48 [0.72-3.06],0.2845911135659149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24309,30,1.49 [0.88-2.53],0.138672442104945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23606,31,0.81 [0.37-1.80],0.6100227551259402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23705,29,0.81 [0.38-1.71],0.5737976367808139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSP90B1,Endoplasmin,27255,35,1.21 [0.86-1.70],0.2841548027259374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA1A,Heat shock 70 kDa protein 1A,28122,35,0.99 [0.66-1.50],0.9768906533773328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA2,Heat shock-related 70 kDa protein 2,24264,30,0.85 [0.30-2.46],0.7696813761336516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB1,Heat shock protein beta-1,27586,33,0.80 [0.53-1.19],0.2700889669970944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,28300,35,0.90 [0.41-1.95],0.7845982160054668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27823,35,1.30 [0.42-4.04],0.6557579808229372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1A,5-hydroxytryptamine receptor 1A,23603,29,1.16 [0.79-1.72],0.4459599288144601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1B,5-hydroxytryptamine receptor 1B,23603,29,0.58 [0.20-1.64],0.304671498365698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTRA2,"Serine protease HTRA2, mitochondrial",28116,35,0.82 [0.50-1.33],0.4199869881357304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYAL1,Hyaluronidase-1,27866,35,2.16 [0.67-7.00],0.1998741397157284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYOU1,Hypoxia up-regulated protein 1,28400,34,0.48 [0.12-1.84],0.2834824757559158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICA1,Islet cell autoantigen 1,27532,33,0.72 [0.48-1.09],0.1175260602947379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM1,Intercellular adhesion molecule 1,27922,35,3.31 [1.40-7.85],0.0065335521917155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM2,Intercellular adhesion molecule 2,28400,34,1.57 [0.60-4.14],0.3589537145160431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM3,Intercellular adhesion molecule 3,28400,34,1.71 [0.58-5.01],0.3285878632686909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM4,Intercellular adhesion molecule 4,28032,35,1.15 [0.65-2.03],0.6344716861718411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM5,Intercellular adhesion molecule 5,28053,34,1.19 [0.61-2.29],0.6097225034405909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICOSLG,ICOS ligand,27925,35,0.73 [0.15-3.47],0.6948918665400727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ID4,DNA-binding protein inhibitor ID-4,23936,31,1.03 [0.48-2.21],0.937401686585704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27384,35,0.84 [0.43-1.64],0.6109168275627621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDO1,"Indoleamine 2,3-dioxygenase 1",23705,29,1.23 [0.73-2.07],0.4324848948963867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDS,Iduronate 2-sulfatase,28389,35,0.56 [0.13-2.43],0.4403199376120551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDUA,Alpha-L-iduronidase,28300,35,1.70 [0.89-3.24],0.1101607042239234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23719,29,2.76 [1.42-5.38],0.0027502852015389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23936,31,1.30 [0.71-2.38],0.4012675974417148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23936,31,1.59 [0.79-3.20],0.1917113996257926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNAR1,Interferon alpha/beta receptor 1,24290,31,1.39 [0.43-4.56],0.5837276454778932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNG,Interferon gamma,27532,33,1.22 [0.93-1.58],0.1454540908239747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,28177,35,1.66 [0.44-6.21],0.4534772281189094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR2,Interferon gamma receptor 2,27859,34,0.77 [0.43-1.39],0.3828048948075817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL1,Interferon lambda-1,27384,35,1.70 [1.08-2.66],0.0214967629030982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL2,Interferon lambda-2,23603,29,0.76 [0.37-1.59],0.4714161671763713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNLR1,Interferon lambda receptor 1,28032,35,1.26 [0.62-2.59],0.5231156408014828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNW1,Interferon omega-1,23606,31,0.78 [0.25-2.41],0.6714505489709439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFT20,Intraflagellar transport protein 20 homolog,23704,29,1.17 [0.54-2.53],0.6963395712458361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGBP1,Immunoglobulin-binding protein 1,24343,30,1.40 [0.81-2.39],0.2255766505210237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23603,29,1.07 [0.56-2.04],0.8314936158414679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24372,31,0.85 [0.24-2.97],0.801379830729345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF1R,Insulin-like growth factor 1 receptor,27925,35,0.38 [0.09-1.64],0.1941674169828826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23606,31,0.60 [0.23-1.57],0.3001241292121477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2R,Cation-independent mannose-6-phosphate receptor,28041,35,2.89 [0.88-9.50],0.0813045564543072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP1,Insulin-like growth factor-binding protein 1,28353,34,1.01 [0.80-1.28],0.922444467461102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,28347,34,2.12 [1.32-3.40],0.0018113343073895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP3,Insulin-like growth factor-binding protein 3,28135,35,0.34 [0.16-0.71],0.0041731310812013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,27682,35,1.71 [0.92-3.19],0.0919986170041593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP6,Insulin-like growth factor-binding protein 6,27924,35,1.19 [0.44-3.18],0.7352673803026477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,28400,34,2.82 [1.69-4.71],7.570475504129178e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,28053,34,2.48 [1.20-5.16],0.0147824282775828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFL4,Insulin growth factor-like family member 4,23683,29,1.09 [0.72-1.65],0.6846943003263497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGHMBP2,DNA-binding protein SMUBP-2,23606,31,1.02 [0.56-1.85],0.9570369153220408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,24377,31,1.60 [0.75-3.39],0.2232686851438039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLON5,IgLON family member 5,23522,29,1.33 [1.06-1.67],0.0136677122878362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF21,Immunoglobulin superfamily member 21,23705,29,0.56 [0.20-1.54],0.2630295598436309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF3,Immunoglobulin superfamily member 3,27925,35,1.56 [0.81-3.00],0.1849665334941962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF8,Immunoglobulin superfamily member 8,28053,34,0.53 [0.19-1.47],0.2220284225301667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF9,Protein turtle homolog A,24383,31,1.07 [0.74-1.56],0.7124497340905735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKBKG,NF-kappa-B essential modulator,28032,35,0.85 [0.61-1.17],0.3177385145029534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKZF2,Zinc finger protein Helios,27370,35,1.17 [0.89-1.53],0.2638114126611804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10,Interleukin-10,27532,33,1.00 [0.67-1.48],0.9891872779974092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RA,Interleukin-10 receptor subunit alpha,27532,33,0.88 [0.47-1.64],0.6862010607966194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RB,Interleukin-10 receptor subunit beta,28177,35,1.13 [0.42-3.03],0.8141536683567668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL11,Interleukin-11,27532,33,0.88 [0.51-1.52],0.6579633375428946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12A_IL12B,Interleukin-12,27925,35,1.30 [0.90-1.89],0.1648366067210676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12B,Interleukin-12 subunit beta,28389,35,1.32 [0.77-2.26],0.3050324356927584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB1,Interleukin-12 receptor subunit beta-1,27532,33,1.37 [0.61-3.08],0.4518734414223666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB2,Interleukin-12 receptor subunit beta-2,23683,29,0.95 [0.40-2.27],0.9076611866786964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13,Interleukin-13,27532,33,1.09 [0.61-1.94],0.7701438817439161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA1,Interleukin-13 receptor subunit alpha-1,27674,35,0.82 [0.24-2.80],0.7517820985970505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA2,Interleukin-13 receptor subunit alpha-2,23603,29,1.33 [0.38-4.63],0.65240432135269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,28032,35,3.46 [1.84-6.49],0.0001117187577198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15RA,Interleukin-15 receptor subunit alpha,27532,33,2.31 [0.99-5.34],0.0514482459942859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL16,Pro-interleukin-16,28389,35,0.69 [0.33-1.45],0.3274136376590185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17A,Interleukin-17A,27488,33,1.12 [0.60-2.10],0.718713700081488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17C,Interleukin-17C,27532,33,1.31 [0.88-1.96],0.1818223213782507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17D,Interleukin-17D,27532,33,1.51 [0.83-2.72],0.1755226191801842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17F,Interleukin-17F,27532,33,0.75 [0.45-1.25],0.2679657721434663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RA,Interleukin-17 receptor A,28041,35,1.01 [0.54-1.91],0.9706962061866092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RB,Interleukin-17 receptor B,27664,35,1.09 [0.63-1.88],0.7584827832152203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18,Interleukin-18,27933,35,1.42 [0.78-2.56],0.2511407920210078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18BP,Interleukin-18-binding protein,28135,35,2.95 [1.41-6.17],0.0041455536914738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18R1,Interleukin-18 receptor 1,28389,35,2.34 [1.04-5.25],0.03997241360469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18RAP,Interleukin-18 receptor accessory protein,27679,34,1.09 [0.93-1.29],0.2995844114176502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL19,Interleukin-19,27361,33,1.03 [0.67-1.57],0.8964116683663989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1A,Interleukin-1 alpha,27532,33,1.29 [0.85-1.95],0.2282279328147813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,27393,32,1.68 [1.16-2.43],0.0058795492339085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,27991,35,2.01 [0.60-6.77],0.2589262654397283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R2,Interleukin-1 receptor type 2,27985,35,4.10 [0.93-18.16],0.0627526376200516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RAP,Interleukin-1 receptor accessory protein,28041,35,0.63 [0.30-1.32],0.2164999887376978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL1,Interleukin-1 receptor-like 1,28300,34,1.84 [0.97-3.51],0.0636041309992613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL2,Interleukin-1 receptor-like 2,27532,33,0.88 [0.40-1.93],0.7549148510172369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,27982,35,1.55 [1.04-2.32],0.0306335729656972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2,Interleukin-2,27532,33,1.20 [0.44-3.24],0.7191980327264045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20,Interleukin-20,27532,33,1.05 [0.58-1.92],0.8675360741509202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RA,Interleukin-20 receptor subunit alpha,27532,33,0.72 [0.31-1.66],0.4425005780421468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RB,Interleukin-20 receptor subunit beta,23683,29,1.03 [0.45-2.36],0.945033346817354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL21R,Interleukin-21 receptor,23683,29,1.05 [0.54-2.02],0.8877158530357802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22,Interleukin-22,24264,30,1.42 [0.93-2.17],0.1056774896089706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22RA1,Interleukin-22 receptor subunit alpha-1,27532,33,1.50 [0.93-2.42],0.0970770302292556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL24,Interleukin-24,27532,33,0.88 [0.44-1.78],0.7272473131767965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL25,Interleukin-25,23440,29,0.43 [0.16-1.19],0.1035996312420225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RA,Interleukin-2 receptor subunit alpha,27873,34,2.36 [1.38-4.04],0.0017961235011304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RB,Interleukin-2 receptor subunit beta,27532,33,1.25 [0.62-2.50],0.5311952139572299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RG,Cytokine receptor common subunit gamma,24264,30,1.42 [0.75-2.72],0.2835301048997103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3,Interleukin-3,23522,29,0.97 [0.54-1.75],0.9139572976613536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31,Interleukin-31,23683,29,1.65 [1.16-2.36],0.0054840703186925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31RA,Interleukin-31 receptor subunit alpha,23598,28,1.10 [0.44-2.72],0.8372122768537049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL32,Interleukin-32,28032,35,1.35 [0.75-2.45],0.3198344909583684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL33,Interleukin-33,27532,33,1.74 [0.89-3.39],0.1035012042140024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL34,Interleukin-34,27333,35,1.39 [0.58-3.36],0.4607873640327479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36A,Interleukin-36 alpha,23683,29,0.88 [0.45-1.73],0.7108538964939588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36G,Interleukin-36 gamma,23605,29,0.94 [0.53-1.64],0.8186048802679061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3RA,Interleukin-3 receptor subunit alpha,27532,33,1.08 [0.41-2.85],0.8832674191167609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4,Interleukin-4,27532,33,1.23 [0.82-1.83],0.3187604922286001
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,28032,35,2.80 [1.55-5.07],0.0006762545316001
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5,Interleukin-5,27532,33,1.21 [1.02-1.43],0.0263641974792523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,28032,35,1.47 [0.89-2.45],0.1355641126124099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,27925,35,1.34 [1.01-1.77],0.040069872034122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6R,Interleukin-6 receptor subunit alpha,27867,35,2.03 [0.87-4.77],0.1026995174438597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6ST,Interleukin-6 receptor subunit beta,28053,34,2.26 [0.46-11.25],0.3180643341986809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7,Interleukin-7,28032,35,0.73 [0.46-1.17],0.1945603766796408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7R,Interleukin-7 receptor subunit alpha,28041,35,0.53 [0.31-0.91],0.0204255116040972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL9,Interleukin-9,23936,31,0.35 [0.13-0.95],0.0395604618282207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27346,35,1.14 [0.70-1.86],0.6022851044645321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMMT,MICOS complex subunit MIC60,24264,30,1.47 [0.82-2.66],0.199709546857002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPA1,Inositol monophosphatase 1,27859,34,0.82 [0.49-1.38],0.4596968160342062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPACT,Protein IMPACT,24309,30,1.54 [0.83-2.83],0.168074474327819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPG1,Interphotoreceptor matrix proteoglycan 1,23603,29,0.41 [0.10-1.71],0.2211986846763575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ING1,Inhibitor of growth protein 1,27334,35,0.87 [0.43-1.76],0.7045855957806672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBB,Inhibin beta B chain,23831,30,2.36 [1.34-4.13],0.0027841735862825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBC,Inhibin beta C chain,28041,35,1.41 [0.66-3.00],0.3725154219862133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP1,Inositol polyphosphate 1-phosphatase,27925,35,0.84 [0.48-1.48],0.5499887348555204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23705,29,1.06 [0.58-1.94],0.8480898391218552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24343,30,0.35 [0.12-1.00],0.0503188981617704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",27925,35,0.83 [0.61-1.12],0.2258670187841021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL3,Insulin-like 3,24309,30,0.70 [0.47-1.05],0.0819424883404884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL4,Early placenta insulin-like peptide,24264,30,0.82 [0.36-1.86],0.6385116156455205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL5,Insulin-like peptide INSL5,24290,31,0.83 [0.58-1.20],0.3189363941568705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSR,Insulin receptor,23683,29,0.43 [0.05-3.89],0.455840319486065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IPCEF1,Interactor protein for cytohesin exchange factors 1,27810,34,0.97 [0.69-1.36],0.8578538387739234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IQGAP2,Ras GTPase-activating-like protein IQGAP2,27925,35,0.97 [0.56-1.67],0.9005713365282867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27549,34,0.70 [0.46-1.06],0.0912297318122654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK1,Interleukin-1 receptor-associated kinase 1,27532,33,0.72 [0.45-1.15],0.1679430714604841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK4,Interleukin-1 receptor-associated kinase 4,28032,35,0.91 [0.69-1.20],0.520170373758144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26967,35,0.94 [0.42-2.07],0.8724693677073868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM1,Isthmin-1,28032,35,0.92 [0.44-1.93],0.832054055642364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM2,Isthmin-2,24372,31,1.07 [0.54-2.13],0.8459537160841885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IST1,IST1 homolog,24116,31,1.02 [0.72-1.43],0.9262029605086206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,28032,35,0.40 [0.17-0.94],0.0358907242452423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA2,Integrin alpha-2,23831,30,0.68 [0.25-1.89],0.4615758668006569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA5,Integrin alpha-5,28041,35,1.53 [0.49-4.80],0.4694797391962143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA6,Integrin alpha-6,28032,35,0.78 [0.43-1.43],0.4232256049504337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAL,Integrin alpha-L,23683,29,0.85 [0.38-1.88],0.686640870418102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAM,Integrin alpha-M,28041,35,0.57 [0.23-1.47],0.2465107649799293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAV,Integrin alpha-V,28300,35,0.69 [0.33-1.46],0.3336796023291347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAX,Integrin alpha-X,23936,31,0.95 [0.47-1.90],0.8816110817431245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1,Integrin beta-1,27997,35,1.07 [0.27-4.24],0.9226934868111462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP1,Integrin beta-1-binding protein 1,27370,35,1.62 [0.84-3.11],0.1491678160712723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP2,Integrin beta-1-binding protein 2,27549,34,0.93 [0.71-1.21],0.5731773677810469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB2,Integrin beta-2,27883,34,0.53 [0.18-1.55],0.2446866372461173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB5,Integrin beta-5,28116,35,0.42 [0.19-0.91],0.0284112512714411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB6,Integrin beta-6,27532,33,0.43 [0.15-1.20],0.1065805286522122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB7,Integrin beta-7,28300,35,0.97 [0.51-1.85],0.9249909943259036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGBL1,Integrin beta-like protein 1,24372,31,2.09 [0.99-4.41],0.0542631606804758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24414,31,1.82 [0.37-8.95],0.4594488276305836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28135,35,1.11 [0.52-2.36],0.7859507479970167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24414,31,1.48 [0.53-4.12],0.4479377151206829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24264,30,1.53 [0.84-2.80],0.1688535283047504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITM2A,Integral membrane protein 2A,28032,35,1.38 [0.84-2.25],0.1991026652327666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPA,Inosine triphosphate pyrophosphatase,23606,31,1.00 [0.60-1.67],0.9992351531073396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23705,29,0.75 [0.41-1.35],0.3337376946042535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23603,29,0.85 [0.37-1.98],0.709040700863989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27384,35,1.25 [0.72-2.16],0.423907129008828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IZUMO1,Izumo sperm-egg fusion protein 1,23522,29,1.13 [0.62-2.07],0.6943087740322812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM2,Junctional adhesion molecule B,28318,34,0.49 [0.14-1.69],0.2602060386991012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM3,Junctional adhesion molecule C,23831,30,1.06 [0.54-2.08],0.8678917487247206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JCHAIN,Immunoglobulin J chain,27532,33,1.13 [0.68-1.89],0.6279037376561387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23522,29,1.19 [0.70-2.03],0.5301738425330031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JPT2,Jupiter microtubule associated homolog 2,24290,31,1.07 [0.73-1.56],0.7396816295630455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JUN,Transcription factor AP-1,27532,33,1.57 [1.12-2.20],0.0094978662478695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,27925,35,0.85 [0.44-1.64],0.6334919577426885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZN,Kazrin,24290,31,1.00 [0.72-1.37],0.9818596612691172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNC4,Potassium voltage-gated channel subfamily C member 4,23603,29,1.27 [0.75-2.13],0.371246342225361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNH2,Potassium voltage-gated channel subfamily H member 2,23704,29,1.19 [0.80-1.75],0.3915124914976819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNIP4,Kv channel-interacting protein 4,27384,35,0.82 [0.41-1.65],0.5846836154742103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCTD5,BTB/POZ domain-containing protein KCTD5,23836,28,0.92 [0.41-2.09],0.8481761060570236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDM3A,Lysine-specific demethylase 3A,23683,29,1.16 [0.84-1.59],0.365829184014546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDR,Vascular endothelial growth factor receptor 2,28116,35,1.37 [0.42-4.50],0.6058271760707914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KEL,Kell blood group glycoprotein,27384,35,1.03 [0.45-2.34],0.949390681522533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHDC3L,KH domain-containing protein 3,23522,29,1.07 [0.67-1.71],0.780188895798832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHK,Ketohexokinase,23705,29,1.01 [0.59-1.75],0.958633776640888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA0319,Dyslexia-associated protein KIAA0319,24309,30,2.15 [0.94-4.92],0.0684696706697194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549,UPF0606 protein KIAA1549,23936,31,0.77 [0.48-1.24],0.2865392320520249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549L,UPF0606 protein KIAA1549L,23936,31,0.53 [0.14-1.98],0.3425669688252339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA2013,Uncharacterized protein KIAA2013,24264,30,1.01 [0.54-1.89],0.967880384556418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF1C,Kinesin-like protein KIF1C,23606,31,0.61 [0.18-2.04],0.4196985448069055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF20B,Kinesin-like protein KIF20B,23603,29,1.40 [1.00-1.96],0.0523708029226686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF22,Kinesin-like protein KIF22,23606,31,0.89 [0.68-1.17],0.4081955407352097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIFBP,KIF-binding protein,27925,35,0.81 [0.57-1.15],0.2387044788346193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24264,30,1.09 [0.73-1.62],0.6773848130939213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27370,35,0.87 [0.59-1.29],0.4823841308548967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24290,31,1.14 [0.94-1.38],0.1964738067631574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27370,35,0.79 [0.61-1.02],0.0652337467608042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23522,29,0.94 [0.58-1.53],0.8045697347143627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL1,Kin of IRRE-like protein 1,23603,29,1.11 [0.64-1.91],0.7120351681058331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL2,Kin of IRRE-like protein 2,27384,35,0.97 [0.46-2.07],0.943212481845795
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIT,Mast/stem cell growth factor receptor Kit,28101,35,0.65 [0.24-1.76],0.3999143969977764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KITLG,Kit ligand,28053,34,0.49 [0.24-1.00],0.0515545820960507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLB,Beta-klotho,27384,35,0.86 [0.57-1.29],0.4703658951036414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLF4,Krueppel-like factor 4,23603,29,1.19 [0.53-2.66],0.679507178736291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLHL41,Kelch-like protein 41,24343,30,1.23 [0.70-2.14],0.4745568705732521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK1,Kallikrein-1,27764,33,1.00 [0.79-1.27],0.999518024760456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK10,Kallikrein-10,28029,35,1.14 [0.55-2.36],0.7316443262056271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK11,Kallikrein-11,27843,34,0.93 [0.33-2.59],0.8843935482826315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK12,Kallikrein-12,27370,35,1.00 [0.80-1.24],0.9703291798967216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK13,Kallikrein-13,27408,35,0.56 [0.28-1.10],0.0917740185913307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK14,Kallikrein-14,28300,35,0.67 [0.36-1.26],0.2143238044360956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK15,Kallikrein-15,24226,30,1.32 [0.65-2.69],0.4417946929790162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK3,Prostate-specific antigen,24372,31,0.82 [0.55-1.21],0.3177964847432883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,28300,35,1.56 [1.06-2.31],0.0254873311899972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK6,Kallikrein-6,28076,35,0.47 [0.21-1.04],0.0637464733724618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK7,Kallikrein-7,23213,30,0.97 [0.40-2.34],0.9471298765437371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK8,Kallikrein-8,27097,33,0.64 [0.27-1.53],0.3187619393808584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLKB1,Plasma kallikrein,23938,30,0.91 [0.24-3.48],0.8897569499142637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28389,35,0.95 [0.44-2.06],0.9031883516420212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23603,29,0.44 [0.18-1.08],0.0728418383069068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRD1,Natural killer cells antigen CD94,28389,35,0.65 [0.35-1.21],0.17629735019884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23683,29,0.90 [0.38-2.15],0.812149669898826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRK1,NKG2-D type II integral membrane protein,24309,30,0.75 [0.36-1.55],0.4318526836991996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT14,"Keratin, type I cytoskeletal 14",26511,32,0.81 [0.50-1.31],0.3941784944965553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT17,"Keratin, type I cytoskeletal 17",23606,31,0.70 [0.27-1.85],0.4764926649506587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT18,"Keratin, type I cytoskeletal 18",27925,35,1.06 [0.76-1.48],0.7412000360622326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT19,"Keratin, type I cytoskeletal 19",27994,35,1.14 [0.74-1.75],0.5656082856735469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT5,"Keratin, type II cytoskeletal 5",27384,35,0.65 [0.34-1.21],0.1738280473279575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT6C,"Keratin, type II cytoskeletal 6C",23606,31,0.76 [0.27-2.14],0.5997919296325525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT8,"Keratin, type II cytoskeletal 8",23603,29,1.01 [0.64-1.60],0.956192347464243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYAT1,Kynurenine--oxoglutarate transaminase 1,28000,34,1.00 [0.59-1.70],0.996910364658969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYNU,Kynureninase,28389,35,1.16 [0.63-2.14],0.6266246780684701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L1CAM,Neural cell adhesion molecule L1,28116,35,0.53 [0.20-1.37],0.1892421339085769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24383,31,1.00 [0.68-1.45],0.9793298349444088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACRT,Extracellular glycoprotein lacritin,24219,30,0.58 [0.22-1.53],0.2735399561456736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACTB2,Endoribonuclease LACTB2,28053,34,0.95 [0.60-1.51],0.842105289823861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAG3,Lymphocyte activation gene 3 protein,27925,35,1.29 [0.69-2.39],0.425427975682256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,28032,35,1.24 [0.69-2.23],0.4662587054206297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27859,34,1.19 [0.87-1.63],0.2652070154582829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA1,Laminin subunit alpha-1,23606,31,0.70 [0.29-1.66],0.4153108992830211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA4,Laminin subunit alpha-4,28177,35,0.65 [0.27-1.57],0.335577556933663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMB1,Laminin subunit beta-1,23705,29,1.39 [0.44-4.41],0.5741313634662021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP1,Lysosome-associated membrane glycoprotein 1,23709,31,0.63 [0.15-2.56],0.516700676916656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP2,Lysosome-associated membrane glycoprotein 2,27204,34,1.98 [0.42-9.39],0.3902922455244708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP3,Lysosome-associated membrane glycoprotein 3,28339,35,2.54 [1.51-4.26],0.0004366029923726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMTOR5,Ragulator complex protein LAMTOR5,24264,30,1.22 [0.57-2.62],0.60236791706724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAP3,Cytosol aminopeptidase,27532,33,1.02 [0.54-1.94],0.9480669743461592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LARP1,La-related protein 1,24264,30,0.95 [0.54-1.67],0.8654227089918666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT,Linker for activation of T-cells family member 1,28389,35,0.88 [0.61-1.27],0.4918461740397969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT2,Linker for activation of T-cells family member 2,27925,35,0.93 [0.73-1.18],0.5320262906396944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LATS1,Serine/threonine-protein kinase LATS1,23683,29,1.00 [0.66-1.51],0.9931610652877816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAYN,Layilin,27809,34,1.07 [0.43-2.64],0.8869362679606322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBP,Lipopolysaccharide-binding protein,28135,35,1.39 [0.85-2.26],0.1895743760431954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBR,Delta(14)-sterol reductase LBR,28318,34,0.92 [0.58-1.45],0.7214113586564186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCAT,Phosphatidylcholine-sterol acyltransferase,24402,31,0.84 [0.18-3.87],0.8199981154257856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN15,Lipocalin-15,24343,30,1.49 [1.03-2.16],0.0354373784898624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN2,Neutrophil gelatinase-associated lipocalin,27167,35,2.06 [1.11-3.79],0.0209869965504965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCP1,Plastin-2,24372,31,1.38 [0.72-2.64],0.3305046777076237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLR,Low-density lipoprotein receptor,28128,34,0.94 [0.53-1.65],0.827686111480473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24343,30,0.99 [0.70-1.39],0.9369505731103678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,24383,31,1.41 [0.89-2.23],0.1414632936927661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEFTY2,Left-right determination factor 2,28263,35,0.80 [0.46-1.40],0.4393399855806577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEG1,Protein LEG1 homolog,22988,29,0.88 [0.53-1.45],0.6129294296778277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LELP1,Late cornified envelope-like proline-rich protein 1,23603,29,0.84 [0.48-1.47],0.5487143759931647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEO1,RNA polymerase-associated protein LEO1,24343,30,1.86 [1.11-3.15],0.0195575170257884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEP,Leptin,28053,34,1.52 [0.97-2.39],0.0683116757894961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEPR,Leptin receptor,28053,34,1.02 [0.39-2.66],0.9719237055249214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LETM1,Mitochondrial proton/calcium exchanger protein,24343,30,1.32 [0.75-2.32],0.3298715933246849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS1,Galectin-1,28053,34,1.02 [0.42-2.45],0.9727067372457656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3,Galectin-3,28125,34,1.77 [0.67-4.69],0.2488062604851612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3BP,Galectin-3-binding protein,24414,31,1.76 [0.83-3.75],0.1415733407078269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS4,Galectin-4,28032,35,1.14 [0.67-1.93],0.631040580227652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,27999,34,1.16 [0.58-2.32],0.6673932170512835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS8,Galectin-8,28318,34,0.71 [0.42-1.19],0.1905090934209686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS9,Galectin-9,28036,35,2.22 [0.97-5.10],0.0602083600399277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGMN,Legumain,28177,35,0.88 [0.39-2.01],0.7605033998906918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHB,Lutropin subunit beta,27370,35,1.26 [0.98-1.62],0.0752943445892637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,28080,35,1.88 [1.25-2.82],0.0023953451163747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIF,Leukemia inhibitory factor,27384,35,1.07 [0.60-1.88],0.8231769204505769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIFR,Leukemia inhibitory factor receptor,28032,35,2.63 [0.99-6.98],0.052818564192486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,28041,35,1.46 [0.65-3.31],0.35921664764786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24372,31,1.06 [0.80-1.41],0.6620408662329571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23606,31,1.17 [0.64-2.15],0.6048141228667359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,28021,34,2.82 [1.23-6.49],0.0143798526348483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24383,31,1.21 [0.77-1.91],0.4159399353985564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28400,34,2.46 [0.85-7.12],0.0974625332586389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28247,34,1.77 [0.73-4.29],0.2057502216410522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27532,33,1.86 [0.96-3.62],0.067916492749528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28400,34,0.98 [0.64-1.51],0.9271444437134572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIPF,Gastric triacylglycerol lipase,23705,29,0.98 [0.54-1.76],0.936127872525944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB1,Lamin-B1,24241,31,0.96 [0.55-1.68],0.8879615235236159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB2,Lamin-B2,24309,30,1.46 [0.47-4.55],0.5166111198187057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,24343,30,1.66 [0.87-3.18],0.1249696177572241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD2,Leiomodin-2,23603,29,0.73 [0.37-1.43],0.3586131144745789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LONP1,"Lon protease homolog, mitochondrial",23705,29,1.01 [0.68-1.51],0.9608526460368134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPA,Apolipoprotein(a),23817,29,0.93 [0.76-1.13],0.4668676087463073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPCAT2,Lysophosphatidylcholine acyltransferase 2,27925,35,1.09 [0.58-2.02],0.7931749422574537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPL,Lipoprotein lipase,28053,34,1.04 [0.57-1.90],0.9017786614048252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPO,Lactoperoxidase,27154,33,1.02 [0.63-1.67],0.9284134319197884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPP,Lipoma-preferred partner,23606,31,0.88 [0.52-1.47],0.6249563939337559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23606,31,1.10 [0.68-1.77],0.7051531972338172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23704,29,0.74 [0.30-1.84],0.5223238008508135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRG1,Leucine-rich alpha-2-glycoprotein,24414,31,1.93 [0.55-6.82],0.3057437009955378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28226,35,0.81 [0.34-1.89],0.6212128837775484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23598,29,1.91 [0.89-4.09],0.0968207063614358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP1,Prolow-density lipoprotein receptor-related protein 1,27925,35,1.56 [0.54-4.50],0.4113154767610832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,28053,34,0.89 [0.38-2.07],0.7897445488015336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2,Low-density lipoprotein receptor-related protein 2,23704,29,0.92 [0.33-2.55],0.875137484072103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2BP,LRP2-binding protein,23704,29,1.14 [0.77-1.69],0.514771657865716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28318,34,1.41 [0.93-2.14],0.1063694561282741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC25,Leucine-rich repeat-containing protein 25,27925,35,2.20 [1.35-3.59],0.0016613865950919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24290,31,2.83 [1.32-6.07],0.0075828303223119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC38,Leucine-rich repeat-containing protein 38,23704,29,0.85 [0.39-1.87],0.6892965327611353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC59,Leucine-rich repeat-containing protein 59,24383,31,1.06 [0.53-2.11],0.8658854508360609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24264,30,0.67 [0.31-1.46],0.3166307063166251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,27532,33,0.39 [0.18-0.83],0.0143538346088196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23704,29,0.77 [0.29-2.04],0.6022896737246498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24343,30,0.75 [0.43-1.30],0.2996722011742478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM1,U6 snRNA-associated Sm-like protein LSm1,27370,35,0.99 [0.57-1.72],0.97663365937405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM8,U6 snRNA-associated Sm-like protein LSm8,23936,31,0.99 [0.65-1.50],0.9517228324949786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSP1,Lymphocyte-specific protein 1,28032,35,1.82 [0.95-3.51],0.0728157035426405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA,Lymphotoxin-alpha,28032,35,1.22 [0.58-2.58],0.6034961319207364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA4H,Leukotriene A-4 hydrolase,28300,35,1.24 [0.79-1.95],0.352531390724309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTB,Lymphotoxin-beta,24264,30,1.25 [0.51-3.06],0.6265571219894666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,28400,34,1.92 [0.78-4.71],0.1556444703038525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP3,Latent-transforming growth factor beta-binding protein 3,27370,35,1.26 [0.80-2.00],0.3189532764391015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,27879,35,1.82 [0.70-4.70],0.2158776986549618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTO1,Protein LTO1 homolog,27532,33,0.97 [0.45-2.10],0.9339430857335216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LUZP2,Leucine zipper protein 2,24264,30,1.30 [0.64-2.65],0.4751678665861545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LXN,Latexin,27717,34,1.58 [1.11-2.25],0.0114134498414328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY6D,Lymphocyte antigen 6D,27884,35,0.89 [0.39-2.03],0.7840945051532916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY75,Lymphocyte antigen 75,28032,35,1.42 [0.64-3.15],0.3911100582829577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY9,T-lymphocyte surface antigen Ly-9,27760,35,1.27 [0.47-3.44],0.6341928614526942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY96,Lymphocyte antigen 96,27859,34,1.62 [0.79-3.29],0.1855417720690671
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYAR,Cell growth-regulating nucleolar protein,27370,35,1.13 [0.70-1.83],0.6230238503806933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYN,Tyrosine-protein kinase Lyn,27925,35,0.94 [0.66-1.33],0.727341702943441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD1,Ly6/PLAUR domain-containing protein 1,27384,35,0.85 [0.47-1.52],0.5769895057182497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD3,Ly6/PLAUR domain-containing protein 3,27905,34,0.76 [0.31-1.82],0.5325283829923779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD8,Ly6/PLAUR domain-containing protein 8,27370,35,0.80 [0.44-1.45],0.455364134002912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPLA2,Acyl-protein thioesterase 2,23603,29,1.00 [0.71-1.41],0.9946122412911672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23704,29,0.94 [0.65-1.37],0.7567781447826013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24414,31,0.86 [0.15-4.99],0.8629499882987604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYZL2,Lysozyme-like protein 2,23522,29,0.83 [0.29-2.35],0.729081239724376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LZTFL1,Leucine zipper transcription factor-like protein 1,23831,30,0.96 [0.59-1.57],0.8822828386870465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,M6PR,Cation-dependent mannose-6-phosphate receptor,23705,29,1.00 [0.40-2.47],0.9944079340429812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27770,34,1.24 [0.75-2.05],0.392881705262073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAEA,E3 ubiquitin-protein transferase MAEA,27370,35,0.93 [0.43-2.02],0.8497460945139836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAG,Myelin-associated glycoprotein,23704,29,0.98 [0.46-2.10],0.953792385055859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGEA3,Melanoma-associated antigen 3,23936,31,0.95 [0.64-1.40],0.7835739415487751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGED1,Melanoma-associated antigen D1,27370,35,0.92 [0.48-1.76],0.8051180941355034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC2,MAM domain-containing protein 2,24383,31,2.96 [1.30-6.74],0.0098530267403531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC4,Apical endosomal glycoprotein,24264,30,1.09 [0.61-1.96],0.7639235423695057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23705,29,0.85 [0.22-3.35],0.8152940795160262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN2B2,Epididymis-specific alpha-mannosidase,24383,31,1.15 [0.65-2.05],0.6335623088379854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23522,29,0.71 [0.36-1.40],0.3233417211494733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANF,Mesencephalic astrocyte-derived neurotrophic factor,28177,35,0.87 [0.70-1.09],0.2329780810753983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC1,MANSC domain-containing protein 1,28116,35,2.10 [0.75-5.84],0.1563616282926376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC4,MANSC domain-containing protein 4,23606,31,0.86 [0.49-1.51],0.6015217638985653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23603,29,0.48 [0.16-1.48],0.2033562502166607
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23606,31,0.95 [0.53-1.70],0.8507896649729757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2,Microtubule-associated protein 2,24309,30,1.19 [0.61-2.33],0.6021446268782137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24290,31,1.09 [0.65-1.82],0.7394095707654549
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,28032,35,0.78 [0.58-1.05],0.1030994379045243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27370,35,0.86 [0.62-1.19],0.3717959341073584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27809,34,0.89 [0.68-1.16],0.38921187210086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK13,Mitogen-activated protein kinase 13,23522,29,1.01 [0.45-2.24],0.9887417923080798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK9,Mitogen-activated protein kinase 9,28032,35,0.68 [0.34-1.33],0.2598384433094755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPKAPK2,MAP kinase-activated protein kinase 2,23936,31,0.90 [0.56-1.44],0.6548935054168541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPRE3,Microtubule-associated protein RP/EB family member 3,23522,29,0.84 [0.61-1.17],0.3059612742942166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPT,Microtubule-associated protein tau,27384,35,1.78 [0.98-3.25],0.0600530941732126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARCO,Macrophage receptor MARCO,28053,34,3.16 [1.00-9.95],0.0493400317066257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARS1,"Methionine--tRNA ligase, cytoplasmic",23780,30,0.85 [0.57-1.29],0.4523338534782168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MASP1,Mannan-binding lectin serine protease 1,27809,34,1.57 [0.44-5.65],0.4888221034828636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,28082,35,1.87 [0.71-4.91],0.2066394448030226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN3,Matrilin-3,27810,34,1.02 [0.41-2.57],0.9663951062416178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAVS,Mitochondrial antiviral-signaling protein,27370,35,0.83 [0.59-1.17],0.2854164173008358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAX,Protein max,27384,35,0.93 [0.70-1.24],0.621544982915852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MB,Myoglobin,28400,34,0.59 [0.32-1.11],0.1019363421626455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MBL2,Mannose-binding protein C,24064,30,1.19 [0.86-1.65],0.2844001152998597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCAM,Cell surface glycoprotein MUC18,28135,35,0.77 [0.31-1.91],0.5783886770178973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24343,30,1.32 [0.69-2.53],0.4010028432390257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEMP1,Mast cell-expressed membrane protein 1,23683,29,1.32 [0.93-1.89],0.1209142867858591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCFD2,Multiple coagulation factor deficiency protein 2,27935,34,0.84 [0.43-1.64],0.6102862826967208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCTS1,Malignant T-cell-amplified sequence 1,24290,31,0.47 [0.10-2.25],0.3458480185520888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27859,34,0.99 [0.65-1.52],0.9632606855907956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDH1,"Malate dehydrogenase, cytoplasmic",24268,31,1.30 [0.59-2.89],0.5141357369665858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,28024,35,1.05 [0.59-1.85],0.8756205081813291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDM1,Nuclear protein MDM1,23704,29,1.37 [0.46-4.07],0.5713902852756513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23705,29,1.04 [0.71-1.52],0.8368419895792159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED18,Mediator of RNA polymerase II transcription subunit 18,27370,35,0.80 [0.54-1.18],0.2513353301507939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED21,Mediator of RNA polymerase II transcription subunit 21,23606,31,0.78 [0.33-1.81],0.5596629221296314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF10,Multiple epidermal growth factor-like domains protein 10,28032,35,0.89 [0.43-1.87],0.7662459193671887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF11,Multiple epidermal growth factor-like domains protein 11,23606,31,0.98 [0.32-3.01],0.9717865467408076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF9,Multiple epidermal growth factor-like domains protein 9,28300,34,1.67 [0.44-6.28],0.4496082742733035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MELTF,Melanotransferrin,24383,31,1.63 [0.54-4.91],0.3877761156493654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MENT,Protein MENT,23831,30,0.41 [0.09-1.75],0.2258688170704038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1A,Meprin A subunit alpha,24290,31,1.26 [0.83-1.90],0.2831248057054951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1B,Meprin A subunit beta,28053,34,1.15 [0.88-1.51],0.2995154076295788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEPE,Matrix extracellular phosphoglycoprotein,28032,35,1.18 [0.35-3.96],0.7846819313312174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MERTK,Tyrosine-protein kinase Mer,28389,35,5.51 [2.13-14.25],0.0004261375210895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MESD,LRP chaperone MESD,28041,35,0.91 [0.72-1.16],0.447627456976754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MET,Hepatocyte growth factor receptor,28130,34,1.14 [0.25-5.29],0.8646524647147805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1,Methionine aminopeptidase 1,27384,35,1.18 [0.45-3.05],0.7396450598110442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",28032,35,0.84 [0.58-1.20],0.3353844397065274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP2,Methionine aminopeptidase 2,28263,35,0.99 [0.59-1.66],0.9647724878065558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3,Microfibril-associated glycoprotein 3,27549,34,1.12 [0.61-2.03],0.7203761847500415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3L,Microfibrillar-associated protein 3-like,23704,29,0.88 [0.46-1.66],0.6896247343830734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP4,Microfibril-associated glycoprotein 4,23831,30,2.27 [0.80-6.46],0.1228166032025726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP5,Microfibrillar-associated protein 5,28400,34,0.69 [0.34-1.43],0.3207987293795623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFGE8,Lactadherin,28041,35,1.24 [0.67-2.33],0.4925389079231803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGLL,Monoglyceride lipase,28134,35,0.82 [0.60-1.13],0.2249123108111566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGMT,Methylated-DNA--protein-cysteine methyltransferase,28032,35,0.94 [0.74-1.19],0.5900598308223634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIA,Melanoma-derived growth regulatory protein,28116,35,0.64 [0.30-1.38],0.2578252518159253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICALL2,MICAL-like protein 2,23704,29,0.75 [0.42-1.37],0.3537336941921217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,28032,35,1.01 [0.83-1.23],0.8997376039011318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIF,Macrophage migration inhibitory factor,27992,35,1.04 [0.67-1.62],0.8453411943528197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MILR1,Allergin-1,27532,33,1.98 [1.17-3.35],0.0106287884591323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24264,30,0.92 [0.67-1.27],0.6213102307026266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINK1,Misshapen-like kinase 1,24309,30,0.95 [0.66-1.38],0.7893597086139419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MITD1,MIT domain-containing protein 1,27859,34,0.92 [0.68-1.25],0.5824572997565287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MKI67,Proliferation marker protein Ki-67,23683,29,1.52 [0.96-2.41],0.0768147743376174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLLT1,Protein ENL,23522,29,1.09 [0.68-1.75],0.7239752571293999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLN,Promotilin,28032,35,0.95 [0.68-1.31],0.7389486920320507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MME,Neprilysin,27925,35,1.38 [0.98-1.93],0.0624318498858455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP1,Interstitial collagenase,27059,34,0.88 [0.64-1.23],0.4688118570109979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP10,Stromelysin-2,28007,35,1.05 [0.63-1.74],0.8522582756464223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP12,Macrophage metalloelastase,28091,35,1.60 [0.95-2.70],0.0770841292891991
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP13,Collagenase 3,27384,35,2.20 [0.86-5.62],0.0982617258540038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP15,Matrix metalloproteinase-15,24383,31,0.98 [0.48-2.01],0.9579139686828828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP3,Stromelysin-1,28041,35,0.80 [0.43-1.49],0.4803100172751477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,27507,34,2.00 [1.05-3.78],0.0338961535321833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,28276,34,1.70 [1.25-2.31],0.0007311759036284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,28004,35,2.25 [1.39-3.64],0.0009142247092953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23606,31,1.26 [0.68-2.35],0.4657198540023701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MN1,Transcriptional activator MN1,23704,29,0.60 [0.27-1.34],0.2147694291227337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNAT1,CDK-activating kinase assembly factor MAT1,23936,31,1.09 [0.53-2.24],0.8097724056520098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNDA,Myeloid cell nuclear differentiation antigen,28015,34,1.36 [1.11-1.68],0.0037217823744224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOCS2,Molybdopterin synthase catalytic subunit,23831,30,1.08 [0.65-1.78],0.7740092103179985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOG,Myelin-oligodendrocyte glycoprotein,28300,35,0.83 [0.34-2.06],0.6919952792036523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORC3,MORC family CW-type zinc finger protein 3,24309,30,1.02 [0.29-3.56],0.9804513443774624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L1,Mortality factor 4-like protein 1,23936,31,1.27 [0.62-2.60],0.5167347978274208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L2,Mortality factor 4-like protein 2,23522,29,0.81 [0.28-2.35],0.700077687823241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORN4,MORN repeat-containing protein 4,23522,29,0.84 [0.49-1.43],0.5157650095035615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPHOSPH8,M-phase phosphoprotein 8,27549,34,0.86 [0.57-1.31],0.4859172935591697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPI,Mannose-6-phosphate isomerase,27925,35,0.93 [0.66-1.32],0.6775980162357182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28134,35,0.77 [0.55-1.09],0.1366643976702095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,28041,35,1.90 [1.16-3.10],0.0109039978036139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPRIP,Myosin phosphatase Rho-interacting protein,24222,30,0.69 [0.31-1.54],0.3659352562864147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRC1,Macrophage mannose receptor 1,24402,31,3.70 [1.33-10.30],0.0121227742084922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRI1,Methylthioribose-1-phosphate isomerase,23704,29,1.35 [0.78-2.34],0.2831595040865251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL24,"39S ribosomal protein L24, mitochondrial",23606,31,0.72 [0.25-2.04],0.5355580962522057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL28,"39S ribosomal protein L28, mitochondrial",24343,30,0.68 [0.18-2.50],0.5586422765377976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL46,"39S ribosomal protein L46, mitochondrial",27384,35,1.44 [0.54-3.84],0.4685032093107586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL52,"39S ribosomal protein L52, mitochondrial",23482,29,2.15 [0.80-5.77],0.1275016424902145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24343,30,1.08 [0.68-1.72],0.7370430378398343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPS16,"28S ribosomal protein S16, mitochondrial",23683,29,0.80 [0.21-3.06],0.7462992375406563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLN,Mesothelin,27886,35,1.28 [0.78-2.11],0.3314962608400909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLNL,Mesothelin-like protein,23704,29,1.45 [0.60-3.49],0.412598149451146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSMB,Beta-microseminoprotein,27983,34,1.20 [0.76-1.87],0.4358534292937038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSR1,Macrophage scavenger receptor types I and II,28318,34,2.18 [1.22-3.90],0.0088762633288024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSRA,Mitochondrial peptide methionine sulfoxide reductase,28116,35,0.86 [0.57-1.29],0.45602129720163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MST1,Hepatocyte growth factor-like protein,24041,30,3.00 [1.14-7.93],0.0266211643125509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSTN,Growth/differentiation factor 8,27549,34,0.64 [0.36-1.11],0.1124623175984697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTDH,Protein LYRIC,23683,29,1.25 [0.87-1.81],0.2276660331612059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24309,30,1.14 [0.31-4.25],0.8440058090393352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23936,31,0.95 [0.70-1.28],0.7154251208921649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTIF3,"Translation initiation factor IF-3, mitochondrial",24290,31,0.99 [0.68-1.44],0.962873565944317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTPN,Myotrophin,27549,34,1.02 [0.41-2.53],0.971722320451219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTR,Methionine synthase,23606,31,0.90 [0.51-1.61],0.732059492124823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS1,Protein MTSS 1,24290,31,0.90 [0.66-1.21],0.4805635490755162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS2,Protein MTSS 2,24264,30,1.35 [0.97-1.88],0.0791222829635938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTUS1,Microtubule-associated tumor suppressor 1,23936,31,1.59 [0.99-2.55],0.0541096740497825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC13,Mucin-13,27384,35,1.31 [0.76-2.24],0.3299028120042959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC16,Mucin-16,27925,35,1.03 [0.87-1.21],0.7367445610998624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC2,Mucin-2,24372,31,1.21 [0.85-1.74],0.2915290849922844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUCL3,Mucin-like protein 3,23522,29,0.71 [0.25-2.01],0.5248125509671807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MVK,Mevalonate kinase,27532,33,1.03 [0.72-1.47],0.8885094887776342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MXRA8,Matrix remodeling-associated protein 8,23831,30,0.50 [0.16-1.53],0.2216692477740913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC1,"Myosin-binding protein C, slow-type",24383,31,1.06 [0.68-1.65],0.812102326656599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC2,"Myosin-binding protein C, fast-type",23705,29,1.00 [0.66-1.50],0.9876120756773424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24343,30,0.96 [0.56-1.64],0.8692265685867824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYDGF,Myeloid-derived growth factor,24383,31,0.98 [0.70-1.37],0.8889626944945553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH4,Myosin-4,23606,31,0.82 [0.35-1.92],0.6449850321302568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH7B,Myosin-7B,23522,29,1.61 [0.92-2.82],0.0978292663788909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH9,Myosin-9,24372,31,1.12 [0.83-1.51],0.4514650771576403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23606,31,0.77 [0.29-2.00],0.5854613446499779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL3,Myosin light chain 3,23705,29,0.94 [0.58-1.50],0.7871987856637155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL4,Myosin light chain 4,23705,29,1.06 [0.55-2.02],0.8681220380878115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL6B,Myosin light chain 6B,23704,29,0.87 [0.56-1.37],0.5551105441756551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23704,29,0.71 [0.31-1.67],0.4388113111240531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO6,Unconventional myosin-VI,24343,30,1.54 [0.89-2.67],0.1196125520103584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO9B,Unconventional myosin-IXb,27532,33,0.54 [0.30-0.95],0.0337549969287001
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOC,Myocilin,28041,35,1.03 [0.54-1.95],0.9307975135655386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM1,Myomesin-1,23603,29,1.24 [0.67-2.31],0.4939562793583109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM2,Myomesin-2,23606,31,0.81 [0.40-1.66],0.5700602141038926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM3,Myomesin-3,23831,30,0.99 [0.69-1.41],0.9417732962820188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZB1,Marginal zone B- and B1-cell-specific protein,28125,35,1.62 [0.95-2.79],0.0783928822764459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZT1,Mitotic-spindle organizing protein 1,27370,35,0.91 [0.50-1.67],0.7646177741336329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA10,N-alpha-acetyltransferase 10,23606,31,0.57 [0.30-1.08],0.0841933301155423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA80,N-alpha-acetyltransferase 80,23704,29,1.00 [0.75-1.34],0.9772711569050456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27721,34,0.86 [0.52-1.42],0.5473947505561831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NACC1,Nucleus accumbens-associated protein 1,24264,30,1.51 [0.92-2.49],0.1022606987416728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NADK,NAD kinase,28053,34,1.36 [0.89-2.09],0.1566928661466519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGA,Alpha-N-acetylgalactosaminidase,23647,29,1.46 [1.00-2.15],0.0526562705673523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGK,N-acetyl-D-glucosamine kinase,23661,29,0.87 [0.47-1.63],0.6666654723889424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23831,30,1.54 [0.32-7.46],0.5916601359925159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAMPT,Nicotinamide phosphoribosyltransferase,27370,35,1.37 [0.93-2.01],0.1116699027312422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAP1L4,Nucleosome assembly protein 1-like 4,24250,31,1.97 [0.82-4.77],0.130655918274665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAPRT,Nicotinate phosphoribosyltransferase,24309,30,1.52 [0.61-3.81],0.3683950337437032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24343,30,0.94 [0.46-1.95],0.870679235555205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,28116,35,1.52 [0.50-4.62],0.4649819718171207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBN,Nibrin,27532,33,1.05 [0.61-1.81],0.857143134053408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM1,Neural cell adhesion molecule 1,28135,35,0.97 [0.38-2.47],0.9410567680531544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM2,Neural cell adhesion molecule 2,28041,35,2.36 [0.80-6.97],0.1189234518006454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAN,Neurocan core protein,28318,34,0.43 [0.20-0.92],0.0302009054395853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCF2,Neutrophil cytosol factor 2,27980,35,1.42 [1.10-1.84],0.0079109680262028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCK2,Cytoplasmic protein NCK2,28177,35,0.89 [0.67-1.17],0.3891955311771873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCLN,Nicalin,27532,33,1.56 [1.14-2.15],0.0057864313878385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR1,Natural cytotoxicity triggering receptor 1,27995,35,1.60 [0.73-3.52],0.2380176630502819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24290,31,2.09 [0.87-4.99],0.0971583716010945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,28300,35,2.25 [0.81-6.28],0.1204710998214727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDRG1,Protein NDRG1,27384,35,0.89 [0.55-1.46],0.6464858545682741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24264,30,0.90 [0.48-1.69],0.7408012401997524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23634,29,1.34 [0.52-3.44],0.5385640241132691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24290,31,0.93 [0.64-1.35],0.7005564363442127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27370,35,1.21 [0.91-1.62],0.1863936084590584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEB,Nebulin,23606,31,0.78 [0.28-2.14],0.626315101291139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECAP2,Adaptin ear-binding coat-associated protein 2,23606,31,1.19 [0.75-1.89],0.4578300629107311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN1,Nectin-1,23683,29,1.19 [0.46-3.11],0.7231153208687066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,28021,34,1.58 [0.60-4.18],0.3553661747530182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN4,Nectin-4,28116,35,0.58 [0.21-1.60],0.2914086771046494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23683,29,1.69 [0.75-3.78],0.2039732123495885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD9,Enhancer of filamentation 1,23683,29,1.68 [0.85-3.32],0.1363785872945551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,27294,35,2.26 [1.43-3.56],0.000491306405612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEK7,Serine/threonine-protein kinase Nek7,23936,31,0.77 [0.44-1.35],0.3616259971032961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL1,Protein kinase C-binding protein NELL1,28116,35,1.06 [0.53-2.13],0.8680497866869576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL2,Protein kinase C-binding protein NELL2,28177,35,0.80 [0.28-2.26],0.6704375810472714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NENF,Neudesin,24264,30,0.93 [0.66-1.33],0.7071422340688284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEO1,Neogenin,24343,30,1.02 [0.24-4.38],0.981731918041399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEXN,Nexilin,24402,31,1.06 [0.65-1.72],0.8183576924537237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFASC,Neurofascin,28389,35,0.76 [0.27-2.14],0.5993396916181792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFAT5,Nuclear factor of activated T-cells 5,23683,29,0.73 [0.45-1.18],0.1938877340963271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",28032,35,0.85 [0.62-1.15],0.295284356848891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27532,33,1.40 [0.90-2.18],0.1385583171826073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFE2,Transcription factor NF-E2 45 kDa subunit,23705,29,0.93 [0.58-1.52],0.7854928787281354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFIC,Nuclear factor 1 C-type,24343,30,1.26 [0.66-2.42],0.486568540338142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23606,31,0.90 [0.56-1.43],0.6456478401387686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23936,31,0.99 [0.54-1.82],0.9780103759508476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKBIE,NF-kappa-B inhibitor epsilon,27370,35,1.00 [0.54-1.86],0.991823253474148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24290,31,0.97 [0.70-1.33],0.8306642690707933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFX1,Transcriptional repressor NF-X1,23606,31,1.03 [0.62-1.71],0.9185529929856404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFYA,Nuclear transcription factor Y subunit alpha,23606,31,1.09 [0.47-2.51],0.8449206078030482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGF,Beta-nerve growth factor,27859,34,0.30 [0.03-3.63],0.3463053431510134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGFR,Tumor necrosis factor receptor superfamily member 16,24383,31,0.63 [0.17-2.30],0.4848511573908031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGRN,Neugrin,24309,30,0.66 [0.12-3.67],0.63726403333719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NHLRC3,NHL repeat-containing protein 3,23282,29,3.17 [1.04-9.69],0.0430405700287254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID1,Nidogen-1,28055,35,1.15 [0.53-2.53],0.7226232702341584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID2,Nidogen-2,28041,35,0.99 [0.66-1.48],0.9553896571844056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NINJ1,Ninjurin-1,27370,35,1.19 [0.75-1.89],0.4487682167694371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT1,Deaminated glutathione amidase,23705,29,0.98 [0.45-2.15],0.9607854032023369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT2,Omega-amidase NIT2,24290,31,1.17 [0.75-1.84],0.4900884425541782
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN1,Neuroligin-1,23704,29,0.66 [0.31-1.41],0.2883385609598591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN2,Neuroligin-2,23603,29,0.48 [0.16-1.44],0.1908887347025147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME1,Nucleoside diphosphate kinase A,23683,29,1.43 [0.30-6.87],0.6518093007494454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME3,Nucleoside diphosphate kinase 3,28082,35,0.87 [0.24-3.14],0.8311061823262598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMI,N-myc-interactor,24162,30,1.25 [0.80-1.95],0.3333244565273551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27859,34,1.23 [0.89-1.71],0.2140921707222645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMRK2,Nicotinamide riboside kinase 2,23522,29,0.62 [0.19-1.99],0.4167866090577818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24343,30,1.26 [0.82-1.95],0.2884626128493476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOMO1,Nodal modulator 1,28041,35,1.80 [0.56-5.73],0.3222760274133381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOP56,Nucleolar protein 56,23606,31,0.76 [0.49-1.18],0.21469507534516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS1,"Nitric oxide synthase, brain",27384,35,0.97 [0.57-1.66],0.918171438078301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS2,"Nitric oxide synthase, inducible",23606,31,1.63 [0.83-3.21],0.159927449831448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS3,"Nitric oxide synthase, endothelial",27384,35,1.34 [0.82-2.20],0.2466474826177972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH1,Neurogenic locus notch homolog protein 1,28400,34,0.69 [0.10-4.55],0.6955884144586422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH2,Neurogenic locus notch homolog protein 2,24372,31,1.73 [0.46-6.56],0.4215368562751933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH3,Neurogenic locus notch homolog protein 3,28400,34,1.11 [0.47-2.59],0.8143665806374352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,23974,30,2.26 [1.12-4.54],0.0220021350939012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,28053,34,1.88 [0.86-4.09],0.1116492807750879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS1,Nephrin,23683,29,1.00 [0.36-2.78],0.9943904192738772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS2,Podocin,23683,29,0.98 [0.69-1.40],0.9231676242392128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPL,N-acetylneuraminate lyase,24383,31,1.19 [0.59-2.43],0.6239850602115249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,27549,34,1.23 [0.95-1.58],0.1154442340779961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPC,C-type natriuretic peptide,28032,35,1.07 [0.60-1.92],0.8258485419791508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPR1,Atrial natriuretic peptide receptor 1,23606,31,0.84 [0.33-2.14],0.7082653451208207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTN,Neuroplastin,27370,35,0.60 [0.34-1.07],0.083905442035614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX1,Neuronal pentraxin-1,28041,35,1.09 [0.54-2.22],0.8088581473856251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX2,Neuronal pentraxin-2,24372,31,1.44 [0.53-3.93],0.4758289713474479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTXR,Neuronal pentraxin receptor,28053,34,1.09 [0.48-2.50],0.8334482406321272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPY,Pro-neuropeptide Y,28300,35,0.91 [0.59-1.40],0.6605298543565092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRCAM,Neuronal cell adhesion molecule,28053,34,1.64 [0.60-4.52],0.337234145510536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRGN,Neurogranin,24402,31,1.00 [0.69-1.44],0.9969689293548024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRN1,Neuritin,24343,30,1.57 [0.95-2.59],0.0769926320298416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,28191,35,1.36 [0.48-3.90],0.5617682986461325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP2,Neuropilin-2,28041,35,1.49 [0.59-3.80],0.4004806979069688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRTN,Neurturin,27532,33,0.71 [0.36-1.38],0.3077881309746131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRXN3,Neurexin-3,23704,29,1.55 [0.74-3.28],0.2466948326814116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NSFL1C,NSFL1 cofactor p47,28318,34,1.22 [0.77-1.92],0.3958593690198506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24383,31,1.24 [0.79-1.95],0.3594694501904404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,24309,30,1.89 [0.93-3.86],0.0781276735398829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C3A,Cytosolic 5'-nucleotidase 3A,27982,35,0.89 [0.64-1.25],0.5053119762410403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5E,5'-nucleotidase,28116,35,1.68 [1.08-2.62],0.0218253901647259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF3,Neurotrophin-3,28032,35,1.61 [0.74-3.50],0.2249751068627183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF4,Neurotrophin-4,27370,35,1.48 [0.92-2.39],0.1079895774766829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK2,BDNF/NT-3 growth factors receptor,28053,34,1.00 [0.31-3.23],0.9978719022380256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK3,NT-3 growth factor receptor,28318,34,0.78 [0.44-1.36],0.3778714280168123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,28053,34,1.27 [0.96-1.69],0.0931400772215411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUB1,NEDD8 ultimate buster 1,28032,35,0.88 [0.61-1.26],0.475315924745893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24264,30,1.13 [0.82-1.56],0.4477303868772814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUCB2,Nucleobindin-2,28261,35,1.11 [0.51-2.40],0.7974798670423056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDC,Nuclear migration protein nudC,28389,35,0.75 [0.48-1.16],0.1923397197919712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23705,29,0.45 [0.07-2.74],0.3847773296376711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23606,31,1.26 [0.74-2.15],0.3929844086771026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT16,U8 snoRNA-decapping enzyme,24254,30,1.14 [0.79-1.66],0.4838327348431921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],27925,35,0.70 [0.40-1.22],0.203457816799124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT5,ADP-sugar pyrophosphatase,28041,35,1.17 [0.66-2.05],0.5916544504643944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUMB,Protein numb homolog,23683,29,1.04 [0.69-1.59],0.8469309452072722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUP50,Nuclear pore complex protein Nup50,23606,31,1.44 [0.65-3.23],0.3708096145941324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPE4,NXPE family member 4,23606,31,0.84 [0.28-2.55],0.7613235141446227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH1,Neurexophilin-1,27384,35,1.15 [0.55-2.43],0.7123394492924251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH3,Neurexophilin-3,23683,29,1.53 [0.47-4.93],0.478571379196598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OBP2B,Odorant-binding protein 2b,27760,34,0.77 [0.48-1.23],0.2769102061535026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,24343,30,1.27 [0.61-2.66],0.5248911721023858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ODAM,Odontogenic ameloblast-associated protein,27333,35,1.19 [0.75-1.90],0.4508503409992924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OFD1,Oral-facial-digital syndrome 1 protein,23936,31,1.25 [0.83-1.89],0.2830260516594072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGA,Protein O-GlcNAcase,24290,31,0.96 [0.60-1.54],0.8689083142545896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGFR,Opioid growth factor receptor,27925,35,1.18 [0.48-2.90],0.710123320200625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,28041,35,1.44 [0.70-2.94],0.3206198215024262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23936,31,0.76 [0.39-1.49],0.4269457988624265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLFM4,Olfactomedin-4,22948,29,1.13 [0.84-1.52],0.4061423120458031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,27783,34,1.78 [1.26-2.53],0.0012164413350708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMD,Osteomodulin,28177,35,0.66 [0.35-1.26],0.2115783182396557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,27925,35,0.83 [0.53-1.29],0.4058800876578913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMP,Olfactory marker protein,23603,29,0.77 [0.33-1.80],0.54504174189748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPHN1,Oligophrenin-1,24309,30,0.96 [0.70-1.31],0.7908301854341924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPLAH,5-oxoprolinase,23705,29,0.87 [0.51-1.47],0.6015732743096687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPTC,Opticin,27925,35,0.84 [0.41-1.70],0.6298432455467393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ORM1,Alpha-1-acid glycoprotein 1,24331,31,5.61 [1.35-23.31],0.0175795179921317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSBPL2,Oxysterol-binding protein-related protein 2,24309,30,1.19 [0.53-2.65],0.6697486664726109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSCAR,Osteoclast-associated immunoglobulin-like receptor,28082,35,2.32 [0.97-5.55],0.0581180551685536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,27890,35,1.73 [1.16-2.57],0.0070564913164763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSMR,Oncostatin-M-specific receptor subunit beta,28191,35,6.25 [1.82-21.43],0.0035814130184928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSTN,Osteocrin,23704,29,0.70 [0.25-1.99],0.5092832809091046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTOA,Otoancorin,23603,29,0.68 [0.28-1.65],0.3952134386723749
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD6B,Deubiquitinase OTUD6B,24290,31,1.14 [0.64-2.01],0.6530049620979954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD7B,OTU domain-containing protein 7B,24343,30,1.02 [0.60-1.74],0.9453854609511188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23705,29,1.13 [0.69-1.84],0.6210190268565067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXT,Oxytocin-neurophysin 1,28318,34,1.16 [0.95-1.43],0.1529701325900829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,P4HB,Protein disulfide-isomerase,27897,35,0.66 [0.31-1.39],0.2761671634530664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PACS2,Phosphofurin acidic cluster sorting protein 2,23606,31,0.81 [0.45-1.43],0.4622073135609881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI2,Protein-arginine deiminase type-2,27532,33,1.02 [0.61-1.72],0.9366226132305726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI4,Protein-arginine deiminase type-4,27333,35,1.30 [0.98-1.73],0.0734425730427786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAEP,Glycodelin,27859,34,0.89 [0.69-1.16],0.4043027181775616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24343,30,1.07 [0.81-1.40],0.6476797342440945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23936,31,1.03 [0.53-2.03],0.9228319175640304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27549,34,0.97 [0.56-1.66],0.8979609499073278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAGR1,PAXIP1-associated glutamate-rich protein 1,23705,29,1.11 [0.52-2.37],0.7783118596423032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23476,29,0.51 [0.24-1.12],0.0924845575941375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAK4,Serine/threonine-protein kinase PAK 4,27384,35,0.91 [0.55-1.50],0.7127403697590902
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALLD,Palladin,23683,29,1.19 [0.54-2.62],0.6676386799069338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM,Paralemmin-1,24164,31,0.90 [0.31-2.62],0.853049873662707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,24309,30,2.23 [1.17-4.26],0.0153649064097224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM3,Paralemmin-3,23606,31,0.80 [0.43-1.48],0.4805861723040397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28260,34,1.60 [0.51-4.98],0.4201669437806969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAMR1,Inactive serine protease PAMR1,28041,35,1.14 [0.39-3.35],0.8099510881897074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAPPA,Pappalysin-1,27532,33,1.72 [0.93-3.16],0.0824830934942687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARD3,Partitioning defective 3 homolog,23936,31,0.75 [0.43-1.29],0.2920862745222027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARK7,Parkinson disease protein 7,28041,35,1.21 [0.69-2.13],0.4979823643391327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARP1,Poly [ADP-ribose] polymerase 1,28032,35,1.16 [0.75-1.79],0.5006627557020105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAXX,Protein PAXX,23831,30,1.12 [0.54-2.32],0.7672579671373762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBK,Lymphokine-activated killer T-cell-originated protein kinase,23522,29,1.58 [0.52-4.82],0.4236370057739768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBLD,Phenazine biosynthesis-like domain-containing protein,27384,35,0.89 [0.51-1.57],0.6949286472581614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24290,31,1.03 [0.34-3.15],0.962832377491678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCARE,Photoreceptor cilium actin regulator,23603,29,1.16 [0.83-1.62],0.396416547736908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23779,30,1.44 [0.78-2.67],0.2403863999888615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBP2,Poly(rC)-binding protein 2,24343,30,1.12 [0.70-1.80],0.6240396537606612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH1,Protocadherin-1,28300,35,0.54 [0.11-2.51],0.4290204292088678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH12,Protocadherin-12,24343,30,1.56 [0.44-5.55],0.4903422433755365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH17,Protocadherin-17,28053,34,1.03 [0.45-2.34],0.9522323173192928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH7,Protocadherin-7,24290,31,1.15 [0.46-2.86],0.7656226107462877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH9,Protocadherin-9,24290,31,0.78 [0.32-1.93],0.5947849713585276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDHB15,Protocadherin beta-15,24264,30,1.44 [0.67-3.07],0.3459595726712118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCNA,Proliferating cell nuclear antigen,23522,29,1.30 [0.92-1.83],0.1374036399289837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK7,Proprotein convertase subtilisin/kexin type 7,24264,30,1.38 [0.76-2.52],0.2871723064292273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK9,Proprotein convertase subtilisin/kexin type 9,28400,34,1.48 [0.70-3.12],0.3061163576169645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24290,31,0.98 [0.63-1.52],0.9156839799852275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24383,31,1.04 [0.74-1.47],0.8149920836007633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1,Programmed cell death protein 1,28258,35,1.60 [0.85-3.04],0.1461584588315907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1LG2,Programmed cell death 1 ligand 2,27925,35,1.23 [0.48-3.16],0.6676772952638261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD5,Programmed cell death protein 5,28318,34,1.15 [0.69-1.92],0.5808777608077529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD6,Programmed cell death protein 6,28053,34,1.69 [0.92-3.11],0.0923026169466493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCL2,Phosducin-like protein 2,23522,29,1.00 [0.50-2.00],0.9912162503413436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23522,29,1.44 [1.00-2.06],0.0469706538140675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23606,31,0.98 [0.55-1.77],0.9516524536628174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23831,30,0.87 [0.63-1.20],0.4053411401850683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFA,Platelet-derived growth factor subunit A,28400,34,0.92 [0.61-1.39],0.6978544701392416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFB,Platelet-derived growth factor subunit B,28177,35,0.90 [0.65-1.27],0.5590346647584385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFC,Platelet-derived growth factor C,27370,35,1.53 [0.59-3.94],0.3797270507486073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRA,Platelet-derived growth factor receptor alpha,28053,34,1.73 [0.64-4.63],0.2769619962093792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRB,Platelet-derived growth factor receptor beta,28400,34,0.77 [0.34-1.78],0.5467652560370453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA2,Protein disulfide-isomerase A2,23522,29,1.24 [0.56-2.75],0.6005237720312573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA3,Protein disulfide-isomerase A3,23831,30,2.72 [1.77-4.20],5.554729238367304e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA4,Protein disulfide-isomerase A4,24372,31,0.96 [0.55-1.66],0.8796905062821139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA5,Protein disulfide-isomerase A5,23522,29,1.28 [0.80-2.05],0.2984458261040383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM5,PDZ and LIM domain protein 5,24343,30,0.92 [0.69-1.21],0.5396060068326386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM7,PDZ and LIM domain protein 7,28177,35,0.91 [0.72-1.15],0.4424100811395658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27370,35,1.01 [0.56-1.82],0.9849832989715336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDRG1,p53 and DNA damage-regulated protein 1,23704,29,0.87 [0.41-1.84],0.7120651002549838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23522,29,0.70 [0.28-1.77],0.4511461021549533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZD2,PDZ domain-containing protein 2,23606,31,0.90 [0.50-1.65],0.7380636185184892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23683,29,2.47 [1.62-3.75],2.618877642263137e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEAR1,Platelet endothelial aggregation receptor 1,28400,34,0.35 [0.10-1.21],0.0985148635166167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEBP1,Phosphatidylethanolamine-binding protein 1,28041,35,1.40 [0.86-2.27],0.1714291028274647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECAM1,Platelet endothelial cell adhesion molecule,28041,35,1.14 [0.43-3.02],0.7892883099788245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23705,29,0.80 [0.22-2.97],0.7435123338718217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PENK,Proenkephalin-A,23831,30,1.14 [0.38-3.44],0.8179060253058767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,24402,31,1.10 [0.30-3.97],0.889191119727465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PER3,Period circadian protein homolog 3,23683,29,0.89 [0.65-1.21],0.4491186645136809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PF4,Platelet factor 4,24233,31,0.99 [0.70-1.41],0.9666581963209352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN2,Prefoldin subunit 2,27384,35,1.88 [1.28-2.77],0.0013903056253556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN4,Prefoldin subunit 4,23522,29,1.49 [1.03-2.16],0.0321180740868845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN6,Prefoldin subunit 6,23704,29,0.86 [0.46-1.61],0.6396531596792288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",27885,35,0.96 [0.65-1.42],0.8334048208683463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGA4,Pepsin A-4,24402,31,0.92 [0.55-1.53],0.7455510070123259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24383,31,1.24 [0.68-2.26],0.4736787855246908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,28389,35,1.90 [0.82-4.39],0.1338428386486415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,28247,34,2.41 [1.42-4.09],0.0011151819011615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24098,30,2.07 [0.64-6.71],0.2253135506354777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP4,Peptidoglycan recognition protein 4,23606,31,1.05 [0.60-1.84],0.8604140338307324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGM2,Phosphoglucomutase-2,23704,29,0.89 [0.45-1.78],0.7403014736525114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGR,Progesterone receptor,23683,29,1.19 [0.92-1.54],0.1902238293832777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHACTR2,Phosphatase and actin regulator 2,24343,30,0.92 [0.68-1.24],0.5870145001979711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB1,Pleckstrin homology-like domain family B member 1,24290,31,0.89 [0.49-1.62],0.7137294233210931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB2,Pleckstrin homology-like domain family B member 2,23522,29,1.41 [1.10-1.80],0.0058594377564225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27859,34,0.92 [0.33-2.55],0.8714738243971738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23831,30,0.95 [0.43-2.12],0.8997125954400608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI16,Peptidase inhibitor 16,24402,31,2.79 [0.70-11.10],0.1454427431558221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,27663,34,1.10 [0.64-1.89],0.7399573906528361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24343,30,1.09 [0.71-1.69],0.6912807641433711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,27687,35,3.71 [2.08-6.62],9.32896114007988e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,28032,35,1.48 [0.95-2.31],0.081471574714916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,28041,35,1.81 [0.65-4.99],0.2534958707783681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23683,29,0.99 [0.53-1.88],0.9837158659937308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRA,Paired immunoglobulin-like type 2 receptor alpha,28041,35,2.63 [1.35-5.10],0.0043200075798034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRB,Paired immunoglobulin-like type 2 receptor beta,28053,34,1.86 [1.04-3.33],0.0374111235378768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23831,30,1.18 [0.70-2.00],0.5393267516465523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PITHD1,PITH domain-containing protein 1,23476,29,1.38 [1.03-1.86],0.0318968386061708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD1,Polycystin-1,24383,31,1.84 [0.53-6.40],0.3409680810728969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD2,Polycystin-2,23606,31,1.38 [0.84-2.26],0.1985189447628804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKLR,Pyruvate kinase PKLR,28079,35,1.57 [1.05-2.34],0.0266249367093943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKN3,Serine/threonine-protein kinase N3,23936,31,0.85 [0.53-1.38],0.5089188530694156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G10,Group 10 secretory phospholipase A2,27859,34,0.87 [0.53-1.44],0.5970313856685204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G15,Phospholipase A2 group XV,28116,35,3.80 [1.49-9.69],0.0052272173613182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G1B,Phospholipase A2,28348,34,0.67 [0.34-1.33],0.2526380096316026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G2A,"Phospholipase A2, membrane associated",27992,34,1.36 [0.90-2.04],0.1411424056638147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G4A,Cytosolic phospholipase A2,28177,35,0.86 [0.62-1.20],0.3814960745358834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G7,Platelet-activating factor acetylhydrolase,28041,35,2.30 [0.87-6.10],0.0949925289978226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAT,Tissue-type plasminogen activator,28300,34,1.21 [0.68-2.15],0.5259625957588432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAU,Urokinase-type plasminogen activator,28041,35,1.70 [0.85-3.39],0.1336752416945252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,27847,35,5.35 [2.23-12.83],0.0001757088673606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLB1,"Phospholipase B1, membrane-associated",24309,30,0.85 [0.48-1.51],0.582827397855517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23683,29,1.69 [1.08-2.65],0.0226426960563739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24309,30,0.98 [0.69-1.39],0.910674306608474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24309,30,0.82 [0.49-1.37],0.4487403702895535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,23783,30,1.08 [0.23-5.14],0.9200757049526482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN1,Perilipin-1,27384,35,0.99 [0.42-2.34],0.9832311801223506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN3,Perilipin-3,28053,34,1.03 [0.51-2.06],0.9434309254987592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLPBP,Pyridoxal phosphate homeostasis protein,28053,34,0.97 [0.62-1.52],0.9074102472498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLSCR3,Phospholipid scramblase 3,24268,30,1.00 [0.56-1.78],0.9891308822722196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLTP,Phospholipid transfer protein,28297,34,0.49 [0.23-1.02],0.056191309648729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC1,Plexin domain-containing protein 1,27370,35,1.49 [0.89-2.48],0.1267836219792315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC2,Plexin domain-containing protein 2,24309,30,2.18 [0.85-5.57],0.1052880851453703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNA4,Plexin-A4,28032,35,0.85 [0.59-1.22],0.3790006250961953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB2,Plexin-B2,28268,34,1.28 [0.39-4.29],0.6833724110165349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB3,Plexin-B3,27949,33,0.75 [0.39-1.43],0.3787821538037418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,27940,34,0.88 [0.76-1.02],0.0827709365712235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMCH,Pro-MCH,23606,31,1.16 [0.83-1.63],0.3929957015832855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMM2,Phosphomannomutase 2,23606,31,1.16 [0.67-2.03],0.5965646396024502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMS1,PMS1 protein homolog 1,23704,29,1.04 [0.52-2.09],0.901050005040148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMVK,Phosphomevalonate kinase,27341,35,0.93 [0.72-1.19],0.5387288978033542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIP,Pancreatic triacylglycerol lipase,24402,31,1.09 [0.65-1.81],0.7422792695825909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24309,30,0.85 [0.56-1.31],0.4713183590771553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP2,Pancreatic lipase-related protein 2,28032,35,0.99 [0.90-1.09],0.8411002648521309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA1,Paraneoplastic antigen Ma1,23705,29,0.54 [0.27-1.08],0.0794042020418828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA2,Paraneoplastic antigen Ma2,23603,29,0.72 [0.29-1.77],0.4747233696271073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27532,33,1.08 [0.85-1.37],0.5526493978180222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL,Podocalyxin,27925,35,0.72 [0.10-5.02],0.7444786300890279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL2,Podocalyxin-like protein 2,28116,35,0.79 [0.28-2.26],0.6645021930598503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POF1B,Protein POF1B,23683,29,1.02 [0.47-2.22],0.9661351793828896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23683,29,1.28 [0.44-3.73],0.6494609286195095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",27925,35,1.26 [0.62-2.59],0.5247272926409206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POMC,Pro-opiomelanocortin,23705,29,1.30 [0.83-2.05],0.2572091458575317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,24402,31,0.57 [0.20-1.64],0.2984169877128395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON2,Serum paraoxonase/arylesterase 2,27549,34,1.23 [0.53-2.89],0.6312575123201959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON3,Serum paraoxonase/lactonase 3,28177,35,0.81 [0.47-1.40],0.4553373546754781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POSTN,Periostin,24372,31,0.56 [0.23-1.40],0.2149706607991273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPBP,Platelet basic protein,24222,31,0.89 [0.60-1.32],0.5574462030074558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPCDC,Phosphopantothenoylcysteine decarboxylase,28318,34,1.19 [0.64-2.21],0.582258370206031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIB,Peptidyl-prolyl cis-trans isomerase B,28052,34,0.88 [0.65-1.19],0.3981206692895481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIE,Peptidyl-prolyl cis-trans isomerase E,23936,31,0.96 [0.53-1.72],0.8806280218915674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24372,31,1.11 [0.67-1.85],0.6853478396956902
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPL,Periplakin,23683,29,1.66 [0.69-4.01],0.2609690159400191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1A,Protein phosphatase 1A,27370,35,1.29 [0.58-2.87],0.5378567593787111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1B,Protein phosphatase 1B,23683,29,1.36 [0.92-2.02],0.1242935632073317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1F,Protein phosphatase 1F,24383,31,0.91 [0.49-1.72],0.7777050803346631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPME1,Protein phosphatase methylesterase 1,27925,35,1.48 [0.91-2.41],0.1096527831412877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24264,30,0.87 [0.57-1.32],0.5116184991929931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,28116,35,0.80 [0.58-1.10],0.1659456412414309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23936,31,0.65 [0.34-1.23],0.1825706674947836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24343,30,0.93 [0.60-1.47],0.7691430912842314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24343,30,2.05 [1.13-3.73],0.0183258715696008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R2,Protein phosphatase inhibitor 2,28053,34,0.88 [0.60-1.28],0.5039089072563947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R9B,Neurabin-2,28389,35,0.83 [0.60-1.14],0.2412338580536157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24290,31,0.97 [0.73-1.29],0.8434554532022785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP3R1,Calcineurin subunit B type 1,27859,34,1.13 [0.55-2.32],0.7294643887141932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPT1,Palmitoyl-protein thioesterase 1,23704,29,1.26 [0.90-1.75],0.1766094890802507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPY,Pancreatic prohormone,27975,35,1.02 [0.76-1.37],0.8762191532690489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PQBP1,Polyglutamine-binding protein 1,27370,35,1.06 [0.64-1.78],0.8132020019800031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAME,Melanoma antigen preferentially expressed in tumors,23522,29,2.13 [0.86-5.24],0.1008330810531837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAP1,Proline-rich acidic protein 1,24372,31,1.76 [0.73-4.22],0.2045180027769934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRC1,Protein regulator of cytokinesis 1,24264,30,1.52 [1.05-2.19],0.0250196132594599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRCP,Lysosomal Pro-X carboxypeptidase,28203,34,1.39 [0.56-3.46],0.4801345757636746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX1,Peroxiredoxin-1,27280,32,1.03 [0.73-1.46],0.8653944866318269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX2,Peroxiredoxin-2,24005,31,1.32 [0.79-2.23],0.2900633779243968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27532,33,0.81 [0.52-1.25],0.3363929117410895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX5,"Peroxiredoxin-5, mitochondrial",28389,35,0.93 [0.61-1.42],0.7479440270003979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX6,Peroxiredoxin-6,28300,35,1.38 [0.88-2.17],0.1588729095138297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PREB,Prolactin regulatory element-binding protein,27532,33,2.30 [1.36-3.88],0.0018897015231171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,28032,35,1.30 [0.32-5.22],0.716282171031621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,24372,31,1.72 [0.96-3.10],0.0706617655518577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG3,Proteoglycan 3,24372,31,1.52 [0.80-2.86],0.1991210756375635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27532,33,0.71 [0.38-1.31],0.2747780613318472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23704,29,0.47 [0.12-1.78],0.2668998232974655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,28053,34,0.81 [0.56-1.15],0.2409936320660934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24261,30,1.06 [0.69-1.62],0.8007843188569874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKCQ,Protein kinase C theta type,27532,33,0.61 [0.26-1.45],0.2661599705736272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKD2,Serine/threonine-protein kinase D2,23606,31,1.06 [0.51-2.23],0.8719773817738359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKG1,cGMP-dependent protein kinase 1,23831,30,0.91 [0.69-1.20],0.5041856359656025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27370,35,0.74 [0.47-1.19],0.2134263931894854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRL,Prolactin,28318,34,1.16 [0.79-1.68],0.4484876138877904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRND,Prion-like protein doppel,24309,30,1.11 [0.57-2.14],0.7656585039379623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROC,Vitamin K-dependent protein C,28101,35,1.18 [0.37-3.75],0.776908379770656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROCR,Endothelial protein C receptor,23606,31,1.31 [0.71-2.41],0.3822377351279321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,28032,35,0.97 [0.58-1.62],0.9103992109597668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROS1,Vitamin K-dependent protein S,24414,31,1.90 [0.60-6.03],0.2753878941358768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR4,Proline-rich protein 4,23672,30,0.88 [0.54-1.46],0.6304801391279692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR5,Proline-rich protein 5,23683,29,1.35 [0.73-2.49],0.3323745073212618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRRT3,Proline-rich transmembrane protein 3,23705,29,1.33 [0.54-3.26],0.536050761913577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS2,Trypsin-2,28135,35,0.99 [0.57-1.70],0.9616230244039462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS22,Brain-specific serine protease 4,23683,29,1.35 [0.59-3.12],0.478771404849712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS27,Serine protease 27,27953,34,0.60 [0.28-1.28],0.185588746390019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS53,Serine protease 53,24309,30,0.60 [0.25-1.45],0.2569528772572119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS8,Prostasin,27944,35,1.74 [0.90-3.35],0.0974918791729461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27384,35,0.89 [0.69-1.15],0.362449763993056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTG,Protogenin,28300,35,0.76 [0.23-2.47],0.6484686762274643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTN3,Myeloblastin,27354,33,1.58 [0.99-2.53],0.0577928569053613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRUNE2,Protein prune homolog 2,23936,31,2.63 [1.41-4.92],0.0024159875977829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAP,Prosaposin,24153,31,2.12 [0.89-5.06],0.0887109598408459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAPL1,Proactivator polypeptide-like 1,24290,31,0.80 [0.41-1.57],0.5197768229634481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSCA,Prostate stem cell antigen,24290,31,1.18 [1.00-1.40],0.0438176304619961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSG1,Pregnancy-specific beta-1-glycoprotein 1,27859,34,0.86 [0.67-1.11],0.235748402527821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSIP1,PC4 and SFRS1-interacting protein,28032,35,1.10 [0.72-1.68],0.6611315094737565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMA1,Proteasome subunit alpha type-1,27370,35,0.75 [0.36-1.54],0.4292955960640544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMC3,26S proteasome regulatory subunit 6A,23522,29,1.05 [0.32-3.44],0.9408213385538744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24343,30,1.49 [0.82-2.72],0.1880984843801242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23704,29,1.08 [0.57-2.02],0.8209653912107386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD9,26S proteasome non-ATPase regulatory subunit 9,27925,35,1.48 [0.94-2.35],0.0936073652656348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME1,Proteasome activator complex subunit 1,27827,33,2.12 [0.96-4.66],0.0617999919925684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME2,Proteasome activator complex subunit 2,27737,34,2.25 [1.02-4.96],0.043534010514358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG3,Proteasome assembly chaperone 3,28032,35,2.09 [1.23-3.54],0.0060629384945737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG4,Proteasome assembly chaperone 4,23683,29,1.81 [1.11-2.95],0.018104199665917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSPN,Persephin,28032,35,1.20 [0.87-1.65],0.2626804741860045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSRC1,Proline/serine-rich coiled-coil protein 1,27370,35,0.86 [0.51-1.47],0.5825117768260212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22957,28,0.92 [0.67-1.28],0.6313205959713579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27384,35,1.22 [0.46-3.29],0.6900600857946695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGDS,Prostaglandin-H2 D-isomerase,27833,35,2.01 [0.88-4.58],0.0990289693515471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGES2,Prostaglandin E synthase 2,23497,28,1.41 [0.77-2.58],0.2725306764799835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGR1,Prostaglandin reductase 1,24383,31,0.88 [0.58-1.32],0.5305505112824861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH,Parathyroid hormone,23704,29,1.05 [0.68-1.61],0.8320481262770211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,28032,35,1.47 [0.88-2.46],0.1363215657240061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTK7,Inactive tyrosine-protein kinase 7,27384,35,1.72 [0.82-3.60],0.1532513663476954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTN,Pleiotrophin,27549,34,1.58 [0.93-2.70],0.0925045894245116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTP4A3,Protein tyrosine phosphatase type IVA 3,23683,29,1.39 [0.77-2.49],0.2718138717430937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27859,34,0.96 [0.65-1.42],0.8388014715961357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28134,35,0.94 [0.68-1.29],0.7006587110516489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23636,29,1.21 [0.55-2.66],0.6436570055227114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24383,31,1.66 [0.56-4.89],0.3610837159438415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRC,Receptor-type tyrosine-protein phosphatase C,24372,31,2.09 [0.52-8.36],0.2993653321003754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRF,Receptor-type tyrosine-protein phosphatase F,28400,34,1.17 [0.41-3.36],0.766796374674579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRH,Receptor-type tyrosine-protein phosphatase H,24290,31,1.03 [0.52-2.04],0.9350992752335388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24290,31,1.68 [0.51-5.50],0.3910534133282877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRM,Receptor-type tyrosine-protein phosphatase mu,27979,35,0.94 [0.29-3.07],0.9129792394978352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27758,34,0.65 [0.25-1.73],0.3907461911196871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRR,Receptor-type tyrosine-protein phosphatase R,24309,30,0.74 [0.29-1.93],0.5426703643096811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRS,Receptor-type tyrosine-protein phosphatase S,28400,34,0.81 [0.24-2.68],0.7305367151605617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24383,31,3.55 [1.69-7.43],0.0007853802507435
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23831,30,1.02 [0.57-1.82],0.9500913573726786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27262,35,1.57 [1.02-2.42],0.0395850183307059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTTG1,Securin,23936,31,1.06 [0.48-2.31],0.887407796577728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTX3,Pentraxin-related protein PTX3,28032,35,1.20 [0.64-2.25],0.5602202511069969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVALB,Parvalbumin alpha,28190,35,0.94 [0.73-1.21],0.6382084006701884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,28318,34,1.42 [0.70-2.88],0.3337127137777961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXDNL,Peroxidasin-like protein,24264,30,1.18 [0.74-1.88],0.4874522396831445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXN,Paxillin,27384,35,1.54 [1.01-2.37],0.047131771272985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYDC1,Pyrin domain-containing protein 1,23705,29,1.07 [0.46-2.51],0.8759979474192836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYY,Peptide YY,23606,31,1.38 [1.00-1.91],0.0513922606502031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PZP,Pregnancy zone protein,24414,31,1.66 [0.90-3.04],0.104063314598535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QDPR,Dihydropteridine reductase,27915,33,0.91 [0.45-1.87],0.8019730006030125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,28055,33,1.57 [0.51-4.82],0.4345235160757782
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,23913,31,1.55 [1.09-2.19],0.0144172306188702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB10,Ras-related protein Rab-10,24383,31,1.10 [0.60-2.03],0.7632924905996551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB11FIP3,Rab11 family-interacting protein 3,24383,31,0.86 [0.63-1.17],0.3495189299382771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB27B,Ras-related protein Rab-27B,24383,31,0.86 [0.58-1.27],0.4415866843722296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB2B,Ras-related protein Rab-2B,24264,30,0.96 [0.56-1.65],0.8839294739204493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB33A,Ras-related protein Rab-33A,23606,31,0.72 [0.42-1.23],0.2265852260177999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB37,Ras-related protein Rab-37,27532,33,1.02 [0.71-1.48],0.9017272223083492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB39B,Ras-related protein Rab-39B,23606,31,1.06 [0.75-1.49],0.7433111409192323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23603,29,0.48 [0.19-1.19],0.1126000317654221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB44,Ras-related protein Rab-44,24264,30,1.31 [0.80-2.14],0.2839953879141006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6A,Ras-related protein Rab-6A,28032,35,0.81 [0.42-1.58],0.544005222932455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6B,Ras-related protein Rab-6B,27384,35,0.97 [0.50-1.90],0.9323007900867728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEP1,Rab GTPase-binding effector protein 1,23831,30,0.85 [0.54-1.36],0.5049178124330008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEPK,Rab9 effector protein with kelch motifs,27370,35,1.08 [0.67-1.74],0.7567930050398163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABGAP1L,Rab GTPase-activating protein 1-like,27532,33,0.91 [0.55-1.53],0.7348328926980294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAC3,Ras-related C3 botulinum toxin substrate 3,23704,29,0.98 [0.57-1.67],0.9272247152375106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD23B,UV excision repair protein RAD23 homolog B,27370,35,0.76 [0.39-1.50],0.4344619036314471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD51,DNA repair protein RAD51 homolog 1,23936,31,0.66 [0.29-1.50],0.3184151554540248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALB,Ras-related protein Ral-B,23683,29,0.76 [0.22-2.58],0.6615071587821124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALY,RNA-binding protein Raly,24264,30,0.76 [0.33-1.73],0.5168486152325906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP1,Ran-specific GTPase-activating protein,23705,29,1.50 [0.79-2.85],0.2142570504625039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP2,E3 SUMO-protein ligase RanBP2,23603,29,1.63 [0.66-4.01],0.2893866743328087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANGAP1,Ran GTPase-activating protein 1,27370,35,1.66 [1.16-2.37],0.0056390706281015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAP1A,Ras-related protein Rap-1A,23683,29,1.04 [0.62-1.75],0.8709049385749531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAPGEF2,Rap guanine nucleotide exchange factor 2,23936,31,0.71 [0.35-1.43],0.3318224163401574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES1,Retinoic acid receptor responder protein 1,27370,35,1.18 [0.52-2.68],0.6956307828196757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES2,Retinoic acid receptor responder protein 2,28191,35,1.57 [0.98-2.50],0.0585219088618562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASA1,Ras GTPase-activating protein 1,27384,35,1.18 [0.50-2.78],0.7092977855232785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23522,29,1.57 [0.83-2.98],0.1636126764791167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASSF2,Ras association domain-containing protein 2,27370,35,1.50 [1.12-2.01],0.0060838767763038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,24343,30,1.56 [0.76-3.19],0.2239420093246959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBKS,Ribokinase,27405,34,2.13 [1.27-3.56],0.0038987857058614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM17,Splicing factor 45,24343,30,1.14 [0.74-1.75],0.5591332429755251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM19,Probable RNA-binding protein 19,23606,31,1.36 [0.79-2.35],0.2700507766666946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM25,RNA-binding protein 25,23522,29,0.96 [0.43-2.13],0.9215306894375568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP1,Retinol-binding protein 1,23704,29,1.13 [0.72-1.76],0.5991345544831352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP2,Retinol-binding protein 2,27925,35,0.83 [0.56-1.23],0.3554661350177821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP5,Retinol-binding protein 5,27925,35,1.46 [0.93-2.30],0.1001261676690487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP7,Retinoid-binding protein 7,24290,31,1.56 [1.06-2.30],0.0250207464660602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS,RNA-binding protein with multiple splicing,23683,29,0.87 [0.47-1.62],0.6607825485830336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS2,RNA-binding protein with multiple splicing 2,23705,29,0.93 [0.66-1.32],0.6772040562912668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCC1,Regulator of chromosome condensation,24264,30,1.30 [0.78-2.16],0.3210700281728561
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCOR1,REST corepressor 1,27549,34,1.24 [0.72-2.14],0.4442728339933715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23705,29,2.21 [0.43-11.31],0.3392785925398149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REEP4,Receptor expression-enhancing protein 4,24343,30,0.89 [0.49-1.59],0.6889109231391954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,27887,35,1.32 [0.76-2.29],0.328231311406334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,28400,34,1.25 [0.77-2.02],0.3740907456774591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,28400,34,1.24 [0.78-1.97],0.364071188710704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3G,Regenerating islet-derived protein 3-gamma,24264,30,1.08 [0.45-2.63],0.8570297817364464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,28082,35,1.05 [0.58-1.92],0.8615422284988126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELB,Transcription factor RelB,23683,29,0.98 [0.47-2.06],0.9675041209861596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,28041,35,1.87 [0.67-5.20],0.2317277422817193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,28053,34,0.99 [0.65-1.50],0.9542856044763748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REPS1,RalBP1-associated Eps domain-containing protein 1,23683,29,1.17 [0.49-2.80],0.7264484688909132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REST,RE1-silencing transcription factor,23522,29,1.06 [0.40-2.80],0.9076572432368906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,27925,35,0.43 [0.20-0.92],0.0285292335840455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,27980,34,1.75 [1.00-3.06],0.0502525630641422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REXO2,"Oligoribonuclease, mitochondrial",23606,31,0.55 [0.20-1.52],0.2496783653510034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RFC4,Replication factor C subunit 4,24264,30,2.11 [0.73-6.08],0.1675866194147341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGCC,Regulator of cell cycle RGCC,24343,30,1.02 [0.65-1.61],0.9277666542799218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23936,31,1.33 [0.91-1.95],0.1402747278119489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMA,Repulsive guidance molecule A,28318,34,0.39 [0.15-1.01],0.0519492370409686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMB,RGM domain family member B,28318,34,0.33 [0.10-1.07],0.0641168672440259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS10,Regulator of G-protein signaling 10,24343,30,1.00 [0.56-1.77],0.9918908025147092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS8,Regulator of G-protein signaling 8,27532,33,0.75 [0.41-1.37],0.3508019209969725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RHOC,Rho-related GTP-binding protein RhoC,27692,34,0.91 [0.71-1.16],0.4314044192186752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RICTOR,Rapamycin-insensitive companion of mTOR,23683,29,1.62 [1.03-2.54],0.0373554105551568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23831,30,1.49 [0.82-2.73],0.1903953180091642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILP,Rab-interacting lysosomal protein,28226,35,1.20 [0.74-1.93],0.4646460208148678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILPL2,RILP-like protein 2,24383,31,1.01 [0.72-1.42],0.9598290422991732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23606,31,1.08 [0.67-1.73],0.7585459401989258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN1,Prorelaxin H1,24343,30,1.01 [0.59-1.73],0.9807909604516744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN2,Prorelaxin H2,23791,30,0.97 [0.67-1.39],0.8590375018698804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE1,Ribonuclease pancreatic,24402,31,3.04 [1.30-7.10],0.0101476921604581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE10,Inactive ribonuclease-like protein 10,23705,29,1.28 [0.67-2.45],0.4626851635036711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE3,Eosinophil cationic protein,27915,34,1.20 [0.96-1.50],0.110723477533932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE4,Ribonuclease 4,23622,30,1.42 [0.41-4.85],0.5808662948709788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,24233,31,2.25 [1.14-4.45],0.0198857144380489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASEH2A,Ribonuclease H2 subunit A,24343,30,0.75 [0.33-1.70],0.4879725512017888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,28252,34,1.57 [0.53-4.63],0.4110166100865927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF149,E3 ubiquitin-protein ligase RNF149,23705,29,1.40 [0.46-4.26],0.5573131027698314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF168,E3 ubiquitin-protein ligase RNF168,23683,29,1.81 [1.08-3.05],0.0251770845822847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF31,E3 ubiquitin-protein ligase RNF31,23683,29,1.61 [0.91-2.86],0.1042909840154004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF4,E3 ubiquitin-protein ligase RNF4,23936,31,0.81 [0.44-1.50],0.5066854867213509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF41,E3 ubiquitin-protein ligase NRDP1,27370,35,0.93 [0.59-1.46],0.7515515227880124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF43,E3 ubiquitin-protein ligase RNF43,23936,31,1.35 [0.89-2.04],0.1531176526654789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF5,E3 ubiquitin-protein ligase RNF5,23705,29,0.89 [0.56-1.43],0.642160441667793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO1,Roundabout homolog 1,28082,35,1.84 [0.58-5.92],0.3031665440132613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO2,Roundabout homolog 2,28318,34,0.53 [0.14-1.98],0.3466580984608797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO4,Roundabout homolog 4,23705,29,1.24 [0.17-9.21],0.8304389095333008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,28053,34,1.37 [0.54-3.50],0.508792212066071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RP2,Protein XRP2,27925,35,1.45 [0.85-2.49],0.1741770569962352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPA2,Replication protein A 32 kDa subunit,23683,29,1.15 [0.40-3.27],0.7986918587949348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPE,Ribulose-phosphate 3-epimerase,23936,31,0.98 [0.60-1.60],0.9238304753164588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPGR,X-linked retinitis pigmentosa GTPase regulator,23704,29,2.17 [1.50-3.14],4.491084182630978e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPL14,60S ribosomal protein L14,23705,29,0.66 [0.24-1.78],0.4122766535905879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPS10,40S ribosomal protein S10,23606,31,0.83 [0.34-2.04],0.6862476935066233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRAS,Ras-related protein R-Ras,23704,29,0.93 [0.71-1.23],0.6306508502169881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27370,35,0.95 [0.51-1.76],0.8751974877217137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27370,35,0.81 [0.52-1.26],0.3456529942174005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRP15,RRP15-like protein,23603,29,1.11 [0.77-1.61],0.5649188056886836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,27859,34,1.16 [0.49-2.72],0.7374695809014508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,28300,35,1.49 [0.52-4.24],0.4567633316390888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTBDN,Retbindin,27925,35,0.66 [0.24-1.87],0.4379562665814428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTKN2,Rhotekin-2,23606,31,1.45 [0.97-2.18],0.0704313726655127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24343,30,0.99 [0.68-1.43],0.9519138357582752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4R,Reticulon-4 receptor,28300,35,0.54 [0.22-1.32],0.1776108808594543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RUVBL1,RuvB-like 1,27370,35,1.15 [0.88-1.50],0.3010610269117632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RWDD1,RWD domain-containing protein 1,28318,34,0.94 [0.59-1.51],0.7960507244216404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RYR1,Ryanodine receptor 1,23606,31,0.56 [0.16-1.97],0.3667907644795235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,27827,33,1.57 [1.02-2.43],0.0410281818552131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A12,Protein S100-A12,27661,35,1.51 [1.04-2.20],0.0292632148445445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A13,Protein S100-A13,23683,29,2.05 [0.93-4.50],0.0732757166602351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A14,Protein S100-A14,24343,30,0.89 [0.44-1.77],0.7298009511363768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A16,Protein S100-A16,27333,35,0.86 [0.51-1.45],0.5688092595065398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A3,Protein S100-A3,24264,30,1.06 [0.51-2.19],0.8753628475859043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A4,Protein S100-A4,28116,35,0.94 [0.56-1.60],0.8314769749245372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100G,Protein S100-G,24343,30,1.02 [0.50-2.11],0.9485267097068026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100P,Protein S100-P,27549,34,1.13 [0.68-1.87],0.6417015210957819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,24414,31,1.54 [0.93-2.56],0.094973485209282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAFB2,Scaffold attachment factor B2,24343,30,1.32 [0.45-3.92],0.6147413458332356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAG,S-arrestin,23603,29,1.01 [0.50-2.04],0.9855709793277662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAMD9L,Sterile alpha motif domain-containing protein 9-like,28032,35,0.90 [0.59-1.35],0.5972402970172999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAP18,Histone deacetylase complex subunit SAP18,23936,31,1.26 [0.90-1.77],0.1761153558336044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SARG,Specifically androgen-regulated gene protein,24305,31,0.95 [0.70-1.28],0.7198137164974667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23606,31,1.15 [0.52-2.50],0.7343063624497557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT1,Diamine acetyltransferase 1,23606,31,1.73 [1.08-2.77],0.0217860675786634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT2,Thialysine N-epsilon-acetyltransferase,23936,31,0.64 [0.35-1.18],0.1548377573966286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SATB1,DNA-binding protein SATB1,24343,30,0.86 [0.24-3.08],0.8174026157559039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SBSN,Suprabasin,24328,31,0.93 [0.35-2.46],0.8859057458760667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCAMP3,Secretory carrier-associated membrane protein 3,27925,35,0.82 [0.57-1.18],0.2809460286785318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARA5,Scavenger receptor class A member 5,28318,34,0.89 [0.32-2.47],0.8291962490317706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB1,Scavenger receptor class B member 1,27384,35,0.94 [0.53-1.68],0.8383494998597614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,27323,33,3.01 [1.41-6.40],0.0042534586667371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF1,Scavenger receptor class F member 1,28400,34,0.89 [0.44-1.79],0.7432933121606996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,28318,34,1.80 [0.62-5.24],0.2773263858017365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG2,Secretogranin-2,28187,35,1.51 [0.61-3.77],0.3746590452635648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG3,Secretogranin-3,28082,35,0.52 [0.21-1.28],0.1541977246119441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB1A1,Uteroglobin,28102,35,0.65 [0.41-1.05],0.0786049849396166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB2A2,Mammaglobin-A,23606,31,1.34 [0.53-3.39],0.5359325000181493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A1,Secretoglobin family 3A member 1,23831,30,1.15 [0.29-4.59],0.8441004600077797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A2,Secretoglobin family 3A member 2,28134,35,0.83 [0.56-1.24],0.3649853479600893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGN,Secretagogin,27532,33,0.71 [0.35-1.45],0.3481908126596106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCIN,Adseverin,23603,29,1.13 [0.72-1.77],0.5938138102201788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCLY,Selenocysteine lyase,28226,35,1.29 [0.74-2.25],0.3738625003852812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2A,Sodium channel protein type 2 subunit alpha,23603,29,0.89 [0.39-2.03],0.7880613246262157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2B,Sodium channel subunit beta-2,23704,29,1.40 [0.43-4.50],0.5738816268546262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3A,Sodium channel protein type 3 subunit alpha,23704,29,1.28 [0.58-2.84],0.5392566846449973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3B,Sodium channel subunit beta-3,23603,29,0.91 [0.39-2.11],0.8229921883748123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN4B,Sodium channel subunit beta-4,23705,29,1.11 [0.50-2.47],0.800171739461847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCP2,Non-specific lipid-transfer protein,27370,35,1.10 [0.77-1.58],0.597329335727512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCPEP1,Retinoid-inducible serine carboxypeptidase,23623,29,1.05 [0.53-2.07],0.8933763570321755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRG1,Scrapie-responsive protein 1,24383,31,1.88 [0.80-4.45],0.1488271946083945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRIB,Protein scribble homolog,23705,29,0.92 [0.60-1.41],0.7052522667544345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRN1,Secernin-1,28032,35,1.08 [0.64-1.82],0.7839754068394134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCT,Secretin,23704,29,1.27 [0.59-2.75],0.5452209817325112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC1,Syndecan-1,28053,34,1.63 [0.85-3.14],0.1420683456016857
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC4,Syndecan-4,28053,34,0.74 [0.39-1.41],0.3649912685599786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDCCAG8,Serologically defined colon cancer antigen 8,24264,30,0.91 [0.67-1.23],0.5297788748307808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDHB,Succinate dehydrogenase,24290,31,1.34 [0.90-1.98],0.1460831686323606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDK2,Protein sidekick-2,23831,30,1.33 [0.56-3.16],0.5214096741705252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEC31A,Protein transport protein Sec31A,23705,29,0.94 [0.60-1.49],0.8032771378945702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEL1L,Protein sel-1 homolog 1,23705,29,1.34 [0.60-2.99],0.4801320080421906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELE,E-selectin,28400,34,0.96 [0.53-1.73],0.8907492383012248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELENOP,Selenoprotein P,24414,31,0.75 [0.38-1.48],0.4050614868956651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELL,L-selectin,24414,31,2.00 [0.53-7.52],0.3057860893951174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELP,P-selectin,28135,35,0.63 [0.37-1.07],0.0872394977980067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELPLG,P-selectin glycoprotein ligand 1,28032,35,1.07 [0.43-2.65],0.8908268894731433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3F,Semaphorin-3F,28053,34,1.76 [0.58-5.40],0.3207852592653238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3G,Semaphorin-3G,23831,30,1.07 [0.49-2.34],0.8569006852189911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4C,Semaphorin-4C,27925,35,0.89 [0.29-2.68],0.8331570664982405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4D,Semaphorin-4D,28318,34,0.71 [0.27-1.86],0.4825783115069051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA6C,Semaphorin-6C,23683,29,2.11 [0.86-5.19],0.1035053522284965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA7A,Semaphorin-7A,28300,34,1.29 [0.45-3.69],0.63562518381274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN3,Neuronal-specific septin-3,24343,30,1.16 [0.77-1.75],0.4716240478439324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN7,Septin-7,23936,31,1.13 [0.64-2.01],0.6642667322903248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN8,Septin-8,24255,30,1.97 [0.87-4.44],0.1037520047647317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN9,Septin-9,27925,35,0.85 [0.29-2.50],0.7721302746664941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA1,Alpha-1-antitrypsin,23978,31,7.07 [0.66-75.51],0.1055630282501429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,28400,34,2.23 [1.06-4.69],0.033545711491115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA12,Serpin A12,27272,32,0.83 [0.62-1.12],0.2278950812834106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA3,Alpha-1-antichymotrypsin,24339,31,1.33 [0.16-11.34],0.7965566057696203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA4,Kallistatin,23975,30,2.86 [0.82-10.01],0.1009051105264204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA5,Plasma serine protease inhibitor,24066,31,0.58 [0.17-1.91],0.3688297417299474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA6,Corticosteroid-binding globulin,24414,31,5.15 [0.89-29.73],0.0670513707383929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA7,Thyroxine-binding globulin,24414,31,0.98 [0.16-5.94],0.9818907614700768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA9,Serpin A9,27794,35,1.10 [0.75-1.62],0.6191970145209837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB1,Leukocyte elastase inhibitor,27955,35,0.89 [0.64-1.25],0.5120585766204987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB5,Serpin B5,27549,34,0.87 [0.47-1.58],0.6389880802839172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB6,Serpin B6,28224,34,0.74 [0.44-1.24],0.2545407600012464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB8,Serpin B8,28389,35,1.43 [1.02-2.02],0.03817744975989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB9,Serpin B9,27859,34,0.85 [0.34-2.10],0.7170629369568483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINC1,Antithrombin-III,24363,31,2.16 [0.21-22.46],0.52035765999788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPIND1,Heparin cofactor 2,24363,31,1.50 [0.47-4.84],0.4963948579167992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE1,Plasminogen activator inhibitor 1,28400,34,0.86 [0.56-1.32],0.4802651827866401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE2,Glia-derived nexin,24383,31,0.98 [0.59-1.64],0.9519948521640852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF1,Pigment epithelium-derived factor,24052,31,0.78 [0.21-2.82],0.6997599704906491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF2,Alpha-2-antiplasmin,23963,31,3.35 [0.34-32.76],0.2981361774729182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPING1,Plasma protease C1 inhibitor,24363,31,1.37 [0.22-8.52],0.7328481915626381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINH1,Serpin H1,23936,31,1.10 [0.85-1.43],0.4669668095031033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI1,Neuroserpin,23780,30,1.59 [0.56-4.52],0.3858543374053099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI2,Serpin I2,24290,31,0.79 [0.43-1.45],0.4487315074688676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27384,35,0.81 [0.50-1.32],0.3975102261748006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SETMAR,Histone-lysine N-methyltransferase SETMAR,27771,34,0.87 [0.32-2.32],0.7772953431987356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6,Seizure protein 6 homolog,23704,29,0.77 [0.24-2.49],0.6590476235693264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L,Seizure 6-like protein,28116,35,0.73 [0.25-2.11],0.55560770439219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L2,Seizure 6-like protein 2,27925,35,0.85 [0.24-2.97],0.8034919793829205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SF3B4,Splicing factor 3B subunit 4,27925,35,1.16 [0.79-1.71],0.4350407518381066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,27759,34,1.05 [0.53-2.09],0.8895953419318868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP4,Secreted frizzled-related protein 4,23831,30,0.72 [0.31-1.68],0.4517384254930167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA1,Pulmonary surfactant-associated protein A1,27370,35,1.23 [0.79-1.90],0.3550953026266025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,27370,35,2.33 [1.46-3.69],0.000345270186128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPD,Pulmonary surfactant-associated protein D,28053,34,1.11 [0.71-1.74],0.6386261571243481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SGSH,N-sulphoglucosamine sulphohydrolase,24007,31,1.20 [0.68-2.12],0.5347308538745672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2B3,SH2B adapter protein 3,27370,35,0.86 [0.64-1.16],0.3290927405220435
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2D1A,SH2 domain-containing protein 1A,28032,35,0.71 [0.38-1.30],0.26230626224898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23603,29,1.40 [0.94-2.07],0.0985310216452456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BP1,SH3 domain-binding protein 1,24290,31,1.06 [0.56-2.02],0.8522120773447133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GL3,Endophilin-A3,23785,31,1.02 [0.67-1.53],0.941785378120528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GLB2,Endophilin-B2,24309,30,1.67 [1.02-2.74],0.0414992699893443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHBG,Sex hormone-binding globulin,24402,31,1.80 [0.91-3.56],0.0914549197211742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHC1,SHC-transforming protein 1,23522,29,0.94 [0.68-1.31],0.7180462537253602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHD,SH2 domain-containing adapter protein D,23569,31,1.26 [0.95-1.68],0.1024130754761057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHH,Sonic hedgehog protein,23683,29,0.54 [0.22-1.35],0.1871049447180743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,24372,31,2.73 [1.29-5.76],0.0083809707108716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHMT1,"Serine hydroxymethyltransferase, cytosolic",28134,35,1.00 [0.71-1.41],0.9891247091419052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHPK,Sedoheptulokinase,23936,31,1.17 [0.53-2.56],0.7040994011342848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIAE,Sialate O-acetylesterase,28068,35,0.66 [0.35-1.24],0.1936918762367103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC1,Sialoadhesin,28177,35,2.52 [1.42-4.48],0.0015860101279725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC10,Sialic acid-binding Ig-like lectin 10,28032,35,2.17 [1.02-4.60],0.0436429859740116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27384,35,1.17 [0.84-1.62],0.3536814672600284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC5,Sialic acid-binding Ig-like lectin 5,28041,35,1.38 [0.99-1.93],0.0570478322434111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28300,35,1.00 [0.40-2.48],0.9958108591579524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC7,Sialic acid-binding Ig-like lectin 7,28053,34,1.93 [0.71-5.24],0.1944272107310027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23705,29,1.49 [0.72-3.09],0.2849752442288187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28263,35,2.17 [0.86-5.48],0.1019580330687592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIL1,Nucleotide exchange factor SIL1,23705,29,0.82 [0.25-2.73],0.7513591963687387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,28118,34,1.12 [0.65-1.92],0.6901990476826738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPB1,Signal-regulatory protein beta-1,27977,35,1.07 [0.56-2.05],0.8339250912795579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23683,29,1.25 [0.93-1.67],0.1326545500076875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT2,NAD-dependent protein deacetylase sirtuin-2,27925,35,1.02 [0.73-1.43],0.9061961530478472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27384,35,1.46 [0.98-2.17],0.0636884516386477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIT1,Signaling threshold-regulating transmembrane adapter 1,27532,33,0.93 [0.54-1.63],0.8112992739039505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP1,Src kinase-associated phosphoprotein 1,27809,34,0.84 [0.55-1.29],0.4221926947023074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP2,Src kinase-associated phosphoprotein 2,28177,35,0.81 [0.61-1.08],0.1446963862463168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKIV2L,Helicase SKI2W,23606,31,0.68 [0.25-1.88],0.4560546220000756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLA2,Src-like-adapter 2,24343,30,1.00 [0.72-1.38],0.9833609036569566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF1,Signaling lymphocytic activation molecule,27532,33,1.39 [0.81-2.38],0.2270499877705948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF6,SLAM family member 6,27370,35,0.60 [0.27-1.36],0.2231690087011442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF7,SLAM family member 7,28032,35,1.26 [0.77-2.07],0.3533160743484765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,27370,35,1.42 [0.79-2.56],0.2408492388568296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC12A2,Solute carrier family 12 member 2,23606,31,0.55 [0.13-2.26],0.407739404098541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC13A1,Solute carrier family 13 member 1,24264,30,1.17 [0.74-1.87],0.5007769353753438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC16A1,Monocarboxylate transporter 1,27384,35,1.03 [0.62-1.71],0.906122378027443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC1A4,Neutral amino acid transporter A,23704,29,1.23 [0.69-2.21],0.4845131954537702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC27A4,Long-chain fatty acid transport protein 4,27384,35,0.81 [0.49-1.36],0.4318371289998803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC28A1,Sodium/nucleoside cotransporter 1,23522,29,1.31 [0.82-2.09],0.2565491235625364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC34A3,Sodium-dependent phosphate transport protein 2C,23522,29,1.65 [1.18-2.32],0.003809859645183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A14,Zinc transporter ZIP14,27384,35,1.35 [0.59-3.08],0.4754313112231557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A5,Zinc transporter ZIP5,28032,35,1.40 [0.96-2.04],0.0850762165405369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC44A4,Choline transporter-like protein 4,23704,29,1.75 [1.41-2.18],4.960461196441641e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC4A1,Band 3 anion transport protein,24372,31,1.01 [0.49-2.07],0.9879101246462496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC51B,Organic solute transporter subunit beta,23606,31,0.97 [0.60-1.56],0.9082439124318298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23831,30,0.93 [0.62-1.39],0.7071893758562162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24290,31,1.22 [0.71-2.08],0.4668375972567896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23522,29,0.78 [0.37-1.63],0.5019662896174586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIT2,Slit homolog 2 protein,27384,35,0.85 [0.45-1.57],0.5961446408465689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK1,SLIT and NTRK-like protein 1,23683,29,0.90 [0.30-2.65],0.8431304583042769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK2,SLIT and NTRK-like protein 2,28300,35,0.64 [0.32-1.29],0.2119450988484876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK6,SLIT and NTRK-like protein 6,27549,34,1.18 [0.50-2.78],0.7121895539390413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLK,STE20-like serine/threonine-protein kinase,23936,31,0.79 [0.44-1.42],0.4313453598003066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLMAP,Sarcolemmal membrane-associated protein,24290,31,0.96 [0.64-1.43],0.8401778533723802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLURP1,Secreted Ly-6/uPAR-related protein 1,24193,30,0.55 [0.18-1.66],0.2879529936413793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD1,Mothers against decapentaplegic homolog 1,27370,35,0.87 [0.61-1.25],0.4480726596682494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD2,Mothers against decapentaplegic homolog 2,24264,30,1.02 [0.63-1.65],0.9375286951476178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD3,Mothers against decapentaplegic homolog 3,24264,30,1.53 [0.82-2.83],0.1786494212799356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD5,Mothers against decapentaplegic homolog 5,27925,35,0.37 [0.10-1.34],0.1298216699993033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMARCA2,Probable global transcription activator SNF2L2,27384,35,0.85 [0.55-1.33],0.479142868775317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMC3,Structural maintenance of chromosomes protein 3,23522,29,1.00 [0.51-1.94],0.9882628771316276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMNDC1,Survival of motor neuron-related-splicing factor 30,24290,31,1.23 [0.81-1.87],0.3285577835214055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,28300,35,1.90 [0.81-4.45],0.1375069005632125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC2,SPARC-related modular calcium-binding protein 2,28177,35,0.95 [0.44-2.05],0.8875868906523539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD1,Sphingomyelin phosphodiesterase,28179,34,1.26 [0.72-2.22],0.4191182945007021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD3,Sphingomyelin phosphodiesterase 3,23683,29,1.42 [0.97-2.09],0.0734486662017881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,28122,35,1.37 [0.85-2.19],0.1961407311416677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24264,30,1.01 [0.64-1.57],0.9784402307349888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMS,Spermine synthase,23603,29,1.47 [1.02-2.12],0.0384462564333439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMTN,Smoothelin,24253,30,0.79 [0.53-1.19],0.2589671533323264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP23,Synaptosomal-associated protein 23,28053,34,0.79 [0.57-1.10],0.1603972430882505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP25,Synaptosomal-associated protein 25,23603,29,1.07 [0.52-2.20],0.8604602837301868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP29,Synaptosomal-associated protein 29,28116,35,0.83 [0.60-1.14],0.2470805817685447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAPIN,SNARE-associated protein Snapin,24343,30,1.03 [0.57-1.86],0.9223339904403248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCA,Alpha-synuclein,23831,30,1.19 [0.88-1.60],0.2594213605986044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,27859,34,0.97 [0.61-1.54],0.90548514269945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23705,29,0.72 [0.23-2.31],0.5866703173134189
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNRPB2,U2 small nuclear ribonucleoprotein B'',24309,30,1.30 [0.79-2.13],0.3033282464834915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNU13,NHP2-like protein 1,23606,31,0.93 [0.53-1.65],0.8160605315392931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX15,Sorting nexin-15,23831,30,1.25 [0.67-2.32],0.4819333363965301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX18,Sorting nexin-18,24290,31,1.16 [0.58-2.34],0.673512000576487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX2,Sorting nexin-2,24264,30,0.77 [0.48-1.24],0.2804403141387519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX5,Sorting nexin-5,23705,29,1.08 [0.34-3.40],0.901311548454257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX9,Sorting nexin-9,28053,34,0.99 [0.64-1.54],0.98152718072619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD1,Superoxide dismutase [Cu-Zn],27449,35,1.54 [0.88-2.72],0.1321826357011452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD2,"Superoxide dismutase [Mn], mitochondrial",28041,35,1.16 [0.56-2.40],0.6962718540423594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD3,Extracellular superoxide dismutase,24402,31,0.90 [0.48-1.67],0.7370739460428557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORBS1,Sorbin and SH3 domain-containing protein 1,24343,30,0.93 [0.36-2.39],0.882592432110107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORCS2,VPS10 domain-containing receptor SorCS2,27370,35,1.40 [0.64-3.06],0.3951475252292388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORD,Sorbitol dehydrogenase,28173,35,1.26 [0.83-1.91],0.2850643397407903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORT1,Sortilin,28021,34,0.62 [0.27-1.41],0.2533596897364154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOST,Sclerostin,28021,34,0.69 [0.32-1.48],0.3419194126097634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23704,29,1.17 [0.60-2.31],0.6394643957150861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX2,Transcription factor SOX-2,24303,30,0.56 [0.12-2.59],0.4567585137892992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX9,Transcription factor SOX-9,23704,29,0.91 [0.24-3.40],0.8857709786386877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24343,30,1.95 [0.95-4.01],0.0683970597849092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPAG1,Sperm-associated antigen 1,24343,30,1.30 [0.82-2.08],0.2642348230772263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARC,SPARC,28116,35,0.82 [0.55-1.21],0.3174599321498945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARCL1,SPARC-like protein 1,28044,35,1.46 [0.53-4.00],0.4652522264226404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPART,Spartin,23831,30,0.82 [0.52-1.30],0.3991564859043536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPESP1,Sperm equatorial segment protein 1,24383,31,0.97 [0.32-2.95],0.9585044864647396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,28041,35,1.35 [0.68-2.66],0.3910283708034087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK2,Serine protease inhibitor Kazal-type 2,23831,30,0.82 [0.34-2.03],0.6746799582063661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,28032,35,1.43 [0.93-2.18],0.1004163179243402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK5,Serine protease inhibitor Kazal-type 5,28041,35,0.85 [0.35-2.03],0.711163014654155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK6,Serine protease inhibitor Kazal-type 6,28300,35,1.20 [0.70-2.08],0.5076548555722304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK8,Serine protease inhibitor Kazal-type 8,23606,31,0.88 [0.32-2.43],0.8059340458473131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,27942,35,1.89 [0.76-4.73],0.1713577803407314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT2,Kunitz-type protease inhibitor 2,28177,35,0.65 [0.32-1.31],0.2288891386696525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT3,Kunitz-type protease inhibitor 3,24290,31,0.91 [0.74-1.11],0.3624847831847059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPOCK1,Testican-1,27859,34,2.01 [0.64-6.29],0.2291508872643163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,28082,35,1.00 [0.40-2.48],0.99440181947773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,27919,34,2.63 [1.16-5.97],0.0206746146223867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPP1,Osteopontin,28347,34,1.89 [1.03-3.49],0.0412442310085076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23683,29,1.60 [0.86-3.00],0.1386924115528223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRING1,SREBP regulating gene protein,23522,29,1.15 [0.68-1.96],0.5984333742949473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR1B,Cornifin-B,23936,31,1.13 [0.79-1.60],0.5087727956011896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR3,Small proline-rich protein 3,24309,30,0.86 [0.50-1.47],0.5777262799078906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRY2,Protein sprouty homolog 2,27532,33,0.95 [0.68-1.32],0.7409049941403368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23603,29,1.02 [0.33-3.17],0.9728276984580644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTLC1,Serine palmitoyltransferase 1,24309,30,0.75 [0.26-2.18],0.5935167918192559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRC,Proto-oncogene tyrosine-protein kinase Src,28072,35,0.89 [0.70-1.13],0.3273298071033169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRP14,Signal recognition particle 14 kDa protein,27925,35,1.45 [0.95-2.22],0.088163662516348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPK2,SRSF protein kinase 2,28032,35,0.91 [0.63-1.32],0.6267942660561734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPX,Sushi repeat-containing protein SRPX,24383,31,1.78 [0.66-4.82],0.2537688411695861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSB,Lupus La protein,27384,35,1.16 [0.74-1.82],0.5248090373592267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23683,29,0.78 [0.25-2.40],0.6616319474929261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,28021,34,0.78 [0.60-1.00],0.0543223159433513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28135,35,1.97 [0.99-3.88],0.0517311060657296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSH3,Protein phosphatase Slingshot homolog 3,23522,29,1.32 [0.45-3.85],0.6127611050829503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24290,31,1.18 [0.63-2.19],0.6059219291939846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST13,Hsc70-interacting protein,23831,30,1.23 [0.65-2.30],0.5244516874030081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",27925,35,0.75 [0.35-1.61],0.4626063303453538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28400,34,1.12 [0.41-3.06],0.8275057839702681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23683,29,1.76 [1.26-2.44],0.0008015177803079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAB2,Stabilin-2,24372,31,1.97 [0.60-6.44],0.2630961170883124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAM,Signal transducing adapter molecule 1,24264,30,0.84 [0.31-2.28],0.7338463368786554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAMBP,STAM-binding protein,27809,34,0.97 [0.60-1.55],0.8867591398924328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT2,Signal transducer and activator of transcription 2,23683,29,1.07 [0.68-1.67],0.7770223641623251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT5B,Signal transducer and activator of transcription 5B,27925,35,0.92 [0.74-1.14],0.4458657191687637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23522,29,0.91 [0.52-1.61],0.749723398115629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC1,Stanniocalcin-1,28318,34,1.00 [0.51-1.96],0.9968950375702548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC2,Stanniocalcin-2,28001,35,1.29 [0.39-4.27],0.6771024723171373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STEAP4,Metalloreductase STEAP4,23603,29,0.71 [0.37-1.34],0.285878807826149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STIP1,Stress-induced-phosphoprotein 1,27992,35,1.13 [0.72-1.76],0.6025202346330845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK11,Serine/threonine-protein kinase STK11,27549,34,0.97 [0.64-1.48],0.9022491691534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK24,Serine/threonine-protein kinase 24,27384,35,0.87 [0.53-1.41],0.5680171491624326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK4,Serine/threonine-protein kinase 4,28053,34,0.85 [0.60-1.21],0.3660441428353662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STOML2,"Stomatin-like protein 2, mitochondrial",23522,29,1.21 [0.90-1.62],0.2113058479698585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX16,Syntaxin-16,27370,35,1.06 [0.63-1.77],0.8269348349415467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX1B,Syntaxin-1B,23704,29,0.78 [0.28-2.18],0.6322549417219249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX3,Syntaxin-3,24309,30,1.34 [0.62-2.86],0.4539049078362999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX4,Syntaxin-4,27925,35,0.67 [0.36-1.25],0.2069036901644514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX5,Syntaxin-5,23683,29,1.32 [0.66-2.62],0.4320089362296905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX6,Syntaxin-6,27370,35,1.05 [0.67-1.63],0.8424460487224946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX7,Syntaxin-7,23683,29,0.87 [0.42-1.82],0.7158671017626874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX8,Syntaxin-8,28032,35,0.92 [0.50-1.71],0.7929420790657553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP1,Syntaxin-binding protein 1,24343,30,0.90 [0.58-1.39],0.6213005961641089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP3,Syntaxin-binding protein 3,27370,35,1.23 [0.67-2.26],0.5010819641139361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGP1,SURP and G-patch domain-containing protein 1,24290,31,0.49 [0.18-1.28],0.1454459471326434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGT1,Protein SGT1 homolog,27370,35,0.89 [0.61-1.28],0.52096526044095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT1A1,Sulfotransferase 1A1,28318,34,0.91 [0.73-1.14],0.4297347532728576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT2A1,Bile salt sulfotransferase,28032,35,1.67 [1.21-2.31],0.00191221987254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF1,Formylglycine-generating enzyme,23683,29,0.83 [0.43-1.60],0.5749868568097721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28318,34,0.75 [0.45-1.27],0.2854475361096329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUOX,"Sulfite oxidase, mitochondrial",24343,30,1.24 [0.75-2.04],0.3998644935443987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD1,Sushi domain-containing protein 1,27549,34,0.77 [0.42-1.42],0.405729432778986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD2,Sushi domain-containing protein 2,28041,35,2.45 [1.23-4.89],0.0112612035313473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD4,Sushi domain-containing protein 4,24264,30,0.86 [0.35-2.13],0.750236843016236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD5,Sushi domain-containing protein 5,23707,30,1.63 [0.60-4.40],0.3349746656313377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SV2A,Synaptic vesicle glycoprotein 2A,23704,29,1.00 [0.56-1.79],0.996730554937458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SWAP70,Switch-associated protein 70,24290,31,1.16 [0.48-2.82],0.7397024210738377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYAP1,Synapse-associated protein 1,23831,30,0.93 [0.51-1.72],0.8278625794650256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23603,29,0.87 [0.43-1.75],0.6868142519896372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYT1,Synaptotagmin-1,24309,30,0.33 [0.09-1.14],0.0791967691955512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYTL4,Synaptotagmin-like protein 4,24383,31,0.91 [0.56-1.46],0.6843436582607936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23936,31,0.83 [0.60-1.15],0.2708105335956849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACC3,Transforming acidic coiled-coil-containing protein 3,27925,35,0.85 [0.66-1.09],0.2052008964125873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,24908,30,1.23 [0.41-3.66],0.7123600455113652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TADA3,Transcriptional adapter 3,24264,30,1.67 [0.75-3.68],0.2073775456982397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,27925,35,1.49 [0.66-3.36],0.3327644575023914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAGLN3,Transgelin-3,23522,29,1.00 [0.55-1.82],0.999002368928432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TALDO1,Transaldolase,24294,31,1.42 [0.71-2.87],0.3208815450718767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TANK,TRAF family member-associated NF-kappa-B activator,27532,33,0.89 [0.57-1.39],0.601020394213654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAP1,Antigen peptide transporter 1,23936,31,0.58 [0.25-1.32],0.1953251166943517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARBP2,RISC-loading complex subunit TARBP2,27384,35,0.89 [0.60-1.30],0.5338285283053026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23704,29,0.93 [0.55-1.55],0.7674608042884494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24264,30,1.84 [0.84-4.04],0.1263628642629902
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAX1BP1,Tax1-binding protein 1,24309,30,0.92 [0.52-1.62],0.7650914722031403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D17,TBC1 domain family member 17,27384,35,1.76 [1.08-2.87],0.0235164328350646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D23,TBC1 domain family member 23,27925,35,0.70 [0.50-0.99],0.0454519506977878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D5,TBC1 domain family member 5,28032,35,0.73 [0.48-1.12],0.1504133790168831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCA,Tubulin-specific chaperone A,23831,30,1.09 [0.73-1.62],0.683960188514512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCB,Tubulin-folding cofactor B,27859,34,0.93 [0.70-1.25],0.646614877770357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCC,Tubulin-specific chaperone C,27859,34,0.92 [0.64-1.34],0.667468774329298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27370,35,0.81 [0.57-1.14],0.2254819223716457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBR1,T-box brain protein 1,23704,29,0.78 [0.32-1.92],0.5878882645902698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,27807,34,0.75 [0.56-1.01],0.0606688964189544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1B,T-cell leukemia/lymphoma protein 1B,27549,34,1.00 [0.68-1.47],0.9945320303006332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN1,Transcobalamin-1,23921,31,1.03 [0.40-2.67],0.9559115544433616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN2,Transcobalamin-2,28347,34,2.04 [0.87-4.80],0.1022529812313122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCOF1,Treacle protein,24383,31,1.45 [0.59-3.56],0.4151082676019803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCP11,T-complex protein 11 homolog,23936,31,0.79 [0.37-1.70],0.5471602765881933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCTN3,Tectonic-3,24383,31,1.35 [0.44-4.09],0.5979351578456789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDGF1,Teratocarcinoma-derived growth factor 1,27384,35,0.86 [0.69-1.08],0.2069366640131942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDO2,"Tryptophan 2,3-dioxygenase",23704,29,0.93 [0.36-2.39],0.8862373557854414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDP1,Tyrosyl-DNA phosphodiesterase 1,24264,30,1.03 [0.63-1.66],0.9177588919701608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDRKH,Tudor and KH domain-containing protein,27384,35,0.91 [0.63-1.31],0.5990869747501711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEF,Thyrotroph embryonic factor,23606,31,1.50 [0.79-2.84],0.2109867079758199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEK,Angiopoietin-1 receptor,28116,35,1.34 [0.35-5.04],0.6677693876492858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TERF1,Telomeric repeat-binding factor 1,23683,29,1.58 [0.54-4.57],0.4019135378181706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TET2,Methylcytosine dioxygenase TET2,23902,31,1.13 [0.86-1.49],0.3841520589500207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX101,Testis-expressed protein 101,23704,29,0.98 [0.50-1.91],0.9416061421446114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX33,Testis-expressed protein 33,23936,31,0.54 [0.17-1.73],0.3015809054102012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TF,Serotransferrin,24414,31,1.66 [0.35-7.91],0.5241447632411977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFAP2A,Transcription factor AP-2-alpha,23603,29,1.20 [0.70-2.04],0.5055905895735382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,27910,35,1.04 [0.73-1.49],0.8089083610017103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,28134,35,1.20 [0.74-1.93],0.4585724588534173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,28013,35,1.49 [0.94-2.37],0.0903194465947828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI,Tissue factor pathway inhibitor,27956,35,1.09 [0.43-2.75],0.8584300684205879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI2,Tissue factor pathway inhibitor 2,28023,35,1.15 [0.58-2.26],0.6931959138124378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFRC,Transferrin receptor protein 1,28150,35,0.88 [0.40-1.94],0.7599557470853135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TG,Thyroglobulin,24264,30,0.98 [0.70-1.36],0.8899371778408183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,28032,35,1.75 [1.03-2.98],0.0384679410672786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB1,Transforming growth factor beta-1 proprotein,28339,35,1.00 [0.48-2.12],0.9902871728618088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB2,Transforming growth factor beta-2 proprotein,24264,30,1.04 [0.55-1.99],0.8946441364081227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBI,Transforming growth factor-beta-induced protein ig-h3,27867,35,0.56 [0.18-1.70],0.3065925145390927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR1,TGF-beta receptor type-1,23683,29,1.66 [0.57-4.85],0.3539509437416335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,28116,35,1.46 [0.62-3.45],0.3869330085054773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR3,Transforming growth factor beta receptor type 3,28400,34,1.32 [0.50-3.49],0.5699401326625494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGM2,Protein-glutamine gamma-glutamyltransferase 2,27999,34,1.11 [0.74-1.66],0.6110965493305587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGOLN2,Trans-Golgi network integral membrane protein 2,24402,31,1.70 [0.48-6.08],0.4149719510020067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23476,29,1.12 [0.79-1.60],0.5271794431047871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBD,Thrombomodulin,28053,34,0.84 [0.28-2.56],0.7643968814191892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,28041,35,1.66 [0.84-3.27],0.142960427340315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,28055,35,1.78 [0.96-3.33],0.0691992009873129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THOP1,Thimet oligopeptidase,27934,33,2.53 [1.16-5.55],0.0203128662461743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THPO,Thrombopoietin,27549,34,0.60 [0.27-1.34],0.2148863555617146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THRAP3,Thyroid hormone receptor-associated protein 3,23606,31,0.97 [0.70-1.35],0.8660632780162867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THSD1,Thrombospondin type-1 domain-containing protein 1,23504,28,0.94 [0.32-2.76],0.9170097375825564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THTPA,Thiamine-triphosphatase,24212,30,1.05 [0.71-1.55],0.8122403034200096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THY1,Thy-1 membrane glycoprotein,28318,34,1.30 [0.44-3.84],0.6361955662512484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIA1,Nucleolysin TIA-1 isoform p40,27244,34,0.97 [0.75-1.24],0.7820437230084185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIE1,Tyrosine-protein kinase receptor Tie-1,28400,34,1.13 [0.53-2.40],0.7527527779671291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27334,35,1.13 [0.61-2.10],0.6977937996168342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23936,31,0.98 [0.38-2.55],0.9712801225296176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28135,35,2.13 [1.12-4.05],0.0208762795751392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24383,31,0.92 [0.39-2.16],0.8456336755298037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24309,30,0.86 [0.57-1.29],0.4576976266702792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,27725,35,1.35 [0.50-3.66],0.5550707032163724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP2,Metalloproteinase inhibitor 2,24383,31,1.40 [0.55-3.58],0.479563927718854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP3,Metalloproteinase inhibitor 3,28177,35,0.90 [0.71-1.14],0.3845150487327726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP4,Metalloproteinase inhibitor 4,28041,35,1.94 [1.01-3.72],0.0467611795793448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TINAGL1,Tubulointerstitial nephritis antigen-like,27970,34,1.38 [0.36-5.34],0.6424996904024729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJAP1,Tight junction-associated protein 1,28116,35,0.79 [0.55-1.14],0.2074902053096531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJP3,Tight junction protein ZO-3,23603,29,1.22 [0.57-2.62],0.609718131277297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TK1,"Thymidine kinase, cytosolic",23936,31,1.43 [0.85-2.42],0.1757878931129988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR1,Toll-like receptor 1,23683,29,2.71 [0.99-7.39],0.0519146560919211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR2,Toll-like receptor 2,23936,31,0.77 [0.17-3.45],0.733154241043344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR3,Toll-like receptor 3,28389,35,1.04 [0.64-1.71],0.868928271190839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR4,Toll-like receptor 4,23683,29,1.46 [0.45-4.75],0.5309282339412411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23704,29,1.20 [0.63-2.28],0.5800795942485034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED1,Transmembrane emp24 domain-containing protein 1,23936,31,1.02 [0.56-1.88],0.9474138328677376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED10,Transmembrane emp24 domain-containing protein 10,23606,31,1.51 [1.09-2.09],0.0129957434799566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED4,Transmembrane emp24 domain-containing protein 4,23606,31,0.79 [0.37-1.67],0.5311813354116808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED8,Protein TMED8,24290,31,0.98 [0.71-1.36],0.91412913999081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM106A,Transmembrane protein 106A,24264,30,0.74 [0.45-1.23],0.2476471212149689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM132A,Transmembrane protein 132A,23705,29,0.90 [0.51-1.61],0.7327849209662867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM25,Transmembrane protein 25,24343,30,1.41 [0.78-2.56],0.2600996098619169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMOD4,Tropomodulin-4,23522,29,0.71 [0.28-1.77],0.4612640913583409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11B,Transmembrane protease serine 11B,23603,29,0.99 [0.61-1.60],0.954262927039812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11D,Transmembrane protease serine 11D,24255,30,0.93 [0.36-2.40],0.8817268272343743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS15,Enteropeptidase,27925,35,1.01 [0.72-1.42],0.9629267238459408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS5,Transmembrane protease serine 5,27714,34,1.56 [0.69-3.53],0.2909172475533355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,28041,35,1.05 [0.71-1.54],0.819121619719932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNC,Tenascin,28135,35,1.48 [0.82-2.70],0.1945832503605644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNF,Tumor necrosis factor,27500,34,1.25 [0.64-2.43],0.5174172650306135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24290,31,1.15 [0.62-2.13],0.654382069653539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27532,33,0.87 [0.37-2.06],0.7519975498330388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23831,30,0.80 [0.46-1.41],0.4461853175359982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27859,34,2.37 [1.25-4.48],0.0080350023922013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27859,34,1.35 [0.95-1.93],0.0914158922237356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,28105,34,1.03 [0.55-1.91],0.9248641442455175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28389,35,1.34 [0.63-2.86],0.4492348738754768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,28032,35,0.92 [0.34-2.48],0.8669415088612483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28116,35,1.33 [0.60-2.97],0.4835277798189227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,28082,35,1.07 [0.43-2.65],0.8881810564842236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27532,33,1.05 [0.52-2.11],0.885688075793919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,28082,35,0.78 [0.29-2.12],0.6229016633297129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23831,30,0.69 [0.29-1.64],0.3964177719585027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28300,35,0.58 [0.21-1.61],0.2940058224661928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,28041,35,2.45 [1.01-5.96],0.0478600343926427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,28041,35,1.71 [1.08-2.71],0.0215686211217369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28318,34,1.91 [0.67-5.44],0.2225532834559967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28339,35,1.68 [0.82-3.45],0.1538536394291659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27859,34,1.80 [1.19-2.72],0.0056304911144081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28318,34,1.80 [1.03-3.15],0.0400011883689347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27859,34,1.85 [1.12-3.07],0.0169535519660878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28389,35,0.78 [0.25-2.41],0.669766869684667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF11,Tumor necrosis factor ligand superfamily member 11,28032,35,1.05 [0.65-1.70],0.8312503164282725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28389,35,0.62 [0.22-1.73],0.3581566147844743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13,Tumor necrosis factor ligand superfamily member 13,28177,35,2.88 [1.06-7.84],0.0381717006977186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28347,34,3.37 [1.61-7.04],0.0012399247621974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF14,Tumor necrosis factor ligand superfamily member 14,27859,34,1.19 [0.72-1.97],0.506020670255017
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24372,31,2.10 [0.97-4.56],0.060099533950532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNIP1,TNFAIP3-interacting protein 1,24309,30,0.90 [0.60-1.34],0.596561904628159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNN,Tenascin-N,24372,31,1.36 [0.63-2.91],0.4301896174770705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNNI3,"Troponin I, cardiac muscle",27549,34,1.05 [0.72-1.54],0.7838190127269685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNPO1,Transportin-1,23936,31,1.25 [0.52-3.01],0.6202477825993773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNR,Tenascin-R,27859,34,0.54 [0.27-1.09],0.0836992328823458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNXB,Tenascin-X,28041,35,1.63 [0.55-4.84],0.3784335809583545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24383,31,1.02 [0.66-1.57],0.9372708358428375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1,DNA topoisomerase 1,24290,31,0.79 [0.60-1.06],0.1168783520362905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1MT,"DNA topoisomerase I, mitochondrial",23522,29,1.58 [1.00-2.50],0.0479460925126764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP2B,DNA topoisomerase 2-beta,23683,29,1.15 [0.75-1.76],0.5139673955699228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOR1AIP1,Torsin-1A-interacting protein 1,23705,29,0.90 [0.45-1.80],0.7637812746826274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53,Cellular tumor antigen p53,27370,35,1.29 [0.68-2.46],0.4317418206253713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53BP1,TP53-binding protein 1,23683,29,1.09 [0.73-1.64],0.6749292644667039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53I3,Quinone oxidoreductase PIG3,23311,29,1.48 [0.79-2.77],0.2241410953064138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27549,34,0.46 [0.11-1.81],0.2630083795356565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP73,Tumor protein p73,23704,29,0.49 [0.17-1.39],0.1785806260506602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPBGL,Trophoblast glycoprotein-like,23704,29,0.86 [0.33-2.25],0.7654399902950736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPD52L2,Tumor protein D54,23831,30,0.95 [0.69-1.30],0.7370039899036431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPK1,Thiamin pyrophosphokinase 1,24383,31,1.05 [0.33-3.37],0.9401175629077472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPM3,Tropomyosin alpha-3 chain,23606,31,0.86 [0.38-1.97],0.7260446210673875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPMT,Thiopurine S-methyltransferase,27370,35,1.23 [0.84-1.79],0.2818047654083905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPP1,Tripeptidyl-peptidase 1,27855,35,0.80 [0.41-1.56],0.5177263723398251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP2,Tubulin polymerization-promoting protein family member 2,23936,31,0.77 [0.46-1.30],0.3335037203521732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP3,Tubulin polymerization-promoting protein family member 3,27384,35,1.26 [0.68-2.35],0.46466442016277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPR,Nucleoprotein TPR,23606,31,1.02 [0.52-1.98],0.96338629828477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPRKB,EKC/KEOPS complex subunit TPRKB,23522,29,1.49 [1.10-2.03],0.0097409920104171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSAB1,Tryptase alpha/beta-1,28338,35,1.50 [0.83-2.70],0.1751018197033696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSD1,Tryptase delta,24343,30,1.00 [0.39-2.57],0.992636504382115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSG1,Tryptase gamma,23683,29,1.57 [0.56-4.46],0.3922140813657444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPT1,Translationally-controlled tumor protein,27532,33,0.93 [0.55-1.57],0.7760057869492778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF2,TNF receptor-associated factor 2,28032,35,0.91 [0.59-1.39],0.6630264696238002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23683,29,1.39 [0.67-2.88],0.3765428103636098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23606,31,0.54 [0.20-1.45],0.2192786229227753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23936,31,0.89 [0.58-1.37],0.5961022418723336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREH,Trehalase,24372,31,1.16 [0.74-1.84],0.5158224192111595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREM2,Triggering receptor expressed on myeloid cells 2,28032,35,1.63 [0.98-2.69],0.0573320703723102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML1,Trem-like transcript 1 protein,24402,31,0.73 [0.38-1.42],0.3595518939993711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML2,Trem-like transcript 2 protein,28041,35,1.16 [0.48-2.79],0.7446049203440305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28300,35,0.95 [0.60-1.52],0.8356035356386098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM21,E3 ubiquitin-protein ligase TRIM21,28032,35,0.86 [0.58-1.26],0.4324334957949716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM24,Transcription intermediary factor 1-alpha,23886,31,0.88 [0.51-1.51],0.6334881784647157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24290,31,0.95 [0.69-1.29],0.7363490534092705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM26,Tripartite motif-containing protein 26,23522,29,1.33 [0.85-2.07],0.2061889566068871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM40,E3 ubiquitin ligase TRIM40,23704,29,1.04 [0.64-1.67],0.8789539932319659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM5,Tripartite motif-containing protein 5,28032,35,0.81 [0.58-1.15],0.2412497469885502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM58,E3 ubiquitin-protein ligase TRIM58,24264,30,0.81 [0.54-1.21],0.2996334798513235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRPV3,Transient receptor potential cation channel subfamily V member 3,23606,31,1.02 [0.52-2.03],0.9476284371645938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC1,Hamartin,23683,29,1.32 [0.94-1.84],0.1074321865369892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC22D1,TSC22 domain family protein 1,24343,30,0.94 [0.56-1.59],0.8247327636249233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSHB,Thyrotropin subunit beta,28053,34,0.95 [0.63-1.44],0.8211263138728266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSLP,Thymic stromal lymphopoietin,27549,34,1.02 [0.61-1.68],0.9531691458375392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSNAX,Translin-associated protein X,23606,31,1.17 [0.50-2.74],0.7197588048801925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN1,Tetraspanin-1,27549,34,0.71 [0.31-1.60],0.4046945269982562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN15,Tetraspanin-15,23606,31,0.90 [0.42-1.92],0.7798089681902852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN7,Tetraspanin-7,23603,29,0.98 [0.66-1.46],0.9308194009693348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN8,Tetraspanin-8,24290,31,1.70 [1.24-2.34],0.0010674329093889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPYL1,Testis-specific Y-encoded-like protein 1,23683,29,0.87 [0.35-2.16],0.7671881606560444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TST,Thiosulfate sulfurtransferase,27345,35,0.78 [0.52-1.17],0.2226879715388925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTF2,Transcription termination factor 2,23704,29,0.80 [0.38-1.68],0.5523025512647222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTN,Titin,23606,31,0.93 [0.54-1.59],0.7786746934728443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTR,Transthyretin,24149,30,0.79 [0.21-2.95],0.7225919949522688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TUBB3,Tubulin beta-3 chain,23603,29,1.02 [0.30-3.45],0.9754357790757752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TWF2,Twinfilin-2,24372,31,1.00 [0.67-1.48],0.9949354525668336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXK,Tyrosine-protein kinase TXK,23936,31,0.65 [0.33-1.27],0.2039312916756199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXLNA,Alpha-taxilin,27859,34,0.84 [0.60-1.19],0.3279906255356946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXN,Thioredoxin,24009,31,1.60 [0.87-2.96],0.1307922963190799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC15,Thioredoxin domain-containing protein 15,28116,35,2.02 [0.75-5.43],0.1643222178643647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC5,Thioredoxin domain-containing protein 5,28318,34,0.98 [0.63-1.51],0.9201958334847872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC9,Thioredoxin domain-containing protein 9,24309,30,0.98 [0.51-1.87],0.9505468645502396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNL1,Thioredoxin-like protein 1,23560,29,1.01 [0.70-1.46],0.943420062302359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",28041,35,1.00 [0.53-1.89],0.9930501496733668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYMP,Thymidine phosphorylase,27882,33,1.00 [0.63-1.58],0.997611884379388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRO3,Tyrosine-protein kinase receptor TYRO3,28053,34,1.38 [0.47-4.02],0.5545694541925825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23683,29,0.91 [0.51-1.62],0.7528706930282205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBAC1,Ubiquitin-associated domain-containing protein 1,27925,35,2.05 [0.88-4.78],0.0951708239352344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2B,Ubiquitin-conjugating enzyme E2 B,24264,30,1.93 [0.70-5.31],0.20334055262861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24383,31,1.54 [0.92-2.58],0.0967892943969282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23683,29,1.54 [1.00-2.37],0.0508833086976059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,23606,31,1.31 [0.77-2.25],0.3225126071051366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBXN1,UBX domain-containing protein 1,23831,30,1.04 [0.63-1.71],0.8817387155079495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24290,31,0.96 [0.76-1.22],0.7420938853455743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UGDH,UDP-glucose 6-dehydrogenase,23606,31,0.98 [0.68-1.40],0.8951061082510737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UHRF2,E3 ubiquitin-protein ligase UHRF2,23606,31,1.64 [0.90-3.00],0.1071544290390751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ULBP2,UL16-binding protein 2,27859,34,1.83 [0.91-3.70],0.0923147217179674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UMOD,Uromodulin,28303,34,0.84 [0.49-1.43],0.5156669375716338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC5D,Netrin receptor UNC5D,23683,29,1.58 [0.53-4.68],0.4127030338038339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC79,Protein unc-79 homolog,23522,29,0.79 [0.40-1.57],0.5014435561444675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNG,Uracil-DNA glycosylase,24264,30,1.19 [0.47-2.98],0.7128833621991132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPB1,Beta-ureidopropionase,24383,31,1.43 [1.05-1.95],0.0215245426100685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3A,Uroplakin-3a,23603,29,1.31 [0.66-2.60],0.4354743671930903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3BL1,Uroplakin-3b-like protein 1,23896,31,0.94 [0.46-1.91],0.8581265454560921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROD,Uroporphyrinogen decarboxylase,23831,30,0.98 [0.59-1.63],0.9307944465044774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROS,Uroporphyrinogen-III synthase,23704,29,0.70 [0.38-1.29],0.2558660317536592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USO1,General vesicular transport factor p115,27925,35,0.94 [0.68-1.31],0.7218341129522297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24264,30,0.98 [0.61-1.56],0.9186733441531808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24309,30,1.19 [0.50-2.83],0.6914228856212252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23606,31,1.02 [0.69-1.51],0.9328468348798652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27549,34,0.99 [0.72-1.35],0.927795655307556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UXS1,UDP-glucuronic acid decarboxylase 1,27370,35,0.99 [0.55-1.79],0.970075162948022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP5,Vesicle-associated membrane protein 5,27549,34,1.49 [1.02-2.19],0.03962865142522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP8,Vesicle-associated membrane protein 8,23683,29,1.14 [0.77-1.68],0.5225004366750647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASH1,Tubulinyl-Tyr carboxypeptidase 1,28032,35,0.88 [0.61-1.27],0.4891792903916262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASN,Vasorin,27599,35,0.73 [0.25-2.18],0.5768435451432244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASP,Vasodilator-stimulated phosphoprotein,24402,31,0.95 [0.60-1.51],0.8352780771689693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,27925,35,0.31 [0.07-1.41],0.129145224809283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAV3,Guanine nucleotide exchange factor VAV3,23603,29,0.83 [0.58-1.19],0.3060469525143158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAM1,Vascular cell adhesion protein 1,28101,35,3.14 [1.24-8.00],0.0162668061022721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAN,Versican core protein,28318,34,2.69 [1.05-6.90],0.039278814753979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCPKMT,Protein-lysine methyltransferase METTL21D,23522,29,0.86 [0.53-1.42],0.5669228924254875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFA,Vascular endothelial growth factor A,28294,34,1.03 [0.62-1.72],0.9026831443027136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFB,Vascular endothelial growth factor B,23683,29,2.07 [0.65-6.53],0.2166564713652831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFC,Vascular endothelial growth factor C,28116,35,0.83 [0.49-1.39],0.4781355545264996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFD,Vascular endothelial growth factor D,28340,34,1.26 [0.55-2.89],0.5929973331826216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VGF,Neurosecretory protein VGF,24343,30,0.45 [0.14-1.46],0.183595739106236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIM,Vimentin,27549,34,1.12 [0.85-1.48],0.4204252149721771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIPR1,Vasoactive intestinal polypeptide receptor 1,23705,29,1.00 [0.24-4.15],0.9958977030675812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIT,Vitrin,24383,31,1.65 [0.68-4.00],0.2662360213596603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VMO1,Vitelline membrane outer layer protein 1 homolog,27925,35,0.91 [0.59-1.39],0.6545227980710948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN1,Pantetheinase,24402,31,1.04 [0.65-1.67],0.8543070125107682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN2,Vascular non-inflammatory molecule 2,27925,35,2.73 [1.34-5.56],0.0057912201193859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23936,31,0.97 [0.58-1.62],0.8992127661974003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS37A,Vacuolar protein sorting-associated protein 37A,27925,35,0.81 [0.55-1.19],0.2770361006779328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS4B,Vacuolar protein sorting-associated protein 4B,24264,30,0.94 [0.66-1.35],0.7507884491413245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS53,Vacuolar protein sorting-associated protein 53 homolog,27925,35,0.82 [0.55-1.23],0.3336312194087922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10,V-set and immunoglobulin domain-containing protein 10,24264,30,0.72 [0.25-2.11],0.5503028563505112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23606,31,0.41 [0.13-1.33],0.136470087536162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,24264,30,1.24 [0.71-2.16],0.4537555135878418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,28001,35,2.21 [1.16-4.22],0.0163357779487571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,28015,34,0.73 [0.43-1.24],0.2471824273122153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSNL1,Visinin-like protein 1,24309,30,0.98 [0.42-2.29],0.9628627102304352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM1,V-set and transmembrane domain-containing protein 1,27384,35,1.50 [0.86-2.62],0.1490399065084312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2B,V-set and transmembrane domain-containing protein 2B,23936,31,1.12 [0.51-2.45],0.7754357399050089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27549,34,0.76 [0.42-1.37],0.3583106728770403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28318,34,0.90 [0.59-1.37],0.6182858631137302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27370,35,0.64 [0.25-1.67],0.3657013804301832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23831,30,0.99 [0.54-1.81],0.9794717612972216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA1,von Willebrand factor A domain-containing protein 1,28263,35,1.57 [0.80-3.05],0.1877316604506372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA5A,von Willebrand factor A domain-containing protein 5A,23522,29,0.74 [0.39-1.37],0.3357418576486175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2,Brorin,27760,34,1.42 [0.67-3.01],0.3555324606322788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2L,von Willebrand factor C domain-containing protein 2-like,24343,30,0.77 [0.30-1.95],0.5786128215790795
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWF,von Willebrand factor,28400,34,0.90 [0.60-1.34],0.5933341756677419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WARS,"Tryptophan--tRNA ligase, cytoplasmic",28041,35,1.83 [0.85-3.95],0.1229890492537214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WAS,Wiskott-Aldrich syndrome protein,27532,33,0.86 [0.53-1.39],0.5309410198547906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF1,Wiskott-Aldrich syndrome protein family member 1,27549,34,0.82 [0.58-1.14],0.2376677667215924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF3,Wiskott-Aldrich syndrome protein family member 3,27384,35,1.01 [0.71-1.43],0.9526787662430906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASHC3,WASH complex subunit 3,24309,30,0.85 [0.53-1.37],0.5051117674266465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASL,Neural Wiskott-Aldrich syndrome protein,23683,29,0.96 [0.51-1.79],0.8944827001522311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WDR46,WD repeat-containing protein 46,24264,30,1.38 [0.65-2.96],0.4047803293468356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC1,WAP four-disulfide core domain protein 1,23785,27,1.02 [0.51-2.05],0.9544655181654876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC12,WAP four-disulfide core domain protein 12,28248,35,0.81 [0.51-1.31],0.3903273147328713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,26598,33,1.91 [0.97-3.75],0.0597050628605802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27771,34,0.47 [0.22-1.01],0.0521584876193916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",28082,35,0.59 [0.28-1.27],0.1787932604269325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,28300,35,1.30 [0.55-3.07],0.542610723037635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,27532,33,1.80 [0.73-4.40],0.1988397638216571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27859,34,0.72 [0.40-1.29],0.2683497678478552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XCL1,Lymphotactin,28300,35,1.36 [0.87-2.11],0.173395273101369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,28252,34,1.03 [0.39-2.68],0.9596844060542428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XIAP,E3 ubiquitin-protein ligase XIAP,23683,29,0.97 [0.53-1.80],0.9343000420850586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XPNPEP2,Xaa-Pro aminopeptidase 2,28116,35,0.86 [0.66-1.12],0.2708398563331348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XRCC4,DNA repair protein XRCC4,27384,35,0.97 [0.42-2.23],0.9453105715634168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,24309,30,1.96 [0.67-5.79],0.2212832452269709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24290,31,1.07 [0.85-1.35],0.5817087379607692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YES1,Tyrosine-protein kinase Yes,27925,35,0.85 [0.65-1.10],0.2127360685097745
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YJU2,Splicing factor YJU2,24264,30,1.44 [0.56-3.71],0.4522523781538692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YOD1,Ubiquitin thioesterase OTU1,23606,31,1.37 [0.80-2.34],0.2475089374799141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YTHDF3,YTH domain-containing family protein 3,27532,33,0.93 [0.65-1.34],0.7083616986409268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YWHAQ,14-3-3 protein theta,23831,30,0.98 [0.61-1.56],0.9343750825297248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YY1,Transcriptional repressor protein YY1,23683,29,1.98 [0.69-5.64],0.2010267850563953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBP1,Z-DNA-binding protein 1,23683,29,1.51 [0.82-2.81],0.1882906648422333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB16,Zinc finger and BTB domain-containing protein 16,27370,35,0.93 [0.61-1.43],0.7498023621042992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB17,Zinc finger and BTB domain-containing protein 17,27549,34,1.64 [1.01-2.66],0.0466572920214517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23606,31,0.90 [0.49-1.68],0.7511223865436086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZFYVE19,Abscission/NoCut checkpoint regulator,24290,31,0.92 [0.64-1.34],0.6655564217980259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZHX2,Zinc fingers and homeoboxes protein 2,24309,30,1.25 [0.56-2.77],0.5901974444359237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF174,Zinc finger protein 174,23683,29,1.83 [1.12-2.99],0.0162868212815067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF75D,Zinc finger protein 75D,23936,31,1.11 [0.67-1.86],0.6827755143848218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF830,Zinc finger protein 830,24264,30,1.37 [0.98-1.92],0.0672636416074829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRD2,Protein ZNRD2,24290,31,0.96 [0.59-1.58],0.8854028606596358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24264,30,1.10 [0.59-2.08],0.7588900662334769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP3,Zona pellucida sperm-binding protein 3,23705,29,1.01 [0.88-1.16],0.8970497154240114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP4,Zona pellucida sperm-binding protein 4,23522,29,0.30 [0.06-1.54],0.1500975818467372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZPR1,Zinc finger protein ZPR1,23603,29,0.95 [0.63-1.42],0.788277391041546
